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CHAPTER I 
 
INTRODUCTION 
 
1. Ion mobility-mass spectrometry as a tool for performing systems biology measurements 
Following the mapping of the human genome in the early 2000’s, biological research has 
experienced a significant shift in philosophy. Genetics research has followed a very successful 
practice of isolated and compartmentalized studies where a single particular gene is perturbed 
and then a single or suite of specific effects is monitored. These methods paved the way for the 
maturation of molecular biology and led to a wealth of information on many genes and gene 
clusters. However, an organism is not a collection of genes and proteins, but something much 
more; something that functions holistically and symbiotically, with all portions working in 
unison. Kitano described protein/gene network diagrams as being “analogous to a static 
roadmap, whereas what we really seek to know are the traffic patterns, why such traffic 
patterns emerge, and how we can control them”.1 This ideology of treating and analyzing 
organisms as a whole as opposed to their isolated parts has become the basis of systems 
biology. 
Systems biology seeks to describe the function of a biological system using a holistic, 
multiscale approach. This approach encompasses the analyses of molecular classes such as the 
genome, transcriptome, proteome, and metabolome (among others) of a biological system. 
Systems biology asserts that while understanding genes and proteins is important, the most 
important aspects going forward are more closely related to the system’s network structure and 
network dynamics.1 Researchers of systems biology have adopted a hybrid discovery-
driven/hypothesis-driven approach to meet these challenges. The first step of this proposed 
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approach is to define all of the components in the system. Then, by systematically perturbing 
this system, while monitoring all of these components, one is able to use computational 
biological methods to generate a network structure model of what is observed. This model will 
define all components of the system in terms of their mathematical relationship with all other 
components. With this model in hand the researcher/computational method generates a new 
perturbation that best tests that network structure model. From here, subsequently more 
refined models are produced until all perturbation reactions can be justified by the model.2 
This type of experiment can be translated into many bioanalytical fields and techniques 
(Table 1.1). Some fields (e.g., genomics) have defined their entire component set, while others 
are well on their way (e.g., proteomics), or are in the early stages (e.g., metabolomics). Crucial 
to this endeavor has been the establishment of internet-based databases.3 Moving forward 
additional techniques are required to sample the dynamics of cellular events and make systems 
biology measurements. Ideally this measurement should monitor as many analytes as possible 
and as frequently as possible in order to garner the most complete picture of the organism as a 
whole. It is the goal of this work to show that ion mobility and mass spectrometry are uniquely 
qualified to make these fast and broad measurements. 
 
2. Overview and theory of ion mobility separations  
A recent advance in mass spectrometry (MS) instrumentation is the incorporation of 
post-ionization separations on the basis of ion mobility (IM) combined with subsequent MS 
analysis (IM-MS). Importantly, IM-MS adds an additional dimension of separations on the basis 
of analyte structure to facilitate interpretation of MS spectra directly from complex biological 
samples. Typically, separations in the IM dimension are completed in hundreds of microseconds 
to milliseconds and yield direct structural information (ion–neutral collision cross sections, or   
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Table 1.1. A table of some of the more popular/recent techniques for performing 
systems biology measurements. Also listed are some general capabilities and limitations 
associated with each technique. Representative references for each technique are 
noted in brackets. 
 
DNA sequencers/ DNA microarrays [4-6] 
 
 
Capabilities 
 Genomes can generally be fully mapped 
 High-throughput 
 Genomes are largely static 
Limitations 
 No direct indication of phenotype 
 Gene network associations must be 
inferred, limiting disease prediction 
abilities 
   
MS-based proteomics [7-10] 
 
 
Capabilities 
 More descriptive than genome 
 High-throughput 
 
Limitations 
 Reproducibility can be problematic 
 Post translational modifications can be 
difficult to observe 
   
MS-based metabolomics [11-14] 
 
 
Capabilities 
 Potentially most indicative of phenotype 
 Provides ability to infer metabolism all 
the way up to genotype 
 
Limitations 
 Most transient/difficult to measure 
 Metabolite databases are largely 
incomplete 
   
Yeast two-hybrid (Y2H) [15,16] 
 
 
Capabilities 
 No protein manipulation required 
 Simple and inexpensive 
 Scalable and amenable to automation 
Limitations 
 Intrinsic caveats related to yeast 
expression and nuclear localization 
 High false positive/false negative rates 
   
Protein-protein immunoprecipitation-mass spectrometry (IP-MS) [17,18] 
 
 
Capabilities 
 Gold standard of protein-protein 
interactions 
 Tagging strategies negate need for 
specific antibodies 
Limitations 
 Only applicable to suspected interaction 
partners 
 Not high-throughput 
 High false positive/false negative rates 
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apparent ion surface area in Å2) for analytes. These characteristics make IM-MS a unique fit for 
exploring the temporal and spatial biomolecular complexities of biological systems, ranging from 
single cell measurements to groups of cells in culture to entire organisms. 
Although gas-phase IM separations have existed for well over a century19 and coupling 
IM–MS has existed since the early 1960s,20,21 the utility of IM-MS for biomolecular separations 
was not fully realized until combined with soft ionization techniques, such as electrospray 
ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI).22-26 Following these 
pioneering studies, research recently has extended IM-MS techniques to the study of various 
biological fields, such as small molecule analyses,27-32 proteomics,33-39, viral assembly studies,40-42 
non-covalent complexes,43-45 or directly from thin tissue sections.46,47 Despite this recent 
expansion, IM-MS was only introduced commercially in 2006. Before that time, this technology 
was only available to those who could build the instruments themselves or get access to a 
custom built instrument. 
Ion mobility-mass spectrometers are composed of an ion source, a mobility separation 
cell, a mass analyzer, and a detector as depicted in Fig. 1.1(a). There are many variations to the 
general design such as different ion sources (i.e., ESI, MALDI) and types of ion mobility 
separation cells used (i.e., whether the ions are dispersed in space or time). For imaging IM-MS 
applications typically time-of-flight (TOF) mass analyzers are used for timescale considerations 
as described below. This work focuses on temporal ion dispersion through the use of drift tube 
ion mobility or traveling wave ion mobility (DTIM and TWIM, respectively). In contrast with high-
energy ion–neutral gas-phase collisions used in collision-induced dissociation (CID), both DTIM 
and TWIM separations utilize low-energy gas-phase collisions to separate ions on the basis of 
predominantly molecular surface areas. Briefly, gas-phase ions are injected into a drift tube 
filled with a neutral drift gas and migrate under the influence of a weak electrostatic field 
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gradient (Fig. 1.1(b)). This field is electrostatic for drift tube and electrodynamic for traveling 
wave separations, respectively. The migration of these ions is impeded by collisions with the 
neutral drift gas to a degree that is proportional to apparent surface area or collision cross 
section. To a first approximation, these collisions are assumed to be completely elastic and the 
conditions of the cell (i.e., electric field, temperature, and gas number density) are tuned such 
that the collisions are of sufficiently low energy to avoid inducing any structural or chemical 
changes. Thus, the elution order of ions is based upon their gas-phase packing density (i.e., the 
physical density to which the individual molecule is folded and packed) in the gas-phase. Thus, 
larger ions have a lower mobility than smaller ions which result in longer drift times versus 
shorter drift times, respectively. Although the experimental parameter obtained from IM 
separations is the ion arrival time distribution (tatd) or the time between ion injection and ion 
detection, it can be converted to collision cross section or apparent surface area as illustrated in 
Fig. 1.1(c). 
 
3. Transforming drift time to collision cross section 
This section details how arrival time distributions may be converted to collision cross 
sections based on the kinetic theory of gases for drift tube separations. Derivations of the ion–
neutral collision cross section theory can be found in several excellent texts and reviews.48-50 
Procedures to estimate collision cross section using traveling wave IM are described 
elsewhere.31,51-59  
The separation of ions in a weak electrostatic field (E) is measured as the ion drift 
velocity (vd) and is related by the proportionality constant, K, which is the mobility of the ion in a 
particular neutral gas: 
     [1] 
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Figure 1.1. (a) A block diagram of the primary components of biological IM-MS instrumentation. (b) A 
conceptual depiction of an IM drift cell. A stack of ring electrodes are connected via resistors in series to 
form a voltage divider, which is typically designed to generate a relatively uniform electrostatic field 
along the axis of ion propagation. Ions of larger apparent surface area experience more collisions with 
the neutral drift gas and therefore elute slower than ions of smaller apparent surface area. (c) A 
hypothetical IM separation for peptide ions exhibiting two distinct structural sub-populations 
corresponding to globular (left) and to helical (right) conformations. The arrival time distribution data 
(top axis), or what is measured, can be transformed to a collision cross section profile (bottom axis) via 
equation [4]. Reprinted from reference 60. 
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The drift cell is of a fixed length (L), and the velocity of the ion packet is determined by 
measuring the drift time (td) of the packet across the drift cell. In evaluating K, the drift velocity 
of the ion packet depends not only on the electrostatic field strength but also on the pressure 
(p, Torr) of the neutral drift gas and the temperature (T, kelvin) of separation. Therefore, it is 
conventional practice to report K as the standard or reduced mobility (K0), which normalizes the 
results to standard temperature and pressure conditions (i.e., 0° C and 760 Torr): 
 
    
 
   
   
 
 
[2] 
 
For applications where IM is used to obtain structural information about the ion, such as 
those in structural proteomics and biophysics, the IM separations are performed using weak 
electrostatic fields (ca. 20–30 V cm−1 Torr−1). Provided the field strength is sufficiently weak, or 
under so-called low-field conditions, a closed equation for the ion–neutral collision cross section 
can be expressed from the kinetic theory of gases. For electrostatic fields higher than the low 
field limit, the ion velocity distribution depends less strongly on the temperature of the 
separation and the mean ion energy increases as it traverses the drift region. Consequently, K is 
no longer constant and depends on the specific ratio of the electrostatic-field to the gas number 
density (E/N) (See Ref. 50 for a derivation of calculating the low field limit for a particular 
analyte.). When the IM separations are performed in low-field conditions, (i.e., constant K) the 
mobility is related to the collision cross section of the ion–neutral pair: 
 
   
        
  
  
        
[
 
  
 
 
  
]
      
 
 
   
 
  
 
 
 
[3] 
 
where these parameters include the charge of the ion (ze), the number density of the drift gas at 
STP (N0, 2.69×10
19 cm−3), the reduced mass of the ion–neutral collision pair (ion and neutral 
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masses of mi and mn, respectively), Boltzmann’s constant (kB), and the ion–neutral collision cross 
section (Ω). Inspection of equation [3] shows that the mobility of an ion is inversely related to its 
collision cross section or apparent surface area. Substituting for K0 in equation [3] and 
rearranging to solve for the collision cross section yields: 
 
  
        
  
  
        
[
 
  
 
 
  
]
      
 
   
 
 
   
 
  
 
[4] 
 
which is the typical functional form of the equation used to solve for collision cross sections 
from IM data. Conceptually, the ion–neutral collision cross section can be thought of as the 
radius of the orientationally averaged projection of the ion in combination with the drift gas, i.e., 
Ω = π (ri+rHe)
2, as depicted in Fig. 1.2(a).49 
In equations [3] and [4], the collisions of ions with neutrals are considered to be a 
completely elastic process (Fig. 1.2(a), (b)). Thus, the collision cross section obtained is termed 
the hard-sphere collision cross section. When compared to molecular simulations, these 
collision cross section measurements can provide detailed structural information about the 
analyte.61-64 
 
4. Data interpretation in conformation space 
Typical data for a 2D IM-MS separation are presented in Fig. 1.3 for the separation of 
lipids and oligonucleotides. Conformation space data (Fig. 1.3(a)) are termed such because they 
represent biomolecular conformation, or structure, as a function of m/z. Presentation of 3D 
conformation space data (IM arrival time distribution, m/z, and signal intensity) is typically 
projected with false coloring or grey scale representing signal intensity. An integrated mass 
spectrum over all arrival time distributions, which is what would be observed in the absence of 
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Figure 1.2. (a) Illustrative representation of the ion-neutral collision cross section. Also depicted is an 
example of an elastic collision where the total kinetic energy of the neutral gas molecule (small sphere) 
and the analyte ion (large sphere) prior to collision is equal to their kinetic energy following the 
collision. (b) Representation of an inelastic collision, where some amount of kinetic energy is lost 
through the collision process. 
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IM is shown in Fig. 1.3(b). An integrated IM arrival time distribution is illustrated by the white 
curve of Fig. 1.3(c). This would be obtained by placing the detector directly after the IM drift cell. 
By plotting the data in 2D conformation space two distinct correlations are observed, one for 
lipids and one for oligonucleotides. Note that either extracted mass spectra or arrival time 
distributions can be derived from conformation space data. For example, an extracted arrival 
time distribution over the m/z range of 860–870 is represented by the gray curve in Fig. 1.3(c). 
This extracted arrival time distribution region illustrates the baseline resolution achieved for a 
sodium coordinated lipid (sphingomyelin 44:1, m/z = 866.7 Da) and a protonated 
oligonucleotide (CGT, m/z = 860.2 Da) of nearly the same m/z. One of the main challenges in the 
analysis of complex biological samples is the large diversity of molecular species with the high 
probability for isobaric molecules at a particular m/z. Structural separations on the basis of ion 
mobility allow isobaric species belonging to different biomolecular classes to be easily resolved 
(Fig. 1.4), resulting in more confident peak assignments. Although biomolecules are generally 
composed of a limited combination of elements (e.g., C, H, O, N, P, and S), different 
biomolecular classes preferentially adopt structures at a given m/z correspondent to the 
prevailing intermolecular folding forces for that class. A hypothetical plot delineating regions of 
conformation space for which different biomolecular classes (e.g., nucleotides, carbohydrates, 
peptides, and lipids) are predicted to occur is presented in Fig. 1.4(a). This is a result of different 
average densities for different molecular classes (nucleotides > carbohydrates > peptides > 
lipids65). Although more pronounced for an m/z range over 2,000, at lower ranges as that 
depicted in Fig. 1.4(b) separations are still feasible but the correlations begin to overlap.  
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Figure 1.3. (a) A 2D IM-MS conformation space plot for several lipid and oligonucleotide standards. This 
data illustrates the variation of gas-phase packing efficiencies for different types of biomolecules. (b) An 
integrated mass spectrum over all arrival time distributions. (c) The white curve represents the 
integrated arrival time distribution over the mass range of 500-1200 m/z, whereas the grey curve 
represents an extracted arrival time distribution over the mass range of 860-870 m/z. The latter 
illustrates baseline resolution of two peaks with similar masses but different mobilities (lipid-
[sphingomyelin 44:1+Na]+, m/z = 866.7 Da; oligonucleotide- [CGT+H]1, m/z = 860.2 Da). Figure reprinted 
from reference 60.  
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Figure 1.4. (a) A hypothetical plot illustrating the differences in IM-MS conformation space for different 
molecular classes based on different gas-phase packing efficiencies. (b) A plot of collision cross section 
as a function of m/z for different biologically-relevant molecular classes, including: oligonucleotides (n = 
96), carbohydrates (n = 192), peptides (n = 610), and lipids (n = 53). All species correspond to singly-
charged ions generated by using MALDI, where error ±1σ is generally within the data point. Values for 
peptides species are from Ref. 66. Reprinted from reference 60.  
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5. Peptide and protein analysis using ion mobility-mass spectrometry techniques 
One of the main applications of IM-MS to bioanalytical fields has been to study peptides 
and proteins. Contemporary proteomics research generally involves either structural/functional 
proteomics or comprehensive protein identification from complex biological samples. 65,67-70  
The native-state structures of large proteins and other biological molecules adopt 
conformations that regulate biological function. Detailed geometries of native state structures 
are typically obtained by using nuclear magnetic resonance71-73 and X-ray crystallography.74-77 
Although these are considered the gold standards for structure elucidation they both have 
attendant limitations. Structural elucidation by nuclear magnetic resonance (NMR) generally 
requires highly purified samples and is generally applicable only to proteins of moderate size. X-
ray crystallography requires that the protein can be crystalized, which can be exceptionally 
challenging for membrane-bound and highly flexible proteins. The conformational changes 
associated with macromolecules in solution-phase, or in gas-phase, are due to transitions 
between native and denatured states, sometimes through thermodynamically stable 
intermediates. Some conformational changes associated with large biological molecules in 
solution are retained in the gas-phase.78-80 Thus, advances in gas-phase structural 
determinations may provide a unique means for performing structural proteomics directly from 
complex samples. 
Rapid peptide and protein identification is facilitated by advances in liquid 
chromatography (LC) combined with electrospray ionization (ESI); this combination has resulted 
in reliable interfaces necessary for quantitative bioanalyses using LC-MS and LC-MS/MS. 
Although LC-MS/MS, combined with bioinformatics, is the work-horse in contemporary MS-
based proteomics research, there remain several significant challenges, including: (i) long 
analysis times, (ii) limited concentration dynamic range, (iii) poor detection of low abundance 
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species (e.g., post-translationally modified proteins), and (iv) simultaneous detection of proteins 
with widely varying physical properties (e.g., hydrophobicity, pI). 
Gas-phase IM-MS separations combined with LC-IM-MS and LC-IM-MS/MS can now 
address, in part, several of these challenges.34,35,37,81-86 By performing separations in the gas-
phase, rather than the liquid-phase, IM separation speed is on the timescale of milliseconds. 
This is well suited for coupling with MS, whereby hundreds of mass spectra can be acquired 
across the IM elution profile and then subsequently stitched together to provide a 2D plot of IM 
vs. mass spectra. For example, a single plasma profiling experiment using 2D LC coupled with 
IM-MS can be completed in ca. 3 h, which is nearly an order of magnitude faster than is required 
for conventional LC-MS/MS.87 
 
A. Characterizing and interpreting peptide and protein structure 
 An increasing amount of research is focused on utilizing IM-MS for the determination 
and characterization of peptide and protein structure in support of structural proteomics, and 
these advances will be important in drug discovery. In this context absolute collision cross 
sections (CCS) are obtained using DTIM instruments and are then interpreted utilizing quantum 
mechanical and molecular dynamics calculations.  
 
(i). Applications of IM-MS to peptide and protein characterization 
IM-MS studies can now be used to structurally characterize peptide systems consisting 
of a few to many amino acids. Further, the approach can be even extended to massive protein 
complexes in structural biology. When combined with LC approaches, IM-MS can be used to 
detect trace level proteins that are present in complex samples such as human urinary and 
plasma samples.34,37,84 A survey of studies using IM-MS to investigate the structural biophysics of 
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model peptides and proteins is presented in Table 1.2. A summary of studies aimed at 
instrumentation for the study of peptides and proteins, proteome profiling, and medicinal 
research is presented in Table 1.3. 
IM-MS can be used to examine the detailed structures of amino acids, as illustrated by 
the work of Bowers group in their gas-phase studies of cationized glycine. This work showed 
that these molecular ions mostly exhibit charge-solvation structures.88 Small alkali ions (e.g., 
sodium) bind to both the N- and the C-terminus whereas larger alkali ions (e.g., rubidium and 
cesium) bind preferentially to the C-terminus.88 The stabilization of the charge-solvation 
structure compared to that of the salt bridge is larger for GlyCs+ than for GlyNa+. The approach is 
to use a high pressure drift cell with ESI introduction and augment with molecular dynamics 
calculations.89 The outcome shows that solvating water molecules primarily bind to the ionic 
functional groups present in peptides. Density functional theory (DFT) calculations for dipeptide 
ions ([Gly-Gly + H+]+, [Gly-Ala + H+]+, [Ala-Gly + H+]+, [Ala-Ala + H+]+, [Pro-Gly + H+]+ and [Gly-Trp + 
H+]+)90 show that the dominant water adsorption process involves a significant conformational 
change to accommodate the bridging water molecule. Molecular modeling and DFT calculations 
of deprotonated dimers of alanine and glycine91 indicate that the charge is poorly shielded and 
readily available for non-covalent interaction with other molecules. 
High-resolution IM measurements and molecular dynamics simulations of larger 
systems, namely protonated polyglycine and polyalanine (GlynH+ and AlanH+, where, n = 3 - 20) 
in the gas-phase, can also be done, as illustrated by the Jarrold group.92 They found that the 
measured CCS for both the polyglycine and the polyalanine peptides are consistent with a self-
solvated globule conformation. Here the change in conformation is due to the peptide chain 
wrapping around the charge located on the terminal amine. The conformations of unsolvated 
leucine-based peptides form helices more readily than alanine, but less readily than valine (Val >  
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Table 1.2. Listing of biophysical studies of model peptides and proteins. Table reprinted from reference 93. 
Model Systems – Peptides/Proteins  Type of Study  References 
Alanine, Glycine, Arginine, mod AA 
gas-phase conformations noncovalent or 
cation/peptide interaction 
88,89,94 
Ala, Gly, Pro, Trp based dipeptides, poly (Ala) folding, gas-phase conformations, helices and sheets 89-91,95,96 
Modified pentapeptides 
 
hydration and folding 90,92,97-112 
poly (Gly) and modified poly (Gly) gas-phase conformations, helices and sheets 
92,100,105,106,110,11
1,113,114 
poly (Pro) anhydrous helices/globules 115 
poly (TrpGly) gas-phase conformations 116 
modified poly (Leu), poly (Val) helices and sheets 100 
di-AA clusters gas-phase conformations, noncovalent interactions 95 
Serine clusters noncovalent or cation/peptide interaction 117-119 
Proline clusters gas-phase conformations 120,121 
Amyloid beta protein gas-phase conformations, noncovalent interactions 89,94 
Angiotensin II noncovalent or cation/peptide interaction 122 
Apomyoglobin gas-phase conformations 123,124 
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Table 1.2, continued   
BPTI (bovine pancreatic trypsin inhibitor) hydration and folding 26,125-127 
Bradykinin H/D exchange, noncovalent interaction 25,89,98,122,128,129 
Bradykinin fragment 1-5 (RPPGF) H/D exchange 130 
Cytochrome C gas-phase conformations 26,124,126,131-135 
Defensins (beta-def., P-defensin DEFB107) gas-phase conformations, hydration and folding 136,137 
Dynorphin fragments noncovalent or cation/peptide interaction 122,138 
mini Gastrin I peptide noncovalent or cation/peptide interaction 138 
Gonadotropin-releasing hormone gas-phase conformations, hydration and folding 136 
Gramicidin S gas-phase conformations 122,139 
Hemoglobin gas-phase conformations, HD exchange 140 
oxidized Insulin chain A (ICA) noncovalent or cation/peptide interaction 98,141 
Kemptide noncovalent or cation/peptide interaction 122 
LHRH (leutenizing hormone releasing hormone) hydration and folding 89 
Lysozyme gas-phase conformations, hydration and folding 66 
Beta(2)-microglobulin (beta(2)m) gas-phase conformations, folding, aggregates 142 
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Table 1.2, continued   
Myoglobin gas-phase conformations, hydration and folding 89 
Neurotensin gas-phase conformations, hydration and folding 89,94,96 
Oxytocin cation/peptide interaction 143,144 
Alpha Synuclein noncovalent interaction 145,146 
Ubiquitin gas-phase conformations, hydration and folding 147-154 
Mobility and CCS database of ESI peptides gas-phase conformations 155-157 
CCS database of MALDI (singly charged) 
peptides 
gas-phase conformations 66 
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Table 1.3. Topical listing of IM-MS studies related to instrumentation, proteome profiling, and medicinal research. Table reprinted 
from reference 93. 
Topics  References 
 
Proteomics 
 
Collision Induced Activation 158-161 
Combinatorial studies 162 
Conserved solution-phase structure 148,163-165 
H/D exchange/labeling structure study 107,137,166-169 
IM-(CID, SID)/MS 35-38,84-86,161,167,170-185 
IM-MS resolution/separation power 
70,81-85,95,156-159,161,163,167,169,171-
174,180,181,183-197 
IM-MS enhanced detection 157,190,192 
Instrumental advances 35,84,85,157,160,161,170-174 
 
 
Ionization type: 
 
ESI studies 
34-38,81-87,95,137,156-160,162,167,170,171,173-
188,197 
MALDI studies 70,163,169,172,189-196 
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Table 1.3, continued  
Peak Capacity of IM-MS approach 185,194,195 
Peptide libraries 82,83,95,174,181,183,186-190,193,195 
Peptide aggregation in gas-phase 95,98,137,198-200 
Peptide Mobility/CCS Prediction Algorithm 155,201-207 
Phosphorylated Peptides 186,191,193 
 
 
Proteome profiling 
 
Drosophila 35,85,86,175-179 
Human urinary proteome 84 
Human plasma proteome 34,37 
 
 
Medicinal research 
 
Alzheimer’s disease 94,198-200,208-211 
Parkinson’s disease 145,146,176-179 
Huntington’s disease 38 
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Table 1.3, continued  
Other 37,84,137,144,197,212,213 
Shift Reagents 188 
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Leu > Ala).100 Interestingly, the side-chain entropy is not the determining factor in helix 
formation when dealing with unsolvated peptides. 
IM-MS methods combined with molecular modeling calculations can be used to 
examine the conformations and charge states of polyproline peptides, [Pron + zH]z+ (where n = 3-
56; and z = 1-6), as was demonstrated by Clemmer and coworkers.115 Their investigations show 
that all proline residues are in the cis configuration, and protonation at the N-terminus allows 
hydrogen bonds to be formed with backbone carbonyl groups of the second and third proline 
residues in each polyproline chain. Protonation at the N-terminus also stabilizes the helix 
macrodipole. Singly charged ions formed from aqueous solutions favor globular and hairpin-like 
conformers that contain both cis- and trans-proline residues, whereas higher charge state ions (z 
= 3-6) formed from aqueous solutions favor relatively extended conformations. With the 
increase in the number of proline residues, however, higher charge state ions became more 
compact. Similar studies can be performed on serine clusters118 by using a sonic-spray ionization 
method in an IM-MS instrument. Experimentally derived cross sections with values calculated 
for trial geometries indicate that large clusters favored tightly packed, roughly spherical 
geometries. 
The collision cross section values of several cationized forms of bradykinin ([BK + H]+, 
[BK + Na]+, and [BK - H + 2Na]+), introduced by MALDI, were calculated by Bowers and co-
workers. All three species had very similar cross sections of 245 ± 3 Å2, and these cross sections 
were independent of temperature from 300 to 600 K. This particular property of bradykinin 
makes it the standard calibrant peptide of choice for many IM studies. 
Ion mobility measurements can be used to characterize the conformations of various 
charge states of proteins. An example is the +4 to +22 charge states of apomyoglobin.123 When 
collisionally heated, the higher (> +7) charge states undergo proton stripping to produce +4 to 
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+7 charge states. This results in spontaneous collapse into partially folded conformations. Only 
extended conformations exist for the high (> +10) charge states in the gas-phase, and they 
become more extended as the number of charges increases, whereas the lower charge states (< 
+7) adopt a slightly more compact structure than the native protein in solution. This study also 
shows that the CCS per residue for the conformations of apomyoglobin and cytochrome c is 
similar.26,123 An important result from these studies is that different proteins share common 
structural motifs in the gas-phase, as they do in solution.26,131,132 One can use desorption 
electrospray ionization (DESI) assisted by IM-MS analysis as shown for solid-phase horse heart 
cytochrome c and lysozyme from chicken egg; the outcome shows, that charge state 
distributions are comparable to those produced by ESI.165 Elongated structures of these two 
proteins are formed when the DESI solvent is mixed with a small amount (~2%) of acetic acid.165 
A peptide library containing 4000 different peptides having the general form: NH2-Xxx-
Xxx-Xxx-CO2H, NH2-Ala-Xxx-Xxx-Xxx-CO2H, NH2-Ser-Ala-Xxx-Xxx-Xxx-CO2H, and NH2-Leu-Ser-Ala-
Xxx-Xxx-Xxx-CO2H (where Xxx represents Ala, Arg, Asp, Glu, Gly, Leu, Lys, Phe, Ser, or Val) is now 
available from LC measurements combined with IM-MS.157 By LC-IM-MS approximately 82% of 
the 4000 library components can be resolved.157 There is also available a CCS database of 420 
singly charged and 240 doubly charged peptide ions introduced by utilizing an ESI source 
followed by IM-MS.155 A similar database of ion-neutral collision cross sections for 607 singly-
charged peptide ions introduced with a MALDI source is available from Russell and co-workers.66 
Protein complexes are large aggregates of often two or more proteins that are non-
covalently bound. These intact complexes are able to perform intricate chemical processes and 
are often the biological machinery at work behind many of the most important physiological 
functions in the body. Understanding their properties will likely be important in drug discovery 
and development. Electrospray ionization-ion mobility measurements of these large protein 
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complexes is now at the forefront of structural biology research following a number of studies 
throughout the 1990’s and 2000’s that showed that predominant secondary, tertiary, and 
quaternary structures were largely conserved during the transition from liquid- to gas-phase.214 
The ability of IM-MS for characterizing molecular structure makes it well suited for gaining 
insights in such structural biology studies. 
Most IM protein complex studies are aimed at probing gas-phase structure as a reliable 
representation of the solution counterpart.215,216 Many of these studies attempt to justify the 
results elicited from ion mobility by comparing them to electron microscopy, X-ray 
crystallography, and NMR data through the use of sources such as the protein data bank.216,217 
Work has progressed to larger and larger species, culminating in the successful ionization and 
structural investigation of the MVP vault protein complex at ca. 9.4 MDa.218 A summary of 
studies using IM-MS to characterize protein complexes is provided in Table 1.4. 
Computational methods have also been used to study these systems.43,45,51 Although 
current computational techniques are not able to handle the large complexes as of yet, 
approximations and coarse-grained models can now be used in these studies, and this work 
does provide significant insight into the experimental ion mobility measurements observed. 
 
(ii). Computational methods for peptide and protein structural interpretation 
 Empirically determined collision cross section values can be used to probe 
structural motifs of various biomolecular ions including peptides/proteins109,131,144 and protein 
complexes.43,51 This is accomplished by augmenting IM CCS measurements with computational 
modeling strategies. For structural interpretation, the CCS is used as a size constraint that can be 
used to discriminate and interpret a subset of structures from a large pool of computationally 
generated conformers. Structural populations can be expected to consist of structurally similar   
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Table 1.4. Listing of IM studies of protein complexes. Table reprinted from reference 93. 
Protein Complexes  Type of Study/Comments   References 
20S proteasome from 
Methanosarcina thermophila 
analysis of the binding and stoichiometry, 
conservation of structure in the gas-phase 
216 
Trp RNA binding protein 
(TRAP) 
stability of complex, effect of Trp, RNA binding 43 
Plasma protein complex 
56kDa tetrameric 
transthyretin (TTR) 
study of stable collision activated protein 
unfolded structures over ms time scales 
45 
Wheat heat shock protein 
TaHSP16.9 
stability of dodecamers in solution and gas-
phases 
51 
Protein kinase G (PKG) 
investigation of global conformational changes of 
intact 152kDa dimeric PKG; structural changes 
upon cGMP-binding 
219,220 
Hepatitis B Virus (HBV) capsid 
protein 
preservation of solution-phase structure in 
vacuo; study of viral capsid assembly 
221 
Bacteriophage P22 portal 
protein 
structure of P22 portal protein; conformational 
changes upon its association with tail factor gp4 
222 
Acr1 Mycobacterium 
tuberculosis heat shock 
protein 
collision induced activation of Acr 1, shock 
protein a 12 subunit 197kDa dodecameric 
protein 
223 
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ions that either undergo thermally accessible structural/conformational 
isomerization/interconversion or, depending on intramolecular forces and atomic arrangement, 
may even remain in relatively fixed conformations on the time scale of the IM-MS 
experiment.151 Therefore, each IM-MS unique signal, ideally corresponding to identical ions with 
different conformations, has its own unique structural signature determined by the average 
shape of the populations of ions that create it. This structural signature is the basis for 
biomolecular separations observed in IM-MS (lipids from peptides, peptides from 
oligonucleotides and carbohydrates).65,196,224 It is also the explanation for the observed 
difference in average IM vs. m/z trendline variability (spread, structural richness) of the different 
biomolecular classes observed by IM-MS.189,224 For example, peptide mobility vs. m/z IM-MS 
spectra can be expected to contain predictable variability due to PTMs186,191,193 amino acid 
content, sequence,81,156,197 and type of cationizing agent. 
 Following the experimental determination of CCS, computational modeling is performed 
in the following general sequence: (i) the structure of the molecular ion is built by using one of 
the available structure-building software packages, (ii) the atomic charge parameters for the 
built structure are determined by using quantum chemical calculations, and point charge 
derivation, and (iii) molecular dynamics is performed to create a large number of structural 
conformers whose CCS can be computationally determined to allow experimental CCS based 
clustering analysis. A schematic of the workflow for combining the measured CCS with 
computational interpretation is illustrated in Fig. 1.5. 
Currently, there are several software packages well suited for structure building of 
peptides and proteins, some proprietary (e.g., Molecular Operating Environment, Chemical 
Computing Group, Montreal, Canada), and some freely available (e.g., SIRIUS, University of 
California, San Diego). One should be aware of online structure databases and search for already   
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Figure 1.5. Modeling protocol used to interpret peptide and protein structure based on the absolute 
collision cross section measurements acquired from IM-MS data. Figure reprinted from reference 93. 
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available structures in publicly accessible databases such as the Research Collaboratory for 
Structural Bioinformatics Protein Data Bank (RCSB PDB, University of California, San Diego) and 
the Protein Databank (European Bioinformatics Institute, United Kingdom), which are both 
closely associated with the worldwide Protein Databank (wwPDB) project. Although computer 
processing speed has increased exponentially over several decades, computation still puts a 
limit on how large a system can be realistically studied by using the protocol described here. 
Quantum chemical minimization and electrostatic potential calculations in charge parameter 
development at intermediate level of quantum theory on the most powerful desktop 
workstations give reasonable 24 h results on systems of 20 atoms. Calculations, however, scale 
up exponentially not only with the level of theory and number of atoms, but also with mass of 
included elements. For example, studies of proteins containing metal ions may require 
additional specialized basis sets and time. Therefore, quantum charge parameterization of larger 
systems has to be done on properly capped fragments, which are later connected for molecular 
dynamics sampling. 
There are many free and proprietary quantum mechanical software packages capable of 
performing the needed minimization and electrostatic potential calculations (e.g., Cerius, 
Jaguar, Gaussian, Spartan) at basic to intermediate levels of theory. Recently DFT methods have 
made inroads into quantum minimization specifically for their ability to efficiently handle 
electron distribution of higher mass elements. However, the accuracy of DFT is still being 
studied and molecular dynamics parameterization lags behind these in parameter development 
for higher mass elements. 
The last step of the computational protocol is the conformational MD sampling coupled 
with computational clustering analysis based on the comparison of the computed CCS values for 
the generated structural conformers with the experimental CCS value. Once the charge 
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parameters for each atom in the built structure are determined, one of the available molecular 
dynamics packages (e.g., Amber,225 CHARMM, ACCELRYS) can be used to perform 
conformational sampling. Conformational sampling is a molecular dynamics calculation that 
yields a large number of structural conformers of the studied peptide/protein ion. Two primary 
challenges of MD-based conformational sampling methods are the use and development of 
reliable MD parameters that assure chemically and structurally relevant results and of 
temperature protocols that lead to a completely randomized pool of final structures. 
Aforementioned MD software packages typically contain reliable MD parameters for standard 
amino acids, carbohydrates and nucleotides. 
 Fully randomized sampling without any bias toward one or several conformations can 
normally be guaranteed by selecting a temperature scheme (heating and cooling algorithm) for 
the MD calculation in which the studied peptide/protein structure is heated to a temperature at 
which it can access all reasonably expected conformational states and then cooled slowly to 
relax into a low-energy structural conformer. An important output result of the MD calculation 
is the relative potential energy value of each conformer within the pool of generated structures. 
The computational collision cross section value for each conformer is then calculated by using 
one of two currently available codes, Mobcal226 or Sigma.62,227,228 Once both the relative 
potential energy and collision cross section values are computed for each member of the 
computationally generated ensemble of structures, a plot of energy vs. computed CCS is 
generated and visually inspected. Typically the lowest energy conformers with a computed CCS 
that matches the experimental value range are selected for further computational analysis (e.g., 
analysis of selected average distances, or clustering on the basis of atomic positions). Following 
cluster analysis, general structural motifs are obtained that are consistent with the 
measurement, while other structural motifs can be ruled out. 
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B. The future of proteomics IM-MS studies 
 Any drug-based treatment (both prophylactic and therapeutic) has its own limitations 
due to the efficacy of the drug and induced side effects that vary from one individual to another. 
Identification of biomarker signatures of individual patients allows for diagnosis of the disease at 
a very early stage and improved treatment strategies with fewer side-effects. Biomarkers can be 
identified by a variety of standard laboratory techniques including common blood tests, 
immunohistochemistry,229,230 and flow cytometry,231 or more recent omics methods such as 
genomics,232 transcriptomics,232 proteomics,10,70,233 peptidomics,234 glycomics,82,235,236 
lipidomics237 and metabolomics.27 Linking the individual patients’ condition with the correct drug 
based on clinical biomarkers opens the door for personalized medicine. Even though the 
instrumentation is now expensive and complex, personalized medicine may become widely 
accessible with advances in high-throughput and routine instrumentation. Advances in IM-MS 
technology over the past few decades have enhanced its ability to analyze samples collected 
from a large number of individuals in a reasonable amount of time; these discoveries may 
contribute to the discovery of biomarkers and play an important role in the field of personalized 
medicine. 
 Like any other technique, progress in the field of IM-MS is governed not only by the 
areas to which it is applied but also by the development of new technologies. An example is the 
work of Russell’s group. Advancing upon initial studies,67,238 they recently developed a variable 
temperature IM-TOFMS239 for studying the structural differences between isomers. At low 
temperatures, a number of favorable changes occur, (i) there are more collisions between the 
ion and the drift gas as the mean free path is shortened, (ii) the internal energy of the ion is 
lowered, and (iii) long-range ion-neutral gas interactions become more pronounced. Therefore, 
low temperature IM-MS offers high mobility resolution, an important advantage for structural 
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separation of isomers having very similar cross section values. Future directions of variable 
temperature IM-MS will likely focus on further eliciting the folding kinetics of peptides, proteins, 
protein complexes, and drug/protein receptor interactions. 
A second goal in instrumentation development is to increase the peak capacity of the 
measurement to facilitate even more comprehensive characterization of complex samples. 
There exist two paths to increasing peak capacity: (i) through combining separation techniques, 
so called ‘hyphenated methods’ (e.g. LC-IM-MS, and IM/IM-MS), and (ii) improvements to 
current designs that lead to increased mobility resolution. The introduction of the ‘combing’ 
technique by Clemmer and colleagues160 is an example of hyphenated strategy to increase peak 
capacity. Recent experiments on a circular drift tube by Clemmer and colleagues240,241 will 
further lead to increased resolution and peak capacity in IM separations. 
In summary, the ability of IM to function as a compartmentalized tool that combines 
well with different types of mass spectrometers and different ionization sources has led to a 
wide variety of applications in peptide and protein science. Ion mobility has been demonstrated 
to be highly useful in the characterization of samples ranging from small peptides to large 
protein complexes, both as a structural characterization tool and as a means for characterizing 
complex biological samples. 
 
6. Instrumentation overview 
The two time-dispersive methods of IM separation are DTIM and TWIM. Drift tube IM 
facilitates absolute collision cross section calculations.27,66,191,242 This data can then be compared 
to molecular simulation results to interpret analyte structural and conformational details. 
Traveling wave IM utilizes electrodynamic fields, which only provides estimated collision cross 
sections when measurements are compared to internal standards with previously measured 
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DTIM absolute collision cross sections.51,52 This is because gas-phase theory is insufficiently 
developed for the fundamental physical processes in TWIM separations, although recent efforts 
in this regard have been reported.31,51-59 Nevertheless, both DTIM and TWIM instrumentation 
are increasingly used for biological IM-MS applications. The most common space-dispersive ion 
mobility technique is High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS). This 
technique will be mentioned briefly in the sections to come but was not used in any studies in 
this work. 
 
A. Drift tube ion mobility 
The first ion mobility instruments were developed on a drift tube design.243 Drift tube 
ion mobility instruments use a static uniform field to cause progression of ions down a (typically) 
stacked ring drift cell. Importantly, because this ion progression is carried out in a static and 
uniform manner, previously developed gas-phase theory can be used to directly assess the 
collision cross section of these ions.49,50,244 This makes DTIM a popular choice of instrumentation 
for structural mass spectrometry applications. Drift cell instruments have been constructed with 
reduced pressure and atmospheric pressure drift cells, each with its own inherent benefits and 
challenges.245 Atmospheric pressure drift cells typically separate ions on a timescale of 10’s of 
ms,246 whereas reduced pressure drift cells can provide separations in <1 ms for relatively short 
drift cells (ca. 10 cm70). This is significant in certain applications where separation speed 
becomes important. For example, in MALDI imaging experiments60, this separation speed is 
crucial because it dictates the fastest rate at which the MALDI laser can be operated without 
losing time correlation in signals arising from different MALDI events (i.e., 10 Hz for 100 ms 
versus 1,000 Hz for 1 ms drift times, respectively192). Drift tube IM resolution typically ranges 
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from 30 to 50 (r=t/Δ t at FWHM), whereas longer, cryogenically cooled, or higher pressure drift 
tubes have been reported with resolutions exceeding 100.241,247,248 
 
B. Traveling wave ion mobility 
The recent commercial availability of traveling wave ion mobility (TWIM) 
instrumentation (Waters Corp.) has made IM-MS accessible to a large number of users. Similar 
to drift tube instruments, TWIM separates ions by time dispersion through collisions with a 
background buffer gas, but in contrast, it uses electrodynamic fields rather than electrostatic 
fields.65,249 This is accomplished by transmitting voltage pulses sequentially across a stack of ring 
electrodes (similar to Fig. 1.1(b)), which creates the so-called traveling wave.250 Conceptually, 
TWIM separations are performed based on the susceptibility of different ions to the influence of 
the specific wave characteristics and have been described as the ability of ions to “surf” on 
waves.249 Adjustable wave parameters include traveling wave pulse height, wave velocity, and 
ramping either of these variables. The commercial platforms (Synapt, Synapt G2, and Synapt G2-
S) are comprised of a MALDI (200-Hz pulse repetition rate) or ESI source, a mass-resolving 
quadrupole, a trapping region for injecting pulses of ions into the TWIM, the TWIM drift cell, an 
ion transfer region, and an orthogonal TOFMS (r=m/Δm at FWHM of >17,500). CID can be 
performed in the regions before and after the TWIM drift cell. In principle, the Synapt has 
sufficient activation/dissociation regions to perform up to MS5, although typically up to MS3 is 
practically feasible. Generally resolution in the TWIM is <15, but this is sufficient for the 
separation of many molecular classes of interest (e.g., isobaric peptides from lipids). For 
example, TWIM has been used to separate biomolecular signals from complex samples251 and to 
study the structure of peptides following CID in the trapping region.184 Although protocols have 
34 
 
been proposed to approximate collision cross section values using TWIM experimental data, the 
calculations still rely on absolute values obtained using drift tube instruments (Fig. 1.6).31,51-59 
 
C. High-field asymmetric waveform ion mobility spectrometry 
FAIMS separations were first documented in the early 1990s by Buryakov et al.252,253 
FAIMS separations are performed on the basis of the nonlinear dependence of the mobility 
coefficient (K) in strongly varying electric fields. Unlike previously mentioned methods of IM 
separation, FAIMS performs separation in a space-dispersive manner rather than a time-
dispersive manner. In FAIMS devices, ions are subjected to both positive and negative electric 
fields, which occur perpendicular to the direction of ion movement known as a high-frequency 
asymmetric waveform. By sending ions between two parallel plates in a separation cell using a 
longitudinal (or axial) gas flow and directing this waveform perpendicularly across them, ions 
that do not meet the exact criteria to traverse the cell will strike either the lower or upper plate. 
Only ions with particular mobility characteristics pass through the cell. The use of compensation 
voltage in FAIMS to achieve a mobility- based selection is roughly similar to the use of radio 
frequencies in quadrupole mass analyzers to achieve mass selection. Although other IM 
separation methods display data as intensity versus arrival time distribution (ATD), FAIMS data 
are displayed as intensity versus the scanned compensation voltage. However, one shortcoming 
to FAIMS is that although mass is an independent, easily calculable variable, mobility in a varying 
electric field is not easily predicted and depends on several variables including composition and 
chemical functionality, among others. Thus, it is presently not possible to make direct 
predictions or calculations of surface area using raw FAIMS data without first running standards 
and determining which compensation voltage is required for each structural representation of a 
particular isobaric set of ions.254-257  
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Figure 1.6. (a) A CAD rendering of a drift tube ion mobility spectrometer (Ionwerks Inc.) in ESI mode 
(adapted from reference 258, courtesy of Jody May). (b) A conceptual drawing of traveling wave ion 
mobility mass spectrometer produced by Waters Corporation also in ESI mode.  
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D. Instrumental arrangements for fragmentation studies by ion mobility–MS/MS 
An additional advantage of IM-MS separations is the ability to obtain mobility-correlated 
fragmentation information by placing a region of ion activation such as CID,259 or surface 
induced dissociation (SID)172,260,261 between the drift tube and mass analyzer (i.e., IM-MS/MS). 
When ion activation is performed following mobility separation, product ions that result from 
fragmentation can be correlated to precursor ions based upon their elution time from the IM 
dimension. This differs from insource fragmentation, which is not mobility aligned, because this 
fragmentation occurs before the mobility cell (Figure 1.7). In contemporary LC–MS approaches, 
ions of a particular m/z are selected and subsequently activated for fragmentation. In 
untargeted approaches, such as Waters’ MSE, there is no m/z selection; rather, each LC 
increment is subjected to activation of all masses. If the LC separation produces coeluted peaks, 
fragment ion spectra can be difficult to assign because they contain fragment ions arising from 
multiple precursor species. However, with the added IM dimension these fragmentation spectra 
are correlated to the precursor based on mobility, and thus enable assignment of the fragment 
ions to respective precursors. It is advantageous in complex biological samples where analyte 
amount may be limited, or when interfering species can suppress or isobarically mask the ion of 
interest.262 Furthermore, additional stages of IM, MS, MS/MS, or IM/IM can be performed 
depending on the specific goals of the experiment.159 
 
E. Ionization source consideration 
It is important to recognize that the two dominant MS ion sources for biomolecular 
species, namely electrospray ionization (ESI) and matrix assisted laser desorption/ionization 
(MALDI) offer complementary capabilities in spite of the fact that there are three primary 
differences when considering which ion source to use for specific experiments. First, MALDI   
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Figure 1.7. ESI-TWIM-MS/MS of the peptide, bradykinin (RPPGFSPFR), illustrating the two modes of IM-
MS/MS. In-source decay fragmentation of bradykinin yields the diagonal line of peaks in the 
conformation space plot. Collision induced dissociation following TWIM separation for this same analyte 
yields fragmentation ions that share the same arrival time distribution as the parent and so shows up as 
a horizontal line starting at the parent at the top right and extending to the left. Reprinted from 
reference 93. 
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generally produces singly charged ions of the form [M+H]+, [M+Na]+, [M+K]+, etc., where M is 
the intact molecular parent ion, while ESI produces singly charged ions for small molecules and 
typically multiply charged ions of the form [M+nH]n+ for larger biomolecules such as peptides 
and proteins. In the analysis of complex mixtures, singly charged ions can result in less spectral 
complexity, while multiply charged ions better facilitate fragmentation studies using tandem MS 
strategies, in which the fragments of an MS-separated molecule are themselves separated by a 
second MS step. Second, owing to the fundamental principles of ion generation, MALDI is more 
tolerant of salts than ESI, but requires empirical selection of appropriate matrices. Third, MALDI 
and ESI generate ions in pulsed and continuous modes, respectively. Thus the choice of MALDI 
or ESI can have pragmatic implications regarding the integration of the biological experiment, 
the ion source, and the selected mass analyzer. Nevertheless, we view these ionization 
techniques as highly complementary. One pertinent point to consider with systems biology 
studies is that ESI is able to utilize a continuous liquid sample. This is could provide a clear 
advantage if one is tracking a dynamic biological system. MALDI, on the other hand, must 
analyze solid sample substrates. This means that any samples collected from the system must be 
discretized and solidified on a MALDI target plate. In the end the solid sample will only 
represents the system at the time the effluent was deposited, such that a time-series analysis 
requires a series of MALDI samples similar to that reported by Chen et al.263 This idea is 
synonymous with watching a movie of what is occurring versus viewing a series of snapshots. 
 
7. Dimensions for expansion 
 Ion mobility-mass spectrometry naturally excels at a number of aspects central to the 
study of systems biology. For example, as shown above, IM is able to simultaneously analyze 
multiple biomolecular classes. In addition, MS has the distinct advantages of sensitivity, 
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accuracy, and a wide detection dynamic range which is an important feature when trying to 
analyze biomolecular species.264 Through the use of MALDI and ESI there is the potential to 
analyze both solid and liquid biological matrices. There are, however, a number of areas where 
IM-MS can be improved to expand its prospects for systems biology research. Through the use 
of MALDI imaging, IM-MS would be an ideal candidate for research on spatial measurements of 
biological systems. For example, IM-MS could be used to not only measure multiple 
biomolecular classes simultaneously but with the help of MALDI imaging, one could measure 
multiple intact sections of an organism in the same analysis. In a separate way, ESI-IM-MS has 
the potential to measure network dynamics from organisms. 
 
A. Spatial 
 Imaging ion mobility-mass spectrometry is based upon the principles of traditional 
imaging mass spectrometry265-267 but with the incorporation of a gas-phase ion mobility 
separation added to increase peak capacity and aid in molecular identification. The first 
examples in the literature of imaging IM-MS was performed using DTIM and demonstrated two 
important advantages over imaging MS strategies, namely (i) the ability to separate isobaric 
species on the basis of structure and m/z and (ii) enhanced signal-to-noise ratios by the 
separation of chemical noise.46,47 The former is demonstrated through the selective 
differentiation of nominally isobaric peptide and lipid species as illustrated in Fig. 1.8(a). In 
proof-of-concept experiments, both the lipid and the peptide were spotted onto a thin tissue 
section of mouse liver (12 μm) using a reagent spotter in either a “\” direction for the peptide or 
a “/” direction for the lipid (Fig. 1.8(a), top left). In the 2D IM-MS plot (Fig. 1.8(a), top right), the 
signal for the protonated forms of the lipid, phosphotidylcholine 34:2, and the peptide, 
RPPGFSP, overlaps in the m/z spectrum, but is baseline resolved in the IM arrival time 
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distribution with the peptide and lipid centered at 449 and 504 μs, respectively. In Fig. 1.8(a) 
bottom, the × represents what would be obtained using conventional imaging MS in the 
absence of IM, which is a convolution of both the peptide and lipid signals. The right two images 
are for the same 1 Da mass range (759 – 760 m/z), but selectively for structures corresponding 
to putative peptides “\” and lipids “/,” respectively.47 Thus, structurally selective imaging on the 
basis of molecular class results in more accurate images in contrast with conventional imaging 
MS alone. In Fig. 1.8(b), imaging IM-MS is demonstrated for a coronal rat brain section (16 μm) 
where the image to the right corresponds structurally to lipids and specifically to the sodium-
coordinated cerebroside 24:0 OH (m/z = 850.7 Da). This results in enhanced signal to noise for 
species of interest through the separation of chemical noise and contaminants with IM.46 More 
recently, imaging IM-MS using a TWIM drift cell has been demonstrated.268 Although the IM 
resolution is more limited using TWIM, it is sufficient for the separation of lipids from peptides 
as illustrated for a coronal thin tissue rat brain section (Fig. 1.9(i)). The utility of imaging TWIM-
MS for mapping the distribution of a drug, vinblastine, in a kidney from a whole body section is 
shown in Fig. 1.9(ii), (b). The accuracy of the obtained image is increased through the addition of 
TWIM due to the removal of isobaric interferences common in highly complex biological 
samples, such as tissue. Since commercial TWIM instrumentation equipped for imaging 
applications was released in 2008, the present number of reports is rather limited but expected 
to increase substantially in the near future. 
When performing imaging experiments, additional confirmation of an unidentified peak 
is often required. A common practice for increasing confidence in peak assignments is to image 
in a selected reaction monitoring mode for a fragmentation channel characteristic of the analyte 
of interest (e.g., using CID259). Similar to traditional MS/MS explained previously, the coupled 
arrangement of IM and MS in imaging experiments yields the ability to obtain structure   
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Figure 1.8. (a) Imaging DTIM-MS of a nominally isobaric peptide (RPPGFSP) and lipid (PC 34:2) deposited 
onto a mouse liver thin tissue section (12 μm) in the pattern of an "X". The "\" line is RPPGFSP, while the 
"/" line is a phosphotidylcholine extract, respectively. (top left) An optical image of the patterned 
matrix/analyte spots deposited on the tissue section. (top right) A zoomed view in the region of PC 34:2 
and RPPGFSP for a representative 2D IM-MS conformation space plot of a mixture of the two analytes. 
IM-MS signal intensity is indicated by false coloring, where purple and yellow corresponds to the least 
and most intense signals, respectively. (bottom left) An extracted ion intensity map over the mass range 
of 759-760 Da representing what would be obtained using conventional imaging MALDI-MS. (bottom 
middle and right) Extracted ion intensity maps for imaging DTIM-MS of the peptide and lipid over the 
mass range of 759-760 Da and DTIM drift times of 447-451 μs and 502-506 μs, respectively. (b, left) An 
integrated mass spectrum of cerebrosides directly from rat brain tissue. (b, right) Imaging DTIM-MS of 
the sodium-coordinated cerebroside 24:0 OH (m/z = 850.7). (b, far right) An optical image of an 
adjacent rat brain section. Histological abbreviations are: Cx - cortex; fmi - forceps minor of the corpus 
callosum; Cpu - caudate putamen (striatum); Acb - nucleus accumbens; ac - anterior commissure; lo - 
lateral olfactory tract. Reprinted from reference 60.  
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Figure 1.9. (i) Imaging TWIM-MS data of a rat brain thin tissue section illustrating selective imaging of 
peptides and lipids on the basis of structure. (ii) Imaging TWIM-MS data obtained in the analysis of a 
small drug molecule, common name vinblastine, in thin tissue kidney sections of vinblastine dosed rats. 
(a) An optical image of the kidney from the whole body section dosed at 6 mg kg-1 IV vinblastine before 
matrix application. (b) The same tissue section as shown in (a) but imaged by TWIM-MS showing the 
distribution of vinblastine within the kidney, with the highest intensity (white) showing a broken ring of 
intensity between the cortex and the medulla. (c) Optical image of the kidney within the whole body 
section dosed with 3H vinblastine. (d) Whole body autoradiography of the tissue section shown in (c), 
indicated is the broken ring of slightly higher intensity (white) between the cortex and the medulla. 
Reprinted from reference 60.  
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information in the MS dimension by performing IM-MS/MS. In IM-MS/MS mode, MS1 can be 
accomplished in two ways: (i) time dispersion in the drift tube can perform parent ion 
selection70 or (ii) a mass analyzer can be used.250 By placing an ion activation region between the 
drift tube and mass analyzer ions may be selected for fragmentation according to drift time. 
Performing the ion selection in this manner provides a multiplex advantage in that all fragment 
ions will possess the same drift time as the parent ion. This is significant in imaging applications, 
because the sample is limited to the spatial coordinates of a particular pixel. In imaging IM-
MS/MS experiments, multiple parent ions can be fragmented whereby fragment ions are 
correlated to their respective parent ions by drift time. A demonstration of the potential utility 
of IM-MS/MS is illustrated in Fig. 1.10 for a carbohydrate, lacto-N-fucopentaose 1 (LNFP1). In-
source decay fragmentation for this carbohydrate is illustrated in Fig. 1.10(a) where fragment 
ions occur at different times in the IM separation. Correlated fragmentation spectra can also be 
obtained as illustrated in Fig. 1.10(b) by using both in-source fragmentation and post-IM CID. 
The CID fragmentation results in ions correlated to the drift time of the parent. Importantly, this 
results in redundancy of the fragment ions that are observed for higher confidence that 
particular fragment ions arise from the parent ion of interest. For example, the integrated mass 
spectra for in-source and CID fragmentation (i.e., pre- and post-IM separation) are illustrated in 
Fig. 1.10(c), (d), respectively. When applied to multiple ions, this operation allows for multiple 
reaction monitoring (MRM) in a single scan. This application is a highly promising yet virtually 
untapped resource for biomolecular imaging MS, where limited sample exists at each pixel 
location. For an example of a typical MALDI-IM-MS imaging protocol, see Appendix B. 
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Figure 1.10. ESI-TWIM-MS/MS of the carbohydrate, lacto-N-fucopentaose 1 (LNFP1), illustrating two 
modes of IM-MS/MS. (a) In-source decay fragmentation of LNFP1 followed by TWIM analysis of the 
fragment ions. (b) In-source decay prior to TWIM separation and collision induced dissociation following 
TWIM separation for LNFP1. The latter results in fragment ions to be observed at the same drift time as 
the parent leading to the possibility for simultaneous CID for various ions at the same time. In both CID 
and ISD, cross-ring cleavages were seen, but glycosidic bond cleavages were the most abundant type of 
fragmentation. (c) In-source decay fragmentation spectrum that was extracted from the IM-MS plot 
above. Along with a zoom in view of the region from ~500-850 Da. Nomenclature for the fragmentation 
pattern of carbohydrates was first used by Domon and Costello (54). All in-source fragmentation and 
collision-induced dissociation peaks are labeled utilizing this nomenclature. (d) CID spectrum of the top 
dotted line for LNFP1 extracted from (b). (c) and (d) can be compared to examine the difference 
between the two different means for fragmenting carbohydrates. Dotted lines are for illustration 
purposes of the fragmentation peaks. Reprinted from reference 60.  
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B. Temporal  
Most modern biological approaches choose to either rapidly sample a single aspect 
(e.g., the electrochemical detection of glucose and the use of green fluorescent protein as a 
means of monitoring translation) or infrequently sample a more comprehensive set of data 
(e.g., proteomics). Intermittent sampling results in a fractional snapshot of the system, upon 
which biological inferences must be placed. When considering the turnover rate of certain 
enzymatically catalyzed reactions (e.g., millimolar per second rates for ATP, ADP, and cytosolic 
glucose) or the rate of ribosomal translation (i.e., six to nine amino acids per second for a 
eukaryotic cell), for example, single minute sampling resolution is considered coarse.269-271 
System dynamics is considered to be one of the key properties of systems biology1 and for this 
reason, systems biology measurements are of most benefit if they are acquired with a very high 
temporal frequency. If likened to a video of a jogger on a treadmill, the need for rapid sampling 
rates in systems biology studies can be explained as follows. If one wishes to use a video to 
analyze how the jogger moves and how the body’s joints and structure work in unison to 
produce forward propulsion, then a video with a very low sampling/frame rate would not be 
very useful. For example, if studying the jogger’s motion through a 1 frame-per-second (fps) 
motion video the jogger may appear to be moving quite slowly and disjointedly, or perhaps may 
appear to not be moving at all. For this study a standard 30 fps (or faster) video would be of 
most use. This example draws many parallels with the sampling of biological systems where a 
high sampling rate is required to confidently identify patterns in metabolic fluctuations. Both the 
jogger video and the biological sampling problems are governed by the Nyquist-Shannon 
sampling theorem which tells us that a function containing frequencies lower than B hertz can 
only be completely identified by collecting measurements at a series of points spaced 1/(2B) 
seconds apart or less.272,273 
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The rapid acquisition rate of time-of-flight mass spectrometry (TOF-MS) measurements 
allows for sampling at a timescale that is relevant for a greater number of biological processes. 
However, MS alone lacks the necessary peak capacity for systems biology analyses, even when 
considering high-resolution methods that can provide a resolving power greater than 
~50,000.274,275 This limited peak capacity may be alleviated through the coupling of mass 
spectrometry to one of several additional separations methods, notably ion mobility (IM).83,189 
The ability of MS and IM-MS to perform proteomic and metabolomic analyses is 
unquestionable.10,13 The sensitivity, dynamic range, and ability to obtain accurate mass 
measurements, among other figures of merit, are the stronger suits of IM-MS. 
Addition of the IM dimension to high-frequency biological mass spectrometry analyses 
allows for reduction of chemical noise (by partitioning inherent chemical noise to other areas of 
two dimensional conformation space) and also separates analytes on the order of milliseconds 
(causing no significant increase in acquisition time). The millisecond time-scale of these 
separations also allows for the addition of an LC- or gas chromatography (GC)-based separation 
before the mobility separation (yielding a three-dimensional data set). This added data 
dimensionality has several key benefits. For example, Clemmer and colleagues37 have recently 
described LC–ESI IM- MS studies of the human plasma proteome whereby three-dimensional 
separations provided an enhanced dynamic range in concentration that was estimated to be 
105–106. Data from LC-IM-MS multiplexed arrangements illustrate the data density of such 
experiments from complex biological samples.  
While exploration of the spatial dimension using IM and MS has already begun,276 there 
is significant room for improvement in the temporal dimension. Accompanying this 
improvement is a substantial need for improved techniques for coupling the system on which 
the analysis is being performed (i.e., the organism) with the detection instrumentation (i.e., the 
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ion mobility-mass spectrometer). Our efforts to improve this interfacing are reviewed in the 
following chapters. 
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STATEMENT OF DISSERTATION 
In regards to this project, my role has comprised the following contributions. I was the 
sole contributor of efforts to design and implement all online desalting techniques involving 
electrochemical and chromatographic means. The final desalter arrangement used in chapter 4, 
however, was a direct result of collaborative work between Dr. Christina Marasco and myself. I 
was the sole contributor of mass spectrometry data collection techniques for this platform. Data 
analysis was a collaborative effort between Dr. Christina Marasco and myself. 
This work has far reaching implications for all of the biological sciences, but in particular, 
pharmacology, toxicology, and natural product synthesis. Online analyses of live cellular cultures 
afford the user an expedient detectable return on variable input parameters. It is this quick 
return that provides the opportunity to study dynamics the effect of highly variable input 
parameters such as various media conditions and challenges that may be used on a microbial 
culture to generate a specific natural product. 
I believe this type of work has not been demonstrated previously because it is unusual 
to have access to and expertise in so many varying analytical and biomedical engineering fields 
(i.e., microfluidics, chromatrography and mass spectrometry), and the few that do have access 
to these fields are not studying systems biology through improved network dynamics detection. 
The online solid phase extraction device (outlined in chapter 3) is the predominant reason this 
type of work has been successful, and previous strategies of this caliber do not prioritize 
dynamics (as evidenced by the fact that most send the incoming sample stream to waste for a 
significant portion of the cycle). 
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CHAPTER II 
 
SYSTEMS BIOLOGY MEASUREMENTS USING ION MOBILITY-MASS SPECTROMETRY 
 
1. Introduction 
As stated previously, most modern biological approaches choose to either rapidly 
sample a single aspect (e.g., the electrochemical detection of glucose and the use of green 
fluorescent protein as a means of monitoring translation) or infrequently sample a more 
comprehensive set of data (e.g., proteomics). Intermittent sampling results in a fractional 
snapshot of the system, upon which biological inferences must be placed. When considering the 
turnover rate of certain enzymatically catalyzed reactions (e.g., millimolar per second rates for 
ATP, ADP, and cytosolic glucose) or the rate of ribosomal translation (i.e., six to nine amino acids 
per second for a eukaryotic cell), for example, single minute sampling resolution is considered 
coarse.269-271 If likened to a video of a jogger on a treadmill, the need for rapid sampling rates in 
systems biology studies can be explained as follows. If one wishes to use a video to analyze how 
the jogger moves and how the body’s joints and structure work in unison to produce forward 
propulsion then a video with a very low sampling/frame rate would not be very useful. For 
example, if studying the jogger’s motion through a 1 frame-per-second (fps) motion video the 
jogger may appear to be moving quite slowly and disjointedly, or perhaps may appear to not be 
moving at all. For this study a standard 30 fps (or faster) video would be of most use. This 
example draws many parallels with the sampling of biological systems where a high sampling 
rate is required to confidently identify patterns in metabolic fluctuations. Both the jogger video 
and the biological sampling problems are governed by the Nyquist-Shannon sampling theorem 
which tells us that a function containing frequencies lower than B hertz can only be completely 
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identified by collecting measurements at a series of points spaced 1/(2B) seconds apart or less. 
System dynamics is considered to be one of the key aspects of systems biology, thus 
necessitating the development of new rapid sampling techniques and platforms.1 
Once one has decided to drastically increase the sampling rate of their method the 
challenge still remains, how does one sample a biological system multiple times over the course 
of an experiment without destroying or even perturbing that system? If compared to a human 
clinical setting, when a doctor wishes to know the overall state of a patient, he/she may perform 
a comprehensive blood test. However, when forming the basis of an analytical platform, a more 
simplified system such as cell cultures are used, and cells don’t possess a comparable “blood 
sample” to be taken. One solution is to run numerous duplicate systems in parallel, sacrificing 
one population for every sample collected; this drastically increases labor and speculatively 
assumes that all the populations are exact biological replicates of one another, which is highly 
unlikely.  
The exometabolome or metabolic footprint represents an opportunity to bridge this 
gap. The exometabolome is everything that is secreted or excreted from the cell and is rich in 
cellular and population conditional information. This means the exometabolome has the 
potential to include proteins, lipids, glycans, metabolites, and in some bacterial and viral cases, 
nucleic acid material. It has been shown that this material can be used to infer intercellular 
processes and overall system states.277,278 The logical next step is identifying a technology that is 
able to sustain live cell populations, while also granting access to the cellular exometabolome. A 
viable technological candidate to meet these needs is microfluidics. 
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A. The multitrap nanophysiometer 
Microfluidics, or lab-on-a-chip (LOC) technology, spans multiple fields including 
engineering, physics, chemistry, and biology. This technology has implemented a shift in the 
traditional experimental techniques of cell and molecular biology towards small-scale on-chip 
research. This shift towards miniaturized chip devices comes with beneficial parameters. Low 
volumes of reagents may be used based on microfluidic device size and length of experiment. 
Also easier fluid handling on the microscale allows for better experimental control. Experiments 
conducted with microfluidic devices offer the potential of being inexpensive not only due to the 
decreased cost of reagents, but also because of low material cost as the devices are typically 
comprised of poly(dimethylsiloxane) (PDMS) and a glass slide or cover slip.279,280 The design and 
fabrication procedures allow for meticulous control of the device features, making the 
technology incredibly versatile. Because these devices consume picoliter to nanoliter volumes of 
reagents and/or cell culture medium, the extracellular contents including autocrine and 
paracrine signaling molecules are not diluted to the large extent experienced with cell culture 
and titer plate techniques.281 In contrast to the macroscale, specific physical phenomena, such 
as diffusion, laminar flow, surface area-to-volume ratios, and other factors, when experienced 
on the microscale, have significant consequences in physiological processes and can greatly 
contribute to a more representative in vitro/in vivo correlation. By taking advantage of the 
numerous benefits of microfluidics researchers have been able to make measurements at the 
microscale that would otherwise not be possible.282 
Cell trapping microfluidic devices sustain a cellular culture population by constantly 
perfusing fresh media through the device. The medium that passes through the device is 
typically directed to waste. This outlet stream, however, is rich in secreted and excreted 
material and can be used to monitor the exometabolome of the population. The Vanderbilt 
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Institute for Integrative Biosystems Research and Education (VIIBRE) Multitrap 
Nanophysiometer (MTNP), a microfluidic device used as miniature bioreactor, allows for studies 
on small populations of cells (1 to ~105). This is in stark contrast to traditional cell biology 
techniques which often require several orders of magnitude larger populations of cells. The 
MTNP lends itself to long-term optical measurements of the dynamic behavior of cells, including 
fluorescent labeling of cells to detect type, activation state, and signaling dynamics.281,283,284 The 
MTNPs can also be readily combined with microfabricated multielectrode arrays for 
electrochemical measurements of the metabolic activity of small numbers of cells and their 
rapid response to drugs and other perturbations.285-291 Sensitivities approaching that required to 
monitor single cells have been achieved in preliminary work.292-297 Together these technologies 
are ideal for studying paracrine and autocrine signaling dynamics. 
An additional benefit of these MTNP systems is the ease with which they can be used 
for stimulus-response experiments. Most MTNPs are designed with three input ports which are 
supplied with solvent/medium by three syringe pumps and a single output port. These input 
pumps can be run simultaneously or consecutively. The latter provides the opportunity to 
expose the cellular populations in the device to varying chemical stimulants (whether gradually 
or sudden) over the course of an experiment. These types of experiments can be of benefit to a 
wide range of applications, including pre-symptomatic response, biological applications of 
bifurcation theory, and glucose-stimulated insulin response, to name a few. Additionally, the 
output port, from which exometabolome rich medium elutes, can be connected online with a 
detector capable of analyzing the potentially complicated matrix of biomolecular material and 
also capable of detecting it at a rate germane to systems biology studies. 
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B. Ion mobility as a tool for measuring temporally dynamic living biological systems 
The rapid acquisition rate of time-of-flight mass spectrometry (TOF-MS) measurements 
allows for sampling at a timescale that is relevant to a greater number of biological processes. 
However, MS alone lacks the necessary peak capacity for systems biology analyses, even when 
considering high-resolution methods that can provide a resolving power greater than 
~50,000.274,275 This limited peak capacity may be alleviated through the coupling of mass 
spectrometry to one of several additional separations methods, notably ion mobility (IM), which 
is a post-ionization separation that resolves ions based on their relative size-to-charge ratio and 
occurs on the order of milliseconds.83,189 The ability of MS and IM-MS to perform proteomic and 
metabolomic analyses has been previously demonstrated.10,13 The sensitivity, dynamic range, 
and ability to obtain accurate mass measurements, among other figures of merit, are the 
stronger suits of IM-MS. 
The simplicity of the design of IM makes the technology versatile and robust enough to 
be found in the commercial and military sectors, where it is used for the detection of explosive 
compounds. In the research laboratory, the millisecond timescale of the separations facilitates 
the multiplexed combination of ion mobility with higher repetition-rate sampling techniques 
such as MS. The addition of IM to MS can be likened to the coupling of liquid chromatography 
(LC) or gas chromatography (GC) to MS, where pre-ionization separations (GC and LC), which 
inherently have a longer separations timescale (minutes to hours), interface with the higher 
sampling rate MS (e.g., microseconds for time-of-flight MS), allowing many spectra to be taken 
for a given LC or GC separation. The resulting data comprise an LC trace with an associated MS 
spectrum acquired at sub-second intervals, which is typically displayed in two dimensions 
(Figure 2.1(a)). The hydropathic separation of LC is highly orthogonal to the m/z separation of 
MS and yields a spectrum where the molecular signals occupy a large and varied region of   
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Figure 2.1. A comparison of the orthogonality of LC-MS and IM-MS. (a) The hydropathic separation of LC 
is highly orthogonal to m/z separation of MS and yields a spectrum where the molecular signals occupy 
a large region of separations space. (b) The drift time of an ion, dictated by its gas-phase packing 
density, is not highly orthogonal to the mass differentiation of MS. This results in more concentrated 
occupation of separations space. This relationship produces lines of gas-phase packing density 
correlation (as seen in (b)) which are indicative of chemical class and provide an important means for 
analytical separations. Reprinted from reference 298.  
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separation space. This correlation is inversely related to the orthogonality of the two 
measurements.299 IM-MS is a similar marriage of two temporally disparate separations, with IM 
dispersing ions based upon their relative gas-phase packing density and charge state and 
occurring on the order of milliseconds, allowing for hundreds of MS spectra to be taken for a 
given IM separation. These data produce two-dimensional spectra, as shown in Figure 2.1(b), 
with the mass of the ion (m/z) displayed on the abscissa and drift time (the time it takes the ions 
to traverse the ion mobility drift cell in milliseconds) on the ordinate. The drift time of an ion, 
dictated by its gas-phase packing density, is not highly orthogonal to the mass differentiation of 
MS. This results in more concentrated occupation of separations space. 
Advantages of the IM dimension include the ability to reduce chemical noise (by 
partitioning inherent chemical noise to other areas of two dimensional conformation space) and 
to perform separations on the order of milliseconds (causing no significant increase in total 
experiment time). The millisecond time-scale of these separations also allows for the addition of 
an LC- or GC-based separation before the mobility separation (yielding a three-dimensional data 
set). This added data dimensionality has several key benefits. For example, Clemmer and 
colleagues37 have recently described LC–ESI IM- MS studies of the human plasma proteome 
whereby three-dimensional separations provided an enhanced dynamic range in concentration 
that was estimated to be 105–106. Data from LC-IM-MS multiplexed arrangements illustrate the 
data density of such experiments from complex biological samples. An example spectrum of 
plasma from whole rat blood is shown in Figure 2.2 as a three dimensional scatterplot. Each 
ellipsoid in the spectrum represents a uniquely identified feature with the relative shapes of the 
ellipsoids in each dimension being governed by the associated resolution of each measurement 
axis. The relative size of each ellipsoid represents the relative intensity of the ion signal. Note 
that there are over 100,000 uniquely defined features contained within this dataset, compared  
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Figure 2.2. A three-dimensional scatter plot of an LC-ESI-IM-MS spectrum displaying plasma from whole 
rat blood. Each ellipsoid represents a unique molecular signal. The shape of each ellipsoid is governed 
by the relative resolution or resolving power of the three dimensions displayed (i.e., drift time, 
retention time, and mass). The relative size of each ellipsoid represents the relative intensity of the ion 
signal. The points shown in this scatter plot occupy only one part in 105 of the possible distinct species 
that could be identified in this plot. Reprinted from reference 298.  
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with ca. 10,000 when performing IM-MS in the absence of LC. This represents only ~10–5 of the 
possible molecules that could be uniquely specified in this scatterplot — another testimony of 
the peak capacity afforded by the three-dimensional separation.  
 
C. Multidimensional data handling 
Because of the large amounts of data generated in an (LC/GC) IM-MS analysis, 
translating the data to meaningful information can be challenging. Data acquired from IM-MS 
separations used in conjunction with any pre-ionization separation must first be discretized to 
finite retention time, drift time, and mass-to-charge values. Data must be aligned in all 
dimensions for cross-sample comparison. Open-source and commercial software is available 
that addresses several of these issues.300-302 The use of internal calibrants and spectral feature 
alignment algorithms compensate for minor separation incongruencies. Additionally, isotopic 
envelopes must be collapsed into monoisotopic peaks and intensities normalized, commonly 
using total ion count. This ensures relevant and relatively quantitative sample-to-sample 
comparability. To date, software that defines peaks using mobility in conjunction with m/z and 
retention time is not widely available, as the processing and alignment of raw data in three 
dimensions are computationally expensive. However, developments in this area are 
forthcoming. The availability of open-source or commercially available software for peak 
identification will be necessary to fully utilize the potential of three or higher dimensions of 
separation.  
Presently, these data are often discriminated using multivariate statistical analyses such 
as principal component analysis (PCA) and partial least squares-discriminate analysis (PLS-DA). In 
essence, these methods seek to distill data to two or three principal components that best 
describe the variability of the data. It is important that this approach allow the analytes that 
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contribute most significantly to differences in sample sets to be identified from tens of 
thousands of molecular signals — the PCA components each represent a particular spectrum of 
analytes that is representative of a specific difference between the two sets. In this manner, 
needles may be drawn from the haystacks of data present in very complex biological systems. 
This method has been employed extensively in metabolomic analyses and is considered a 
reliable method for untargeted analyses, allowing for the prioritization of peaks of interest for 
database searching using publicly available databases.11,12,303  
 
D. Combining IM-MS with microfluidics for cellular culture effluent analysis 
Microfluidic chips have been successfully integrated with capillary electrophoretic (CE) 
separations of biomolecules.304-307 However, because CE is a condensed-phase separation, it still 
relies on liquid-phase physical properties for separation and typically requires 10’s of minutes 
for separation. Several studies have focused on integrating the numerous benefits and flexibility 
of microfluidics with the sensitive analytical power of mass spectrometry.308 Some have used 
microfluidics to increase the ease and efficiency of proteomic analysis using on-chip immobilized 
enzymatic degradation for ESI and MALDI.309,310 Mellors et al. were able to demonstrate 
complete integration of the ionization source into the microfluidic chip311. In that study ESI was 
performed from the corner of the glass device without the need for external pumping or spray 
tips.  
Integration of PDMS cell-trapping microfluidic devices, such as the MTNP,281,283,284 in an 
online manner with IM-MS involves sampling the continuously flowing output effluent of the 
MTNP. Fortunately, the flow rate (ca. 500 nL/min) and the general aqueous nature of this 
sample stream make it a good candidate for ESI analysis. This sample stream contains 
temporally related biomolecular signatures of the exometabolome of cellular populations   
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Figure 2.3. A schematic diagram for the online ESI-IM-MS analyses of the cellular exometabolome. 
Media is typically perfused using Harvard syringe pumps. Cell trapping microfluidic devices are 
fabricated from PDMS. These devices (not drawn to scale in this figure) are roughly 2 cm in total length 
and composed of 7000 cell traps which measure 18 μm wide and 18 μm deep. The interior space has a 
typical height of ca. 20 μm. Following perfusion of cell culture media across the cells, the sample 
effluent is subsequently analyzed by IM-MS. Reprinted from reference 312.  
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(Fig. 2.3)312. Media is typically perfused through the MTNP using syringe pumps. These devices 
(not drawn to scale in Figure 2.3) are roughly 2 cm in total length and are composed of 7000 cell 
traps that measure 18 μm wide and 18 μm deep. The interior space has a typical height of ca. 20 
μm. Following perfusion of cell culture media across the cells, the sample effluent is analyzed 
online by ESI-IM-MS. This method serves as an option for the integrated and comprehensive 
online systems biology measurement of biological systems, potentially overcoming the 
difficulties related to sample fraction collection and system preservation. 
In the sections to follow, the integration of PDMS microfluidic cell-trapping devices with 
ESI-IM-MS will be presented. The ability to explicitly control the conditions of the 
microenvironment of the device will be demonstrated. This is crucial for stimulus/response 
experiments where conditions may change quickly and frequently. 
The future of systems biology research will lie not in the division of divergent and highly 
specified analyses of individual components of biological systems, but rather in the holistic and 
convergent simultaneous measurement of all parts of a biological system. It is the optimization 
of combining these aspects into a single experimental platform, while also overcoming the 
inherent difficulties, which will result in the greatest insight into these systems. An integrated 
IM-MS platform coupled to real-time experiments on small populations of live cells with the 
possibility of feedback291,313 will likely be useful for the present and future direction of systems 
biology– level experiments.  
 
2. Methods 
ESI-IM-TOFMS measurements for the preliminary desalting and diffusion studies were 
performed with a nanoflow-ESI ionization source held at +2.25 kV. After exiting the ESI tip the 
ions were directed through a 500 μm ID, 6 inch long steel capillary heated to 100°C and held at 
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ground potential. Upon exiting the steel capillary the ions were held in a keyhole ion funnel 
trapping region in order to be pulsed into the 14 cm long drift tube for temporally resolved 
measurement.258 Once the ionized species traversed the 4 Torr He-filled drift cell under the 
influence of a weak electric field held at -100 V potential at the front and -1900 V at the back 
plate, they were guided by ion optics into the low-pressure (ca. 10-8 Torr) TOFMS region. Two-
dimensional spectra (arrival time versus m/z) of each sample were analyzed and compared using 
custom visualization software (Ionwerks, Houston, TX, USA) developed on the IDL platform (ITT 
Visual Information Solutions, Boulder, CO, USA). Desalting studies were performed using a 1 
inch packed LC column. The 250 μm ID column was packed in-house with 30 μm C18 beads. 
Cheminert (Valco Instruments Co. Inc., Houston, TX, USA) valves and an Eksigent nanoflow 2D LC 
pumping system (Eksigent Technologies, Dublin, CA, USA) was used to drive the desalting 
process discussed below. Mass calibration of the instrument was performed externally using a 
mixture of C60 and C70, which also serve as structural standards. A MALDI–TOFMS (Voyager DE-
STR, Applied Biosystems, Foster City, CA, USA) operated in reflectron mode was used to confirm 
the identities of various signals. 
Data for the yeast analyses were recorded on an Applied Biosystems Voyager DE-STR 
mass spectrometer. Data were processed using the Voyager Control Panel Version 5.10 (Applied 
Biosystems) and MALDI MS Imaging Tool, version 2.2.2 (developed by Markus Stoeckli, Novartis, 
Switzerland)314. Both BY4741 and ATCC #9763 Saccharomyces cerevisiae strains were used. Cell 
stocks were initially stored at -80°C. A portion was plated on yeast peptone dextrose (YPD)-rich 
agar plates and allowed to grow for three days at 30°C. Inoculation was carried out overnight in 
synthetic minimal media (SD). Before experimentation, subculture cell density was confirmed 
using optical density (OD) measurements at 600 nm. The OD was confirmed to be in the optimal 
range of 0.5 to 1.0, indicating that the yeast cells were in the active phase of their logarithmic 
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growth. Throughout the course of the experiment deionized water was rinsed over the cells at a 
flow rate of 200 nL/min for 3 hours. The cells were captured in multitrap nanophysiometers for 
optical monitoring and to allow collection of the undiluted yeast secretome in the effluent.281,283 
Data for the Jurkat cell spectra were collected on a Synapt HDMS ion mobility-mass 
spectrometer platform (Waters Inc., Manchester, England). Data were processed using the 
Waters Driftscope 2.0 software package. Jurkat T cells (clone E6-1) were obtained from ATCC 
and cultured in RPMI 1640 medium supplemented with 10% FBS (ATCC) and 10 mg/ml 
Ciproflaxin (Cellgro). Cells were maintained in a sterile environment at 37°C with 5% CO2. 
Supplied media was maintained at a flow rate of 200 nL/min. MTNP effluent was collected for 
off-line MALDI-IM-MS analysis. 
 
3. Results and discussion 
 
A. Preliminary studies 
Our initial experiments have gauged the general compatibility of microfluidics liquid 
handling with IM-MS. Many variables were considered in order to validate suitable experimental 
conditions, including flow rates, measurement timing, pressure tolerances, and chemical 
compatibility (between necessary chemicals for biological microfluidics and IM-MS). Aimed at 
answering questions of compatibility, initial experiments sought simply to demonstrate that 
molecular events occurring inside the microfluidic device could be observed with confident 
identification and with appropriate temporal resolution. To this end, for our first experiments 
we used a microfluidic trap device with two inlets and one outlet and alternatively infused a 
blank methanol solution and a sample solution containing 20 μg/mL of a standard cardiac 
peptide (bradykinin, RPPGFSPFR). The infusion cycles were 10 minutes, meaning the blank 
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methanol solution was infused for 5 minutes followed by the sample solution for 5 minutes, etc. 
Figure 2.4 shows that not only could we detect small amounts of a biological sample through a 
trapping device but also that we could measure it with a temporal resolution of < 5 min and a 
very high signal-to-noise ratio between peptide and control blank infusion cycles. This also 
indicates that longitudinal diffusion between adjacent solution packets was minimal, providing 
confidence that secreted biomolecular material would not get displaced from its original 
temporal location in the flow stream. Although it appears that the noise level increases 
following the third injection cycle in all subsequent injection cycles the noise level remains at a 
steady state level. We speculate that this rising noise level plateaus when sufficient sample 
conditioning of the tubing between the MTNP and nESI source is achieved. 
 
B. Saccharomyces cerevisiae 
Given the demonstration of compatibility of microfluidics and IM-MS, it was important 
to test IM-MS as a detection method using a living biological system. Saccharomyces cerevisiae 
was chosen because it is a well-developed, well-understood system. It is also known for its 
resiliency as a biological system, enabling time-intensive experiments. S. cerevisiae cells were 
loaded into a trapping device and were supplied 100% deionized water. This water rinse 
activates a dormant state in the yeast cells with reduced metabolic activity.315 The water rinse 
was begun at time zero and the progression of various ion species was monitored over time. 
Figure 2.5 shows images of budding yeast in an MTNP. Effluent from the experimental trapped 
yeast cells was spotted onto a MALDI plate every 5 minutes to retain time resolution, while not 
requiring extensive sample preparation. A sample spectrum (Fig. 2.5) displays the species that 
were monitored temporally in this experiment (Fig. 2.5). These three example sets of data show   
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Figure2.4. (A) Bradykinin standard (at a concentration of 20 μg/mL) and pure methanol were infused 
into a two-inlet, single-outlet microfluidic trap device. The two solutions were separately flowed 
through the trap in a consecutive fashion for 5 minutes each. The resulting m/z spectra demonstrated 
that not only was it possible to detect small amounts of biomolecular material through the trap but also 
that these materials could be measured with a temporal resolution <5 minutes. (B) 2D spectra during 
infusion of bradykinin (upper) and methanol alone (lower), plotted with different signal intensity scales. 
Due to the sharp detected distinction between the two flows, it can also be inferred that longitudinal 
diffusion between these two solution packets was minimal, providing confidence that secreted cellular 
material will not be displaced from its original temporal location in the flow stream. Reprinted from 
reference 312.  
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Figure 2.5. (A) Time-lapse images showing yeast that is budding while in an MTNP. (B) A MALDI-MS 
spectrum collected during the course of the water-induced dormancy state experiment. The samples 
were collected by spotting the effluent on a MALDI plate in a sequentially different position every 5 
minutes. The three peaks marked were selected due to their observed increase in signal intensity over 
the 180 minute experiment. (C) The time-dependent signal intensities for the three species selected 
from a series of spectra as in (B), showing a marked increase in all three peaks after 180 minutes with a 
high degree of temporal correlation. Reprinted from reference 312.  
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an increase in relative abundance over time as the cells begin to enter their dormancy and also 
illustrate a highly correlated temporal response. 
 
C. Jurkat cells 
Jurkat cells at a density of ca. 1 x 10-6/mL were loaded into the MTNP (Fig. 2.6) and 
supplied RPMI 1640 media. The effluent from the trap was flowed over a packed C18 column for 
ca. 2 hours, theoretically saturating the column with cellular secretion material. This column was 
then rinsed of any contaminant material that was nonspecifically bound (using deionized water 
with 0.1% acetic acid) and then eluted (using methanol with 0.1% acetic acid) into an Eppendorf 
tube. The resulting IM-MS spectrum collected from this elution wash is presented in Fig. 2.6 and 
shows that this method is able to produce an abundance of signals, hundreds to thousands of 
different species, directly from biological cell trap effluent. When compared to the RMPI 
medium control (Fig. 2.6) a drastic increase in biomolecular material can easily be observed in 
the experimental spectrum. These data illustrate the use of reverse-phase chromatography for 
preconcentrating analytes and purging the effluent of media salts and non-pertinent material. 
This work demonstrates that in principle this technique should be effective, however, future 
chapters will demonstrate our efforts to make this system more automated and also to make it 
possible to perform the load/rinse/elute cycle on the order of a few minutes. 
 
4. Conclusions  
Systems biology focuses on a holistic approach to biological research. Intrinsic in this 
dogma is the need for accurate representations of network dynamics. Only through more rapid 
sampling can the kinetics and details of biological processes be fully observed and described. 
This necessitates the need for more improved detection strategies which excel at dynamic,  
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Figure 2.6. (A) Time-lapse images displaying multiplying Jurkat cells in an MTNP. (B) The resultant IM-
MS spectrum collected from these cells with a desalting column load time of 2 hours to concentrate 
secreted material. The column was rinsed with 1 mL of water containing 0.1% acetic acid and then 
eluted with 50 μL of methanol containing 0.1% acetic acid. A portion of this 50 μL was spotted onto a 
MALDI plate and produced the IM-MS spectrum shown. (C) Control spectrum of medium used in 
spectrum (B) containing no cellular excretion. This medium was spotted on a MALDI plate under the 
same matrix conditions as the effluent from (B). Reprinted from reference 312.  
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broad and accurate measurements. 
Advances in systems biology measurements which focus on improved dynamic 
detection strategies were presented in this chapter. Our preliminary work shows the potential 
for this system to provide temporally resolved systems biology data directly from complex 
cellular culture populations. Precise and expedient control of the microenvironment of the 
MTNP with regards to input concentrations (i.e., stimuli) has been demonstrated (Fig. 2.4) and 
shows that biomolecular temporal events on the order of 5 minutes are observable with this 
platform. This accomplishment is critical for future stimulus/response experiments. The broad 
and temporally accurate detection capabilities of IM-MS have been demonstrated for complex 
biological samples originating from a sustained yeast cellular culture inside of a microfluidic 
device (Fig. 2.5). The potential of the combination of microfluidics and IM-MS has been shown 
by the sheer number of analytes detected from a simple Jurkat cell population (Fig. 2.6). This 
Jurkat cell data illustrates the abundance of secreted material which is observable with the use 
of ion mobility-mass spectrometry. 
An important aspect of combining cell trapping microfluidics with IM-MS in a temporally 
accurate manner is the need for online sample preparation strategies. It is essential that these 
techniques remove suppression-causing contaminants (e.g., salts) while also preserving the 
temporal dynamics of the continuous microfluidic flow stream. Much of the work presented in 
the remaining chapters is centered on perfecting this manner of online sample preparation. 
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CHAPTER III 
 
ONLINE SOLID PHASE EXTRACTION AS A MEANS OF OVERCOMING NON-VOLATILE INORGANIC 
ION MASS SPECTROMETRY SIGNAL SUPPRESSION 
 
1. The history of charged droplet formation for purposes of analytical chemistry 
The interactions of liquid and electricity is a topic that has garnered intense interest 
since man first harnessed electricity in the 1600s. Studies continued on this subject throughout 
the 17 and 1800’s through the work of Alessandro Volta, Georg Ohm, Michael Faraday, and 
Friedrich Kohlrausch. In the late 1800’s John William Strutt, also known as the third Baron 
Rayleigh or The Lord Rayleigh was interested, among many other things, in the theoretical basis 
of electrified water droplets and developed some basic principles that he detailed in some of his 
earlier works.316-318 One theory Lord Rayleigh established was that a fundamental limit exists to 
dictate the charge magnitude a droplet of liquid may assimilate before undergoing spontaneous 
droplet fission. This limit beyond which the surface tension of the liquid can no longer hold out 
against the force of the Coulombic charge repulsion is now known as the Rayleigh limit. Rayleigh 
proposed that beyond this limit the liquid would throw out “fine jets” of additional highly 
charged droplets to regain stability as highlighted in this passage from his 1882 publication: 
“When Q is great, the spherical form is unstable for all values of n below a certain limit, the 
maximum instability corresponding to a great, but still finite, value of n. Under these 
circumstances the liquid is thrown out in fine jets, whose fineness, however, has a limit.”.
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John Zeleny, as documented in two landmark publications in 1914 and 1917, was the first to 
observe these “jets” (later termed Rayleigh jets) and was able to photographically capture their 
bizarre behavior under various conditions of potential (Fig. 3.1(a) and (b)).319,320 Zeleny’s 
technique of creating Rayleigh jets and ionized droplets from a tube became the basis of what is 
today known as electrospray ionization (ESI). After 1917, electrospray disappeared from the  
71 
 
 
 
Figure 3.1. Images of the first observations of electrospray from a tubular sprayer. In 1914, John Zeleny 
was considered the first to document these sprays with his drawings shown in (a). Then in 1917, Zeleny 
became the first to photograph this spray as seen in (b). Taylor made a significant leap when he worked 
out the mathematical formation of this spray in 1964. A few of the images he gathered are shown in (c). 
From references 319-321.  
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Figure 3.2. Spectra demonstrating the first use of ESI for analyzing high mass molecules. The specta in 
the top half show PEG samples with average masses of 400, 1000, 1450, and 3350 Da. The spectrum 
below is Cytochrome C. The inset shows the result of an algorithm which transforms the multiply 
charged peaks into a singly charged combined peak. From reference 322.  
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literature for nearly 45 years until Victor E. Krohn Jr. explored its use as a means of aerospace 
propulsion in 1961.321 
In 1964, in the latter stages of his career, Sir Geoffrey Taylor rekindled his interest in 
electrical activity in thunderstorms, brushing up his knowledge by reading through Lord 
Rayleigh’s works from over half a century earlier. Expounding upon the above quoted passage 
from Lord Rayleigh and also on the work of John Zeleny, Taylor developed an experiment to test 
the instability of these “fine jets” using glycerin and soap film (Fig. 3.1(c)).322 As Taylor was the 
first to derive a mathematical model for this jet phenomenon in the context of a conducting 
spray tip, the geometrical anomaly took on his name: Taylor cone.  
Later in the 60s, Malcolm Dole developed the charge residue model (CRM) which states 
that in charged droplets a sequence of Rayleigh instabilities or Coulomb explosions (with 
intermittent solvent molecule evaporation) causes smaller and smaller droplets to form until 
there is just one analyte molecule with a few adducted charge-containing solvent molecules. 
The last step explains that the “molecule becomes a free gas-phase ion by retaining some of its 
droplet’s charge as the last of its solvent evaporates”.323 Röllgen and coworkers324-326 furthered 
this theory beyond Dole’s original experiments, which coincidently involved special 
circumstances of ionization due to the polymeric system he was studying.327 In 1976, 
meteorologists Iribarne and Thomson proposed a slightly different theory on the formation of 
these gas-phase ions. Known as the ion evaporation model (IEM), this theory states that after a 
series of Rayleigh instability-related fissions, the field on the surface of the daughter droplets 
increases greatly. This highly charge-congested droplet surface is so densely packed that the 
analyte ion is able to overcome the surface tension of the solvent molecules and evaporate from 
the surface of the droplet.328,329 This opposing or rival view and the various researchers that 
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were won over on either side have inevitably helped spur the research and investigations 
further. 
 John Fenn, using his vast experience of free jet expansion, brought ESI into the modern 
age by providing “wings for molecular elephants”330 and solving a large number of mechanistic 
challenges that prevented the vaporization of large biomolecules on earlier electrospray 
devices. Fenn and coworkers’ initial success with ESI came when they altered Dole’s original 
design323 to avoid the drastic amounts of re-solvation that Dole was unknowingly causing.322,331 
Once over this hurdle they showed that ESI could be used to ionize what was at that point-in-
time considered the ‘unattainable’: proteins (Fig. 3.2).322 Importantly, Fenn and coworkers took 
the stance that IEM was the most likely mechanism of ultimate ion formation in ESI, except 
when it came to large macromolecules (i.e., large proteins and polymers) at which point they 
believed the CRM mechanism was most probable.332 Fenn also expanded on the IEM mechanism 
by theorizing that a multiply-charged macro ion (which is charge-neutralized due to negative 
counter ions in solution) can experience Brownian motion within a droplet. In doing this the ion 
may, on occasion, cause one of its more terminal protonation sites to pick up a charge at the 
surface of the droplet. Once this happens, the charge may protrude beyond the boundaries of 
the droplet. This would cause repulsion between the macro ion terminal charge and the droplet 
surface, thus desorbing the rest of the molecule out of the droplet with it. This theory is still 
regarded by many as a very likely form of ion generation in ESI. 
 
2. Fundamentals of electrospray formation  
 With the history and theoretical foundations in place, the utility of electrospray 
ionization is clear and can be successfully harnessed, though the phenomenon is still not entirely 
understood. The process begins by preparing a solution consisting of the analyte of interest and 
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a charge donor dissolved in a “sprayable” solvent. The analyte should be at a concentration 
appropriate for the detector and instrument being used and so will vary greatly accordingly. The 
charge donor identity and concentration is dependent on the analyte being investigated. For 
proteomic and small molecule investigations this charge donor is often a proton donor (e.g., a 
strong acid) prepared at a 0.1% vol/vol concentration. Consequently, under the right conditions 
analyte ionization can occur without the aid of a charge donor through encouraged oxidation 
reactions at the electrospray tubing surface.333-335 The solvent in which these compounds are 
dissolved should be one of a moderate surface tension to allow the proper formation of a Taylor 
cone spray and a vapor pressure sufficient for reasonable evaporation before entering the 
instrument. Some common ESI solvents are listed in Table 3.1. Often for biomolecular/organic 
studies, a 50/50 mixture of water and methanol is used with a small percentage (i.e., 0.1%) of a 
strong acid. 
 The prepared electrospray analyte solution is perfused through a metal (e.g., stainless 
steel) tube of an inner diameter in the range of 100-300 μm at flow rates anywhere from 
6μL/min to 2mL/min for traditional ESI. This metal tube is held at a potential in the kV range and 
is aimed either directly (straight-on) or orthogonally towards the lower-potential instrument 
orifice. As the solution passes over and through the stainless steel tube, charge separation 
occurs where the applied charge forces like-charged ions away from the tube. Conversely, 
oppositely-charged species are drawn in or held more closely. In positive mode for example 
(where a positive potential is applied to the tube), all solution-phase positively-charged species 
are pushed through and away from the tip while natively negatively-charged species are drawn 
close to the charged tube, often inducing oxidation to complete the flow of electrons (as seen in 
Fig. 3.3(a)). This process of charge separation whereby a high localization of positively-charged 
species (in the case of positive mode ESI) is formed around the end of the tube facilitates  
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Table 3.1. Surface tension and vapor pressure values for some common ESI solvents. 
Values obtained from reference 336. 
 
  All values in air at 20°C 336 
Solvent 
Surface Tension 
(dyn/cm)  
Vapor 
Pressure (bar) 
Water 72.8 0.023 
Propanol 23.7 0.024 
Methanol 22.6 0.130 
Ethanol 22.3 0.058 
Isopropanol 21.7 0.044 
Acetonitrile 19.1 0.093 
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protonation (through proton exchange reactions) of organic and biological species with basic 
functional groups.337 This charge separation process is also the driving force behind the 
formation of the Taylor cone. As the localized positively-charged pool of molecules attempts to 
escape the positive charge of the tube, the solution forms a swell at the center of the tube,- 
somewhat owing to the fact that this singular point is the farthest from the tube these species 
can travel. As the amount of charge in the tip of this swell increases it comes to a point and a 
Taylor cone is formed. This cone formation is a combination of many forces, including the relief 
of charge repulsion between the accumulated ions, the “push” of the electrified tube on the 
ions of like charge, and the “pull” the solution experiences due to the opposing (or lower 
potential) charge of the orifice plate. This tip of the cone eventually reaches the Rayleigh limit 
and the Coulombic repulsion of all these positive charges overcomes the surfaces tension of the 
bulk solution which retains it. As the limit is reached, a volume of solution is able to separate 
from the bulk. Under higher strengths of electric field, this spray can take on many shapes 
including a varicose wave filament (seen in Fig. 3.3(b)338) which in fact, was also first theorized 
by Lord Rayleigh.339 Aside from a filament this spray can take on many other shapes as well 
depending on the specific spray parameters (tip voltage, flow rate, etc.), in order to obtain 
electrostatic stability.340 These pockets of solution that separate from the bulk solution, 
regardless of shape, initially contain a sufficient volume of solvent to stabilize the number of 
charges present. However, through the rapid evaporation of the high vapor pressure ESI solvent 
(table 3.1), the volume/charge ratio again reaches the Rayleigh limit and primary droplet fission 
occurs. The daughter droplets are expelled out of the original droplet from Rayleigh jets which 
spray orthogonal to the droplet vector (Fig. 3.3(c)).341 This ejection has also been studied 
intently through experiments on levitated droplets (Fig. 3.3(d)).342,343 Studies on this fissioning 
process have shown that parent droplets have a much higher volume/charge ratio than the   
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Figure 3.3. (a) Schematic of the electrospray process as depicted in reference 337. (b) A photograph of 
the varicose properties of the filament formed at the end of the electrospray cone, from reference 338. 
(c) Photographic observations of Rayleigh jet formation on electrosprayed droplets in mid-flight. 
Interestingly, droplet fission in this study was observed to always take place orthogonally to the electric 
field (from reference 341). (d) Photograph of Rayleigh jets formed on a levitating droplet and showing 
the return to the stable spherical shape in the final image on the right (from reference 342).  
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expelled daughter droplets344,345 (i.e., daughter droplets take proportionally much more of the 
charge then they do the volume of the parent droplet). 
This evidence gives credence to the theory that the predominance of charge resides on 
the parent droplets’ surface and as daughter droplets are expelled they take with them not only 
most of the surface charge but also those analyte molecules which tend to reside near the 
surface of the droplet. Convincingly, it has been shown a number of times that the daughter 
droplets tend to be the major source of analyte ions observed.341,345,346 The large parent droplets 
that are left over after fission contain the remaining charge-paired ions.347 These findings imply 
that electrospray ion detection favors species which are more surface-active and, in fact, this 
implication has been demonstrated experimentally.348,349  
 Beyond the point of initial parent droplet fission, there is a divide amongst researchers 
regarding the next series of steps. It is argued by Kebarle350 that present critical evidence351-353 
suggests Iribarne and Thomson’s IEM mechanism as the most likely model for electrospray 
droplet evolution. Conversely, Kebarle also argues that multiply charged globular proteins most 
likely ionize and vaporize by way of Dole and Röllgen’s CRM mechanism because the 
volume/charge ratio of the unsolvated proteins themselves are approaching the values required 
for Rayleigh instability.354 This phase in the electrospray process becomes increasingly more 
difficult to study as the droplets decrease in size and increase in velocity.  
It has been mentioned that ionization predominantly occurs in the Taylor cone during 
charge separation at the end of the electrospray tip and can also occur at the electrospray tip 
surface through controlled oxidation reactions; however, apart from this some evidence 
suggests that ionization can also occur as far out as daughter droplet formation and fission. 
Studies on solution composition have produced environments where solution-phase 
protonation (such as in the Taylor cone during charge separation) is greatly hampered.355 This is 
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done by running positive mode ESI in extremely basic conditions such that any spare protons 
will immediately be consumed by the basic solution. In one such experiment the pH was 
adjusted to 10 using an ammonium hydroxide (NH4OH) solution. In this solution one would 
expect the excess solution-phase cation (NH4
+) to be the dominant charge-donating specie such 
that analyte ions would be observed as [M+NH4
+]+. The subsequent observation of a strong 
[M+H+]+ peak led to the prediction that NH4
+ reacts with the analyte to produce ammonia gas 
(NH3) and a protonated analyte. This reaction which normally would not occur in the solution-
phase alone is bolstered by the complex chemical interactions between the reactants present in 
different states of matter and the contribution of the solution-phase proton affinity and gas-
phase basicity strengths. However, in another experiment the same conditions were carried out 
by adjusting the pH with sodium hydroxide (NaOH). The persistent presence of the [M+H+]+ ion 
in this case has eluded explanation; however, the authors suggest that the onset of a corona 
discharge may have led to an atmospheric pressure chemical ionization (APCI) mechanism 
involving the production of H3O
+ that acts as the main proton donor. Research in this regard is 
still ongoing and has not yielded definitive answers. 
Performing electrospray ionization at nanoliter volume and size scales has yielded what 
initially appeared to be a very similar source type, dubbed nanoelectrospray ionization (nESI).356 
Although nESI is operated under the same general conditions, a few caveats separate it from ESI 
in some very critical ways. Instead of using a stainless steel capillary with direct potential 
applied, a fused silica capillary (sometimes coated in gold) is used and charge is often applied by 
connecting it to a metal union fitting which is electrified. Nanoelectrospray typically operates at 
between 20-500 nL/min with a spray tip inner diameter of 1-100 μm. Because of these nano size 
regimes, nanospray produces droplets that are already in the nanometer diameter range. This 
causes the initial fission to occur much more quickly due to the increased charge/volume ratio. 
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This is different from standard electrospray in which case an additional fission step must occur 
in between primary droplet formation and the production of nanometer diameter sized 
droplets. In addition, it can be said that nanospray discourages droplet fission by spraying 
droplets that already have on average only one analyte molecule per droplet.357 
 
3. Fundamentals of electrospray suppression 
 Contaminating sample matrices (i.e., salts and other nonvolatile species) have long been 
known to have serious suppression effects on the electrospray process and in fact this 
suppression and its close relation to poor quantitation conditions is considered by many to be 
the major drawback to ESI. Familiarization with the mechanisms of charged droplet formation 
and fission is imperative to understanding the causes of this suppression. For this reason, most 
studies take a fundamental approach to assessing suppression effects. Many findings support 
the idea that the most likely suppression mechanism involves reduced evaporation efficiency.358-
362 The main cause of this reduced evaporation is thought to be several-fold (Figure 3.4):  
 
(i) The nonvolatile contaminants raise the boiling point of the droplet through alteration of 
the colligative properties of the solution. 
(ii) Certain nonvolatile contaminants (e.g., detergents) congregate at the surface of the 
droplet due to their increased surface activity and compete with analyte molecules for 
these sites. This increase in nonvolatile species at the surface of the droplet increases 
the surface tension and thereby decreases evaporation of solvent (by way of the CRM 
mechanism) and analyte (by way of the IEM mechanism) from the droplet. 
(iii) Some contaminants such as salts readily crystalize and, in turn, encourage co-
crystallization with analyte molecules thereby locking them in the solid state and 
negating gas-phase mass spectrometric detection. 
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Figure 3.4. A depiction of the various effects of salt on electrospray analysis. (a) In the depicted 
electrospray droplet, solvated inorganic ions (e.g., sodium, potassium) restrict movement of hydrophilic 
analytes towards the droplet exterior. Surface-active contaminants preferentially occupy the droplet 
surface and reduce the likelihood of analyte evaporation, resulting in ion suppression. Additionally, as 
the solvents evaporate, the salt concentrations increase, and trap analyte in the solid-phase (upper 
right inset region). (b) An illustrative example showing the effect of salt concentration on a standard 
peptide, bradykinin (observed in the spectra in its [M+2H]2+ form, m/z 531.12). Even at a salt 
concentration of 10 mM (compared to cellular medium salt concentrations of 100-150 mM) extensive 
signal suppression and increased baseline effects can be readily observed. 
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(v) The sphere of hydration for strongly solvated ions (e.g., Na+, K+, Li+) is very large and 
restricts mobility of not only the solvated ion but also surrounding analyte ions in the 
droplet bulk solution. This constrained mobility prevents ions that may initially exist in 
the bulk from migrating to the surface to be evaporated. In addition this large sphere of 
hydration charge protects the droplet by presenting uncharged solvent molecules on 
the droplet surface to the surrounding electric field. 
 
Multiple studies on nanoelectrospray have noted its increased tolerance for nonvolatile 
contaminants.356,357 The authors of these studies claim this is a result of the differing 
mechanisms at play in the nanoelectrospray process compared to conventional electrospray. In 
electrospray it is argued, the primary droplets produced are electrostatically stable and present 
in the micrometer diameter range and therefore must undergo considerable solvent 
evaporation before the first Rayleigh instability is reached. This initial evaporation step is 
strongly discouraged as the high nonvolatile contaminant concentration causes the above 
mentioned effects to be heavily exacerbated. If the evaporation is facilitated by adding heat to 
the desolvation region the evaporation process produces highly concentrated small droplets 
which increases clustering of the salt molecules and dramatically increases the background 
noise (Fig. 3.5). Contrarily, in nanoelectrospray the primary droplets formed are already in the 
nanometer range and therefore undergo their first Rayleigh limited fission almost immediately. 
 
4. A dual-column solid phase extraction strategy for online collection and preparation of 
continuously flowing effluent streams for mass spectrometry 
 
With the rise of systems biology, biological research has experienced a shift of emphasis 
over the years from comprehensive measurements of the genome, transcriptome, and 
proteome to dynamic measurements of the metabolome. Methods such as DNA microarrays   
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Figure 3.5. Examples of salt clustering and ion suppression (from reference 357). Panels (a) and (b) show 
nanospray and electrospray (ionspray) spectra of 10mM NaCl. Note the increased background noise in 
the lower spectrum which the authors attribute to “differently charged larger salt cluster ion species”. 
Spectra (c) and (d) demonstrate the increased sensitivity of insulin (at 10μM) in 10mM NaCl.  
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and two-hybrid screening, which have been critical for the advances in genomics and 
proteomics, are less useful for establishing the instantaneous metabolic state of an organism. 
Instead, techniques more capable of rapid analysis have come to the forefront of biological 
research due to the highly transient nature of the metabolome. Temporal integrity has become 
a vital component in these analyses, especially in fields such as cellular dynamics, where 
sufficiently frequent global metabolomics measurements can provide an understanding of 
internal metabolism kinetics.363 A faster sampling frequency and a greater number of detectable 
analytes allow for a more comprehensive interpretation of the system. Analyses on these 
timescales and breadth are well suited for the fast, broad detection capabilities of mass 
spectrometry (MS). 
 Mass spectrometry, when paired with electrospray ionization, is capable of complex and 
dynamic liquid sample analysis, making it a unique fit for the measurement of dynamic living 
systems. However, the application of MS in these areas has been encumbered in the past by the 
need to prepare all samples to remove the abundant low-volatility inorganic salts essential to 
life. Salts, or electrolytes, are used by cells as a general means of maintaining a precise osmotic 
balance and resting transmembrane potentials. In addition, they are required by certain cell 
types for other functions, such as muscle contraction (e.g., heartbeat), nerve signaling, and 
blood homeostasis. Electrolytes are found in varying concentrations in extracellular and 
intracellular fluids, and levels rise and fall through ingestion and perspiration.364 To sustain cell 
viability in culture, cell culture medium contains these essential salts, typically at concentrations 
of 100-150 mM.365,366 These salts significantly interfere with the processes required to ionize and 
vaporize the sample prior to mass analysis. The suppression of ion signal in ESI involves charge 
competition mechanisms during ionization and decreased sensitivity due to a division of ion 
signal across multiple salt cluster species.360,361,367 
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 There are several techniques available to remove contaminant salts from biological 
samples in an offline, or quasi-offline fashion, including but not limited to solid phase extraction 
(SPE), liquid chromatography (LC), and capillary electrophoresis (CE). Collecting samples such as 
blood, lymph, serum, plasma, or cell culture medium effluent from a dynamic system (e.g., living 
organism or live cell culture) and preparing the samples offline result in an accumulation of 
samples and a proportional increase in sample preparation time. Additionally, the collection of 
fractions in this manner results in averaging of dynamic responses with a temporal resolution 
proportional to the duration of each fraction collection. In order to properly sample dynamic 
fluctuations, the frequency with which these samples are collected must be no less than half the 
frequency of the highest fluctuation required by the Nyquist-Shannon sampling theorem.272,273 
For example, if a biomolecular secretion is oscillating at a frequency on the order of 0.1 min -1 (as 
may be seen in glucose-stimulated insulin secretion368), each sample fraction collection must 
contain no more than 5 minutes of secreted material (assuming continuous collection and no 
sample loss) in order for the oscillation to be observable without aliasing. 
 Separation techniques such as LC and CE can perform sufficient online salt removal, but 
often at the cost of losing significant temporal resolution. Numerous online SPE methods exist in 
the patent and research literature;369-381 however, these methods can suffer from extensive 
sample loss, inadequate handling of contaminant streams, and/or poor time resolution. 
Additionally, many of these online techniques are used exclusively to process fractionated 
samples, not continuous sample streams. Dynamic measurement requirements necessitate 
several modifications for such methods to be integrated into a rapid-sampling platform. These 
modifications require the apparatus to accept a constantly flowing sample stream, whereas 
most current online preparation methods utilize single or discrete injections for sample 
introduction (similar to an LC autosampler). Another modification includes a second column to 
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continue to accept sample eluent while the first column is being prepared for analysis. This 
minimizes sample waste and therefore loss of valuable information and temporal resolution. A 
waste cycle needs to be incorporated so that contaminants (salt, etc.) are not directed towards 
the mass spectrometer, as this could cause fouling and plugging of nano-junctions and orifices, 
which is of particular relevance to ESI. Lastly, the apparatus would ideally be miniaturized in 
order to accept and prepare the output flow of various cell culture microfluidics, which could be 
as low as 50 to 500 nL/min. 
 With these considerations in mind, we designed and implemented a three-valve, dual-
column online SPE apparatus that is able to (i) handle a continuously flowing sample stream 
(without directing to waste), (ii) direct contaminants to a separate waste port during washing, 
(iii) analyze flow rates on the order of 500 nL/min or less and, (iv) provide variable 
preconcentration durations to optimize temporal resolution based on analyte concentrations. In 
these studies we implemented our online dual-column SPE apparatus in conjunction with a 
poly(dimethylsiloxane) (PDMS) microfluidic bioreactor as proof-of-concept of this approach. 
Specifically, we have used a cell trapping microfluidic device known as a Multitrap 
Nanophysiometer (MTNP).281,283,288,312 This device is designed to trap and sustain cultures of 
adherent and non-adherent cells. We sequentially perfused solutions of varying biomolecular 
identities through the microfluidic bioreactor to simulate the dynamic online output of a cellular 
culture for temporally coherent preparation of this continuous bioreactor effluent stream for 
ESI-MS. 
 
5. Experimental 
 Desalting Instrumentation. SPE columns are made of 360 μm OD/100 μm ID fused 
silica tubing and are packed with 3 μm, 300 Å, C18 phase Jupiter Bulk Packing 
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(Phenomenex, Torrance, CA) using a PIP-500 Pressure Injection System (New Objective, 
Woburn, MA). Packing was performed at ca. 1000 psi, with column length ranging from 
10-15 cm. Similar to typical chromatography specifications, these columns are replaced 
following ca. 200 injections, and are noted to retain consistent load and elution 
characteristics throughout. The Phenomenex Jupiter phase has been found to have an 
80% recovery rate with a small molecule, hematin (Fig 3.6). Three 10-port Nanovolume 
UPLC Valves with 360 μm fittings, C72MH-4690ED (VICI Valco Instruments Co. Inc., 
Houston, TX), were used to implement the online desalting apparatus. Valve actuation 
was automated using VCOM software v1.1.01 (VICI Valco Instruments Co. Inc., Houston, 
TX). The aqueous solvent and both organic solvent lines, running at 500 nL/min, were 
supplied with an Eksigent Nanoflow Metering System (AB SCIEX, Framingham, MA). 
Additionally, 360 μm OD/50 μm ID PEEK tubing was used between all junctions and 
throughout the entire assembly except for the SPE columns.  
 Sample/Solvent Preparation. RPMI-1640 media (ATCC, Manassas, VA) was mixed with 
Val5-Angiotensin I and Val5-Angiotensin II (Sigma-Aldrich, St. Louis, MO) to make 5 μg/mL 
standard solutions of each. Aqueous solvent (solvent A) is composed of 95% distilled deionized 
water (DDW, 18.2 MΩ cm) and 5% Chromasolv methanol (Sigma-Aldrich, St. Louis, MO) with 
0.1% formic acid (Fisher Scientific, Pittsburgh, PA). Organic solvent (solvent B) is composed of 
95% Chromasolv methanol (Sigma-Aldrich, St. Louis, MO) and 5% DDW with 0.1% formic acid 
(Fisher Scientific, Pittsburgh, PA). 
 Microfluidic Bioreactor/Online SPE Apparatus. A MTNP microfluidic device designed to 
culture mammalian cells was used to simulate the biological microenvironment.281,283,288,312 This 
device was fabricated in-house out of PDMS and silanized with 2- 
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Figure 3.6. Absorbance spectra resulting from the samples measured. For the analysis of the recovery of 
the SPE columns used in this strategy we have performed UV-Vis absorbance measurements on 
solutions of hematin. We have dissolved hemin (Sigma Aldrich) in 0.1M NaOH to substitute the chloride 
moiety for a hydroxyl moiety and thereby produce the water soluble hematin. A Cary 100 Bio UV-Visible 
spectrophotometer was used to measure the absorbance of a blank, which constituted the elution 
solvent (i.e., 95% methanol, 5% water, with 0.1% formic acid). Also measured was a 47 ng/mL solution 
of hematin. This represented a 100% recovery event of a 100 ug/mL hematin solution from a sample 
loop with a total volume of 0.47 uL (roughly 24cm of 0.002” ID/360 um OD PEEK tubing). Next a sample 
solution was measured. This sample solution was generated by filling the sample loop (described 
previously) with a 100 ug/mL solution of hematin (in 0.1M NaOH) and loading this onto a column that 
was bomb loaded (as in the experimental section of the main article), to a length of 11.4 cm with 3 μm, 
300 Å, C18 phase Jupiter Bulk Packing (Phenomenex, Torrance, CA) using a PIP-500 Pressure Injection 
System (New Objective, Woburn, MA). Upon collection of the elution solution (which amounted to only 
about 2 uL), the sample was diluted to 1mL and measured on the UV-Vis. At the peak of the absorbance 
band (397 nm) the sample (blue) spectrum reached an absorbance level of 80% of the total 100% 
recovery solution spectrum (red). This corresponded to absorbance values of 0.016 above baseline for 
the sample (blue) and 0.020 for the 100% recovery solution (red). The red line indicates the spectra for 
the 100% recovery calibrant hematin solution. The blue is the result of the actual sample that was 
eluted from the column. The black spectrum was the blank.  
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[methoxy(polyethyleneoxy)propyl]-trimethoxysilane (Gelest, Morrisville, PA) to minimize 
analyte adhesion.382 No cells were used in this proof-of-concept study. Online sample effluent 
from a dynamic biological system was simulated by using a PicoPlus syringe pump (Harvard 
Apparatus, Holliston, MA) to perfuse media solutions through the PDMS bioreactor.  
 Mass Spectrometry Analysis. All mass spectrometry analyses were conducted on a 
Synapt G2 (Waters Corp., Milford, MA) time-of-flight mass spectrometer (TOFMS) with a nano-
electrospray ionization (nESI) source. Data were collected in continuous fashion to demonstrate 
the characteristics of the desalting apparatus. 
 
6. Results and discussion 
 A detailed examination of prior strategies for continuous flow stream online desalting 
showed that these techniques did not meet our requirements for dynamic cellular studies. To 
address these needs we propose the present dual-column solid phase extraction strategy. The 
following describes (i) the metrics and design criteria for comparing allied desalting techniques, 
and (ii) the evaluation and validation of the dual-column solid phase extraction strategy.  
 
A. Metrics and design criteria  
There are several techniques available to desalt time-course or time-correlated samples 
for mass spectrometry in an offline or online fashion (Table 3.2). In these types of analyses the 
general workflow follows the basic scheme and order of (i) sample/fraction collection (i.e., from 
the organism or bioreactor), (ii) sample preparation (i.e., desalination), and (iii) sample analysis. 
An important distinction is made here to differentiate offline from online experimental 
protocols. In this work, offline techniques are defined as those where sample/fraction 
collection, sample preparation, and sample analysis are performed in separate locations or on   
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Table 3.2. Typical relative figures of merit for methods commonly used for the removal of salt from biological samples 
 
 Relative figure of merit 
Desalting techniques Acceptable flow rate Sample loss
a
 
Ability to pre-
concentrate
b
 
Commercially 
available 
Representative 
references 
Continuous sample treatment (i.e., online) 
Dual-column solid phase extraction nL/min to mL/min No Yes No Present studies 
Online microdialysis nL/min to μL/min No No No 389-391 
Single-column solid phase extraction nL/min to mL/min Yes Yes Yes 
372,373,377,3
79-381 
Capillary electrophoresis nL/min to μL/min Yes Yes Yes 385-388 
Liquid chromatography μL/min to mL/min Yes Yes Yes 383,384 
Discrete sample treatment (i.e., offline) 
Solid phase extraction N/A No Yes Yes 392 
Microdialysis N/A No No Yes 393 
Capillary electrophoresis N/A No Yes Yes 394,395 
 
a Distinguishes the prospect of this technique to direct the incoming flow stream to waste 
 
b Specifies the capacity of the technique for allowing sample material to accrue in some manner
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separate non-connected pieces of equipment. This is often accomplished by storing samples in 
discrete containers (e.g., well plates or microcuvettes). Online techniques are those where these 
steps are performed on the same piece of equipment; all parts and processes are fluidly 
connected in series without human intervention occurring between steps. The techniques listed 
as “Continuous sample treatment” in Table 3.2 are those which are able to accept a continuous 
incoming flow stream, purge it of contaminants such as salts, and subsequently direct it to a 
detector. Online capillary electrophoresis and liquid chromatography are not exclusively used to 
prepare continuous samples streams; however, in principle they are capable of doing so, and 
there are examples of this type of implementation in the literature.383-388 
The most common offline techniques, such as SPE, dialysis, and CE, are generally 
straightforward methods to implement using well-established protocols. When used to desalt 
time-correlated samples offline, these types of techniques require that sequential fractions be 
collected in order to store and later prepare the samples elsewhere. The time-consuming 
sample preparation protocols which follow are often countered by collecting fewer fractions or 
pooling fractions. This, however, leads to lower sampling frequency and increased averaging of 
analyte levels, and precludes the observation of high-frequency perturbations. Additionally, 
offline sample preparation often involves multiple transfer steps that may contribute to sample 
losses.  
 Online methods of desalting, such as LC,383,384 online CE,385-388,396-398 and online single-
column SPE, 369-381 do not suffer as much from long preparation times since sample collection 
and sample detection is integrated with the sample preparation. They do, however, encounter 
challenges related to sample loss and sampling frequency. LC, CE, and SPE utilize one 
column/capillary to do all sample accumulation, processing, and eluting. This dictates the use of 
discreet samples, or in the case of a continuous sample stream, that the incoming sample 
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stream be directed to waste while the single column is being prepared. This sample loss is 
detrimental to a complete temporal record (i.e., between input and output streams) since the 
analyte and information inherent to this lost material are unrecoverable. In terms of continuous 
flow, packed phase column-based techniques (such as LC and SPE) and open capillary column 
techniques (such as CE) are generally able to accept a wide range of collection flow rates. In 
these online techniques, analytes must physically stop for a period of time (whether it be on the 
LC or SPE column or in the CE capillary) in order to carry out the physical separation of salts from 
analytes of interest. While this does increase averaging of molecular signal and preparation 
duration, it also provides an opportunity to preconcentrate low abundant signals.  
 Microdialysis methods as described in the recent literature are a viable option for 
continuous online sample analyses.391,393,399-401 They have the best potential for high temporal 
integrity because it involves diffusional forces across a concentration gradient in an often 
constantly flowing solution stream. Ignoring the potential for loss of low molecular weight 
material through the dialysis membrane itself, online microdialysis does not require the 
incoming sample stream to be diverted to waste and therefore retains all incoming analyte 
material. Microdialysis, when paired with MS, may require post-dialysis solvent conditioning for 
optimal ESI performance and consequently analyte dilution. It should be noted that flow rate 
and back pressure need to be optimized for fundamentally different processes in both 
microdialysis and for ESI and that these values may be dissimilar depending on the arrangement 
that is used. Cell trapping microfluidics, such as the MTNP used in this work, function at flow 
rates on the order of 500 nL/min with minimal back pressure (conditions required for cell 
viability). 
 Dual-column online SPE, such as that presented here, has the potential to provide a 
method of desalting which provides favorable figures of merit for those outlined. The use of two 
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columns negates sample loss by accepting the continuous sample stream on one column while 
the other column is being purged and eluted. The preparation time, while not as expedient as 
online microdialysis, is variable and can, in principle, achieve temporal resolution depending 
only on the number of columns utilized and the duration necessary to wash out salts given the 
particular column characteristics. The non-instantaneous nature of the preparation also 
provides the opportunity to preconcentrate the sample should it be necessary for the detection 
of low abundance analytes. Additionally, similar to most column-based methods, it is better 
suited for low collection/sample flow rates. 
 
B. Method validation.  
The valve arrangement presented here (Fig. 3.7(a), (b)) uses a six-step cycle (Fig. 3.7(c)) 
which provides a constant loading condition, ensuring that all analyte material in the online 
sample effluent will be collected if desired. In addition, contaminants are rinsed from the SPE 
columns during a purge step which is directed to waste. Valve cycle steps can be scaled in time 
uniformly to yield a cycle which is better for detecting high frequency oscillations (short step 
durations) or one which is better for detecting very low abundance analytes (long step 
durations). Figure 3.7(c) outlines the valve switching scheme for online sample preparation. In 
step 1, the valve orientation is as pictured in Figure 3.7(a), such that SPE column A is loaded with 
online sample effluent and SPE column B is desalting a sample plug and sending salts to waste. 
Valve 3 is switched such that SPE column A is receiving sample effluent and SPE column B is 
eluted and directed towards the MS for ion detection. Because this is the first cycle, column B 
has not actually been loaded with any analytical material at this time and so this elution is blank 
(as observed later). After this, valve 3 is switched so that SPE column B is equilibrated with 
aqueous solvent in preparation for its subsequent loading step. SPE column A continues to load   
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Figure 3.7. (a) The three-valve arrangement used in the online SPE experiments. All three valves were 
individually actuated by coordinated, automatic computer control. The legend indicates the valve 
orientation notation. (a) Simplified diagram showing 4- and 6-port valves. (b) Implementation of (a) 
using 10-port valves with unused ports being capped. (c) A chart showing the sequence of states for 
valves (listed in numerical order), SPE column A, SPE column B, and the detector (MS) through the six-
step cycle.  
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sample throughout the equilibration of SPE column B. Next, valve 1 is switched such that the 
online sample effluent is directed to the newly equilibrated SPE column B. SPE column A is 
purged with water at this step, allowing for desalination of the sample collected on the column. 
Valve 2 is switched and SPE column A is eluted with organic solvent, while SPE column B is left in 
the loading position. Lastly, valve 2 is switched to equilibrate SPE column A and the SPE 
apparatus starts the entire cycle again. Note that the MS is analyzing a sample for only two of 
the six steps. Were Fig. 3.7 implemented in triplicate, it would be possible for six samples to be 
interleaved without sample loss or overlap, enabling analysis, for example, of three parallel 
bioreactors that could provide one control and two different experimental conditions near 
simultaneously.  
Various standards were perfused through a MTNP microfluidic bioreactor and onto the 
dual-column online SPE apparatus to validate temporal response and reproducibility (Fig. 
3.8(a)). Figures 3.8(b) and 3.8(c) depict the valve timing and resulting total ion chromatogram 
(TIC), respectively, for the online SPE apparatus. The valve cycle produces a pattern of two 
alternating sets of peaks (i.e., every other peak originates from the same column). When the 
time-step durations are set equally, this yields a single time period of elution followed by two 
time periods of clean solvent, hence the rise and fall shape of the chromatogram. Importantly, 
the length of these time steps can be adjusted to shorter durations to emphasize temporal 
dynamics or longer durations to extend preconcentration steps and thereby aid in identifying 
lower abundance signals. In Figures 3.8 and 3.9 the time steps were set to one minute, yielding 
three minutes of load time, and one minute each for purging, eluting, and equilibrating. Using 
this timing scheme the limit of detection for a model metabolite (hematin) was observed to be 
50 ng/mL or ca. 75 pg (118 fmol) of total material (see Table 3.3 for details).   
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Figure 3.8. Experimental scheme with valve timing and sample elution for the online apparatus. (a) 
Scheme depicting how the various sample solutions were perfused through a MTNP microfluidic device 
and then into the desalting apparatus. This arrangement was chosen to simulate a dynamically varying 
continuous sample stream originating from a live cell bioreactor. (b) Chart illustrating the valve cycle. 
Importantly, the chart shows that the loading step is continuous and occurs on one column while the 
other column is purged of contaminants, eluted to remove analyte material, and then equilibrated to 
prepare for the next loading cycle. (c) An example total ion chromatogram (TIC) showing the typical 
peak and trough pattern produced from the cycle shown in (a). The peaks are labeled based on the 
column from which the analytes are eluted.  
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Table 3.3. Quantitative data demonstrating the limits of detection for the dual-column online solid 
phase extraction desalter. The previously mentioned procedure (Fig. 3.6/Experimental section) was 
used to produce hematin standards at concentrations of 1000, 500, 100, 50, and 10 ng/mL. These 
hematin standards were run through the desalter setup (presented in figure 2) to evaluate the system’s 
limit of detection. The overall integrated peak areas for the resulting chromatograms are presented in 
Table S1. Interestingly, since these solutions were made in 0.1 M NaOH, these samples also contained 
an unusually high amount of salt (4 g/L). These samples were not preprocessed in any way prior to 
running through the online SPE desalter. 
 
Hematin (in 0.1M NaOH) 
Concentration 
(ng/mL) 
Molarity 
(nM) 
Total material 
(pg)† 
Total moles 
(fmol) 
Integrated area* 
1000 1578.38 1500 2367.57 3.23E+04 
500 789.19 750 1183.79 2.21E+03 
100 157.84 150 236.76 914 
50 78.92 75 118.38 273 
10 15.78 15 23.68 0 
† With a load time of 3 min at 500 nL/min 
* Using a MassLynx peak to peak amplitude of 200  
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In order to simulate dynamic cellular output, three syringe pumps were connected to 
the inlets of an MTNP microfluidic bioreactor device (Fig. 3.8(a)). The first pump delivered a 
solution containing 5 μg/mL of Val5-Angiotensin I (Standard #1) in RPMI 1640 medium through 
the device and into the desalting apparatus for 15 minutes, followed by delivery by the second 
pump of RPMI 1640 medium (without any additives) for 15 minutes, and then the third pump 
delivered 5 μg/mL of Val5-Angiotensin II (Standard #2) in RPMI 1640 medium for an additional 
30 minutes. After this, RPMI 1640 medium was flowed for 30 minutes using the second pump, 
followed by clean deionized water for 80 minutes using the first pump, which originally 
delivered Angiotensin I (sequence shown in Fig. 3.9(a)). 
In Figure 3.9(b), the data show a total ion count increase for 30 minutes, at which point 
the ion signal reaches a steady state, and then decreases after the deionized water has been 
flowing for ca. 30 minutes. The TIC peaks displayed in Fig. 4b were integrated to determine the 
repeatability of these elution cycles. Importantly, only the peaks occurring from minute 27 to 
minute 120 were used, as this was considered the time over which the signal was in equilibrium. 
The peak areas were found to have a percent relative standard deviation of ca. 15% throughout 
these experiments. Note that intracolumn (only for column A or B) reproducibility and 
intercolumn (for both column A and B) reproducibility are 14.6 % (n = 16, m = 2) and 15.0 % (n = 
32), respectively. Figure 3.9(c) shows the extracted ion chromatogram for Val5-Angiotensin I, 
m/z 642.40. These data show that although Val5-Angiotensin I was perfused at minute 0, it was 
not detected until the second cycle (minute 6), owing to the inherent blank first cycle (discussed 
above). Additionally, the signal for Val5-Angiotensin I was not greatly reduced until minute 25 
and residual traces of m/z 642.40 were observed throughout the experiment. This hysteresis is 
typical when using C18 phase SPE columns and can be mitigated by using more rigorous column 
conditioning methodologies.402 Figure 3.9(d) shows an extracted ion chromatogram (XIC) for  
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Figure 3.9. A variable analyte concentration experiment, showing perfusion of different analytes (in RPMI 1640 medium) and 
H2O through the MTNP, to characterize the online SPE desalting apparatus. (a) A chart showing the progression of solutions 
through the apparatus over the course of a 170-minute experiment. (b) The TIC for the experiment. (c-e) Extracted ion 
chromatograms for (c) Standard #1, Val5-Angiotensin I, m/z 642.40, (d) Standard #2, Val5-Angiotensin II, m/z 516.80, and (e) 
the [M+Na]+ ion of glucose, m/z 203.01, in the RPMI common to the first four analytes. The asterisk (*) corresponds to a 
break in the data between minutes 86 and 88, which was the result of the data file reaching its maximum length and the 
initialization of a second file. The two files were combined based on their accurate time tags 
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Val5-Angiotensin II, m/z 516.80. Similar to Val5-Angiotensin I, the signal for Val5-Angiotensin II 
appears at the second cycle and some hysteresis is observed. In Figure 3.9(e), the XIC for glucose 
([M+Na]+, m/z 203.01) is shown. Glucose was a unique identifier of cellular media in these 
experiments (i.e., only present in the RPMI 1640 media). RPMI 1640 medium was present from 
0-90 minutes in this time course; however, the ion signal for glucose was not detected until 
minute 27. These results suggest changes in column affinity as other cellular material began to 
bind and interact with the column. Glucose was also susceptible to hysteresis, as evidenced by 
the lingering signal even 60 minutes after RPMI 1640 medium was discontinued. Alternatively, 
the hysteresis effect could be related to carbohydrate affinity for silica surfaces (e.g., C18 phase 
bead surface). Increasing the time-step duration (and thereby decreasing the resolution) allows 
one to better observe lower abundance analytes and mitigates the observed hysteresis. 
Decreased hysteresis is accomplished due to a longer elution step, which ensures that more 
material is removed from the SPE column every cycle. To further assess the repeatability of 
these elutions, the peaks resulting from glucose specifically (from minutes 27-120), were 
integrated and found to have percent relative standard deviations of ca. 20% for both 
intracolumn and intercolumn precision. Regardless, this apparatus exhibits satisfactory desalting 
capabilities, as shown in Figure 3.10. In the absence of any form of desalting, a stable 
electrospray was not able to be generated and therefore no ions were observed. With the use of 
the dual-column SPE apparatus, an abundant analyte signal was observed for both model 
peptides. 
This apparatus demonstrates the capability to successfully analyze and ionize small 
peptide analytes within a continuous salt-rich sample stream using dual-column online SPE 
desalting techniques (Fig. 3.9). This capability is required when performing analyses on lab-on-a-
chip/microfluidic bioreactor devices or other bioreactors where analyses need to be performed   
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Figure 3.10. Demonstration of desalting capabilities of the dual-column SPE apparatus when used to 
assess an online dynamically fluctuating flow stream. (a) Combined mass spectrum from minute 45 to 
48 showing the peptide DRVYVHPF from desalted cell culture medium. (b) Inset of the mass spectrum 
for the region immediately surrounding the peptide DRVYVHPF (standard #2, Val5-Angiotensin II), at m/z 
516. In a companion experiment without desalting, a stable spray could not be produced for this sample 
without first desalting it, thus no ions were observed and no spectrum was generated 
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online in a temporal fashion and with small sample amounts. Measurements on this timescale 
were previously time-consuming due to the offline nature of most preparation work-flows. By 
keeping the sample online and preparing sample material using two SPE columns in parallel, 
sample loss is negated and sample preparation time is drastically reduced. Thus more frequent 
measurements and comprehensive data can be used to interpret biological systems.  
For a representative experiment to demonstrate the applicability of this strategy to 
collect data from a biological system, we have presented here, spectra collected from a 
microfluidically-cultured population of insulinoma (Rin-m5f) cells. Upon exposure of the cells to 
glucose a number of signals were detected3. Among these was the clear presence of a protein 
of similar mass to ubiquitin (Fig. 3.11(c), (d)). This protein has been observed in similar 
traditionally-cultured offline studies of this nature.1 Concurrent with these desalting/mass 
spectrometry analyses we also performed fluorescence analysis on these cells (Fig. 3.11(a), (b)). 
Fluo-4 fluorescent calcium indicator dye used was used in conjunction with a Nikon Eclipse Ti 
inverted fluorescence microscope for visualization. This data demonstrates the potential for this 
strategy to be used for analysis of biological systems and also in conjunction with other 
analytical techniques to aid in systems-level studies. 
 
7. Conclusions 
 We have described a strategy with a demonstrated ability to perform temporally 
resolved online desalination of a continuous sample stream at a resolution of three minutes 
with minimal loss of analyte and a lower limit of detection in the fmol to pmol range for small 
molecules. Under these conditions recoveries of ca. 80% are obtained even at fmol loadings. 
These experiments show that highly dynamic analyte fluctuations can be observed and non-
volatile contaminants can be removed prior to downstream ESI-MS. Continuous online  
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Figure 3.11. Data from a microfluidically-cultured population of insulinoma (Rin-m5f) cells. (a) 
Fluorescence microscopy showing baseline calcium secretion. (b) Calcium secretion upon exposure to 
glucose. (c) The extracted ion chromatogram (XIC) for the 12+ charge state of ubiquitin (the highest 
intensity isotopic peak, m/z 714.64, was chosen for visualization of the XIC). (d) The resulting mass 
spectrum of ubiquitin. 
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desalination provides a decrease in sample preparation time compared to fractionation (on the 
order of 10-30 minutes per sample). Importantly, we demonstrated the ability to observe 
analyte concentration changes in less than five minutes. This feature could prove useful for 
metabolic flux analyses and metabolic control analyses. This apparatus can also be used to 
prepare fractionated samples; however, the most beneficial application will be the study of the 
dynamic metabolic output of living systems or organisms. 
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CHAPTER IV 
 
REAL-TIME CELLULAR EXOMETABOLOME ANALYSIS WITH A MICROFLUIDIC-MASS 
SPECTROMETRY PLATFORM 
 
1. Introduction 
Cellular response is a complex phenomenon that manifests both physically and 
chemically. While physical responses can most often be analyzed visually, chemical responses 
are difficult to characterize even with modern detection methods. Adding to the difficulty is the 
influence of timing when dealing with cellular response. When responding to a biochemically 
altering stimulus, such as naïve T cell response to an antigen presented by a dendritic cell, a cell 
undergoes a series of biochemical pathway shifts that allow it to adapt to its new conditioned 
state. The cell’s temporal response, therefore, provides insight into the interspersed pathway 
shifts that occur throughout the various stages of stimulus exposure. Temporal response is 
especially relevant to toxicology, where, despite experiencing a toxin and undergoing numerous 
metabolic shifts, an organism may not show observable external symptoms until much later, 
when effective treatments are no longer as useful.  
Nonetheless, time remains a largely underappreciated or neglected variable in most 
comprehensive cellular response experiments, not as much for its perceived lack of value as for 
its difficulty of precise temporal resolution and control of measurements. Biological 
measurements typically take one of two forms; either they sample a small number of targets 
very frequently (e.g., immunoassay or fluorescence measurements) or they sample a plethora of 
targets over a broad time span (e.g., proteomic workup). The limitations of current 
methodological strategies and detection technologies stymie the combination of these two 
approaches. The most comprehensive analysis would track as many analytes as possible and 
sample these analytes as frequently as possible to capture the truly dynamic properties of 
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metabolic responses. As the frequency of sample collection is increased, previously unidentified 
patterns in signal response may begin to emerge, according to the Shannon-Nyquist theorem, 
which states that in order to properly characterize a pattern containing a frequency of Y, the 
sampling must occur at an interval greater than 1/(2Y).272,273 Also, increasing the sampling 
frequency may reduce the possibility of aliasing, wherein rapidly varying phenomena are 
undersampled in violation of the Shannon/Nyquist theorem to produce misleading results. 
With the approach in place, a major logistical problem still remains: how does one 
sample a biological system multiple times over the course of an experiment without destroying, 
or even perturbing, that system? The exometabolome, or suite of biomolecules that are 
secreted or excreted from a cell into the surrounding matrix, represents a promising target. The 
exometabolome has been demonstrated as a viable indicator of internal cellular processes and 
can be easily assessed without any disturbance of the system from which it originates.278,404 
Changes in exometabolomic species transport provide information on the current state of the 
cell population, which can lead to a more thorough understanding of the particular cell’s biology 
and to the ability to control the cell’s behavior.  
The cell is constantly surveilling the surrounding environment. Perceived changes in this 
microenvironment lead to alterations of intracellular and intercellular signaling, which in turn 
lead to shifts in gene regulation and modifications in protein and metabolite production. 
Depending on the signal received, the intracellular processes enacted may lead to the secretion 
of another signaling factor to extend the complex web of communication. These signaling 
factors are produced by a given cell for communication with 1) nearby cells of the same type 
(autocrine signaling), 2) adjacent cells (juxtacrine signaling), 3) nearby cells of a different type 
(paracrine signaling), and 4) distant cells (endocrine signaling). The exometabolome not only 
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includes traditional signaling molecules, but also enzymatically produced metabolites of 
xenobiotics (i.e., drugs, toxins) introduced to cells.  
 The Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE) 
Multitrap Nanophysiometer (MTNP) is a poly(dimethylsiloxane) (PDMS) microfluidic device that 
functions as a miniature bioreactor. In contrast to traditional cell biology techniques that often 
require cellular populations on the order of >108, the MTNP allows for studies on small 
populations of cells or simple organisms (<105). The MTNP has been used for long-term optical 
measurements of the dynamic behavior of cells, including fluorescent labeling of cells to 
determine type and activation state and detect signaling dynamics.281,283,284 This device provides 
a framework on which to study numerous cells, i.e., T cells, beta cells, and breast cancer cells, as 
it traps both non-adherent and adherent cells with structural barriers instead of with chemical 
surface modification that may cause cells to be exposed to higher shear stresses resulting from 
direct contact with fluid flow. The MTNP is well suited to detect secreted molecules in cellular 
effluent, and it is also unique in its ability to provide a system for investigating the dynamic 
response of a cell population to a stimulus. The constant perfusion design of the microfluidic 
bioreactor gives rise to a platform component capable of real-time alteration and control of the 
cellular microenvironment, in addition to providing an opportunity for monitoring the effluent 
output from the device.  
 The complexity of biological samples often overwhelms standard screening techniques 
seeking to discover biomarkers of disease or rapidly assess drug efficacy. This unique problem 
warrants an analytical technique capable of both rapid screening of samples and sufficient 
sensitivity to account for the many analytes in low abundance that typically comprise 
metabolomic and signaling experiments, which often either defy detection or appear collectively 
as chemical noise. The use of mass spectrometry (MS) as the leading detection method of 
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proteomic,405 lipidomic,406 and glycomic407 studies has led to many advances in elucidating the 
complexity of the cell.  
 The combination of constant microfluidic perfusion bioreactors with mass spectrometry 
has the potential to rapidly screen cell effluent for secreted species indicative of internal 
metabolic perturbations. Several studies have taken on the challenge of integrating these 
technologies to produce a powerful analytical platform. In an early experiment, Chan et al. 
verified that using PDMS bioreactor devices to transfer samples into the electrospray ionization 
mass spectrometer (ESI-MS) did not contaminate the samples.309 On-chip ultrafiltration and 
analyte pre-concentration for high-throughput small molecule screening with ESI-MS were 
performed with the resulting detection sensitivity shown to increase by one to two orders of 
magnitude over off-chip screening strategies.311 A significant impairment in coupling cellular 
bioreactor microfluidic devices with online-MS is in the suppression of signals of interest by salts 
present in biological samples. To combat this problem, some form of desalting is typically 
performed offline, using either a solid phase extraction (SPE) column and vacuum manifold or 
some form of liquid chromatography. These techniques desalt samples by providing a 
functionalized surface for which salts and analytes have differing affinities. For example, liquid 
chromatography (LC) typically uses C18 columns, which provide good affinity binding sites for 
non-polar molecules but lack sufficient interaction prospects for salts, thereby allowing for an 
aqueous rinse to clear the column of salts and a subsequent organic elution of analytes without 
the suppressing contributions from salts. These methods, while providing an efficient means of 
desalination, come at the expense of temporal resolution, and they are not designed for online 
analysis. One recent development in the online desalting of effluent from a microfluidic 
bioreactor is the work of Chen et al., which incorporates a packed micro-solid phase extraction 
column.378 
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 We have previously demonstrated the ability to rapidly desalt a continuous sample 
stream using online SPE.312 This work directly translates to the processing of continuous sample 
streams originating from a MTNP. Using online SPE for such applications provides a surface for 
which analytes of interest have affinities but unwanted salts do not. This allows for variable 
duration periods of pre-concentration of the analytes. 
 As an initial proof of concept experiment for this integrated platform, we selected 
cellular memory of drug exposure, specifically Jurkat T cell memory of cocaine, for ease in 
identification of known drug metabolites and for its unique biological information. The choice of 
cell type was based upon cocaine’s classification as an immunosuppressive agent, whether by 
mechanisms of direct and/or indirect actions on immune cells. Findings from experiments tying 
cocaine to immune function suppression have been contradictory at times,408-412 most likely 
because of the complex biological systems under investigation and wide variety of experimental 
procedures. A major hurdle in determining these mechanisms is the lack of an assay capable of 
tightly controlled environmental parameters, temporal robustness to avoid loss of intermittent 
changes, and multi-parameter sampling for unique evidence of experimental variable 
interconnection. The platform proposed herein allows for such an assay to be conducted. 
Through the comparison of naïve Jurkat T cells and those with prior cocaine exposure on this 
platform, differences in cocaine metabolism may be detected. Figure 4.1 demonstrates the 
experimental concept. Exposure of a naïve cell to cocaine may lead to a certain exometabolomic 
profile which defines the state of the cell. However, when a cell with prior cocaine experience 
receives a subsequent dose, the exometabolomic profile may either be identical to that of the 
naïve cell under exposure or distinguish the cell as unique. With a near real-time readout of 
cellular metabolic events on our integrated microfluidic-solid phase extraction-ion mobility- 
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Figure 4.1. Experimental scheme showing the potential cell fates (in terms of exometabolomic profiles), 
demonstrated here as color change, for naïve and cocaine-experienced cells upon exposure to cocaine 
in a microfluidic bioreactor.   
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mass spectrometry platform, it may be possible to determine variations in exometabolomic 
profiles that will provide evidence of cellular memory of cocaine exposure. 
 
2. Methods 
 
A. Microfluidic bioreactor design and fabrication 
 The VIIBRE Multitrap Nanophysiometer (MTNP) was previously designed in AutoCAD 
and converted to a chrome mask on glass (Advance Reproductions, North Andover, MA). A 
silicon master was produced through photolithography methods which include spinning a 
negative photoresist, SU-8, onto silicon wafers, exposing them to UV light through the desired 
mask to crosslink the SU-8, then developing to remove non-cross-linked polymer.413 
Poly(dimethylsiloxane) (PDMS) (Sylgard 184 Elastomer Kit, Dow Corning, Midland, MI) was then 
cast onto the silicon and SU-8 master, cured, and removed from the master. Inlet and outlet 
ports were punched and PDMS replicas were bonded to glass coverslips by O2 plasma treatment 
(Harrick Plasma Cleaner, Ithaca, NY).  
 
PDMS Surface Modification 
 Liquid 2-[methoxy(polyethyleneoxy)6-9propyl]trimethoxysilane (PEG-silane) was 
obtained from Gelest (Morrisville, PA). Immediately following plasma treatment, devices were 
intubated and a 2% solution of PEG-silane in 95% ethanol, 5% H2O, and 11 mM acetic acid was 
injected until the device interior was filled. Devices were allowed to incubate at room 
temperature for 10 minutes followed by a rinse with ethanol, then water. A final incubation on a 
hot plate at 110°C for 10 minutes was then performed to evaporate any remaining solvent and   
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Figure 4.2. PDMS silanization scheme showing hydrolysis of methoxy group from PEGn trimethoxysilane 
to form silanol groups (A) and the steps of PDMS activation (B(i)), silane deposition (B(ii)), condensation 
of the silane into chains (B(iii)), hydrogen bond formation between silanol and oxidized PDMS surface 
(B(iv)), and covalent bond formation between silane and PDMS surface (B(v)).   
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complete the surface modification. Supplemental Figure 4.2 portrays the steps in the covalent 
surface modification of PDMS. 
After at least 24 hours at room temperature, each device was perfused with 
fluorescently labeled insulin at a rate of 500 nL/min for 30 minutes and then rinsed with Ringer’s 
buffer (118 mM NaCl, 5.4 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 20 mM 
HEPES) for another 30 minutes. Images were collected every 15 seconds during the perfusion 
and rinsing stages with an inverted Nikon Eclipse Ti-e fitted with a 495 nm/521 nm 
excitation/emission filter set for fluorescent imaging of adsorbed insulin. Images were aligned 
and processed with Image J for comparison of total fluorescence intensity. 
 
B. Cell culture and “in-culture” cocaine exposure 
 Jurkat T cells (clone E6-1, TIB-152) (ATCC, Manassas, VA) were cultured in 90% RPMI 
1640, 10% fetal bovine serum (FBS, heat inactivated) (Lonza, Allendale, NJ) at 37°C, 5% CO2 
according to the manufacturer’s instructions. 
 In-culture cocaine exposure experiments were performed as follows (Figure 4.3). Two 
populations of Jurkat T cells (passage 6, 2 million cells/ml, 500 µL, in biological triplicate) from 
the same culture flask were added to two separate microcentrifuge tubes. Both tubes were 
centrifuged at 200 × g for 2 minutes and supernatant was removed. Cells in tube one were 
resuspended in 500 µL of RPMI 1640 and incubated for 54 minutes at 37°C, 5% CO2. The cells 
were then centrifuged as above and resuspended in RPMI with cocaine at 60 µg/ml, then 
incubated for another 54 minutes. This cell population received two more steps of media 
switching, RPMI then cocaine, for a total of four 54-minute exposure periods. Each time the cells 
were centrifuged, the supernatant was reserved for protein precipitation and metabolomic 
analysis. Since these cells lacked pre-exposed to cocaine, they were termed “naïve.”  
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Figure 4.3. Cocaine exposure scheme for both in culture and online cell experiments showing the time 
course of cocaine administration to naïve (blue) and experienced (green) T cell populations.   
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 Cells in the second tube were resuspended in 500 µL of cocaine in RPMI 1640 (60 µg/ml) 
and incubated for 216 minutes at 37°C, 5% CO2. After this period, cells were again centrifuged 
and then exposed in the same manner as tube one with alternating exposure to plain RPMI 1640 
and cocaine. Supernatant from these samples was also kept for metabolomic analysis. Since 
these cells had an extended cocaine pre-exposure period, they were termed “experienced.” 
 In order to investigate the cocaine degradation over the time course of the experiment, 
samples of cocaine in RPMI were incubated in the same conditions as the cells and sampled at 
each 54-minute time point starting at time zero and ending at 10.5 hours.  
 
C. Metabolomics sample preparation and UPLC-ESI-IM-MS analysis 
 As each 54-minute time point was taken, supernatant was placed on ice to halt any 
continued metabolite modifications and immediately processed for protein removal with cold 
methanol. To each 300 µL supernatant sample, 900 µL of cold methanol was added, vortexed, 
allowed to sit for 10 minutes at 4°C and then centrifuged at maximum speed for 10 minutes in a 
Heraeus Fresco 21 temperature-controlled centrifuge (Thermo Scientific). Supernatant was 
transferred to a new microcentrifuge tube and kept at 4°C until all samples were collected and 
processed. All samples were then dried down in a Savant DNA 110 Speedvac overnight with low 
heat and reconstituted in 300 µL 5% methanol/95% water (0.1% formic acid).  
 Samples were placed in the sample tray of the NanoAcquity UPLC with autosampler 
(Waters, Milford, MA), which remains cooled to 4°C to prevent sample degradation. Ultra 
performance liquid chromatography was performed on 1 µL samples loaded on a HSS C18, 1.8 
µm particle size column with mobile phase A (0.1% formic acid in H2O) by ramping from 100% 
mobile phase A to 100% mobile phase B (0.1% formic acid in MeOH) over 11 minutes, then 
holding at 100% mobile phase B for 2 minutes. Ion mobility-mass spectrometry and MSE were 
117 
 
then performed on the eluted analytes using the Synapt G2 ion mobility-mass spectrometer 
(Waters, Milford, MA). Quality control samples were dispersed every 10 samples in the Waters 
MassLynx v4.1 software sample list among technical triplicates of each biological sample. 
 
D. Online cell loading and experimentation 
 Prior to experimentation, 500-1000 µL of cell suspension was removed from culture 
flasks. Cells at passage 6 were used for experiments. Cells were then gently pelleted and 
aspirated into polyether ether ketone (PEEK) tubing connected to pump-controlled syringes. The 
flow direction of the pump was reversed upon intubation of the MTNP and cells were collected 
into microfluidic traps for experimentation. Cell-loaded devices were then perfused with 
selected media components and bright-field images were collected by an inverted Nikon Eclipse 
Ti-e (Nikon Instruments, Melville, NY). Cells in the MTNP were maintained at 37°C and 5% CO2 
during experimentation. 
For T cell cocaine metabolism studies, populations of naïve T cells and experienced T 
cells (exposed to cocaine at 60 µg/mL in RPMI 1640 for 4 hours) were stimulated with either 
cocaine (60 µg/ml in RPMI 1640) or RPMI 1640. Cells were initially exposed to plain RPMI media 
for 54 minutes, followed by exposure to cocaine at 60 µg/mL in RPMI for 54 minutes. Both steps 
were repeated for a total of four steps. Experiments with naïve and experienced cells were 
performed on the same day, in series, to exclude any variation in cell population from day to 
day. The cocaine exposure scheme is the same as the in-culture exposure, shown in Figure 4.3. 
 
E. Solid phase extraction desalter 
Columns are made of 360 µm OD/100 µm ID fused silica tubing and are bomb-loaded in 
house with 3 μm, 300 Å, C18 phase Jupiter Bulk Packing (Phenomenex, Torrance, CA) using a PIP-
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500 Pressure Injection System (New Objective, Woburn, MA). Three 10-port Nanovolume UPLC 
Valves with 360 µm fittings, C72MH-4690ED (VICI Valco Instruments Co. Inc., Houston, TX) were 
used for the valve arrangement (Figure 4.4). The aqueous solvent and both organic solvent lines, 
running at 500 nL/min, were supplied with an Eksigent Nanoflow Metering System (AB SCIEX, 
Framingham, MA), which has four independent flow channels. The output lines from the two 
downstream valves were connected with a micro-T junction and fed directly into the mass 
spectrometer via a nano-electrospray ionization (nESI) source. Cheminert 360 µm unions (with 
100 µm bore) were used for all tubing-to-tubing connections (not shown). Only fittings for 360 
μm OD tubing were used as the more popular 1/16” fittings requiring sleeves to connect to 
smaller bore tubing instigated leakage at high backpressures. Other than the columns, which 
were made of fused silica, 360 µm/50 µm PEEK tubing was used. Prior to experimental use a 2 
μg/mL solution of polyarginine was run through the system to bind all non-reversible interaction 
sites. Elution cycles were then run overnight to ensure all reversibly bound material was 
removed before experimentation. Sample loops were added to the system (as seen in Figure 
4.4) to reduce backpressure buildup. 
 
F. Online cell effluent desalting and mass spectrometry analysis 
 All online cell effluent experiments were conducted using PDMS MTNP devices. 
Cellular effluent from the device was processed online prior to mass spectrometry analysis using 
the online SPE desalter in Figure 4.4. Cell effluents, driven by syringe pumps upstream of the 
bioreactor, were filtered with an inline filter (1 µm stainless steel frit, followed by a 0.5 µm 
polymer mesh, IDEX Health & Science, Oak Harbor, WA) and loaded into each sample loop. 
Sample loops, which were made of 360 µm OD/250 µm ID tubing, were 12.2 cm long, providing 
a sample loop volume of 6 μL. The continuous sample stream was diverted into each sample   
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Figure 4.4. Solid phase extraction desalter setup starting from initial sample effluent flow incorporates 2 
sample loops, 3 valves, and 2 C18 columns. During (A), sample effluent fills sample loop 2 for 9 minutes, 
while the aqueous solvent flows through sample loop 1, over column 1 and to waste. The organic 
solvent flows over column 2 and to the mass spectrometer. B) Upon switching of the valves, the sample 
effluent fills sample loop 1 for 9 minutes. Aqueous solvent forces the 1.5 µL head of aqueous solvent, 
the 4.5 µL of sample effluent, and an additional 2.1 µL of aqueous solvent over column 2 to equilibrate 
the column, load the sample, and rinse away the salts. Organic solvent runs through column 1 and to 
the detector. C) The next valve switch again exchanges the sample loop filled by effluent, while column 
1 is equilibrated, loaded, and rinsed. The analytes captured on column 2 are eluted by the organic 
solvent and sent to the detector. D) When the valves switch again, the sample effluent fills the opposite 
loop, column 2 is equilibrated, loaded, and rinsed, and column 1 is eluted with organic solvents and 
those analytes are sent to the detector. The pattern repeats until the experiment is completed.  
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loop for exactly 9 minutes at 500 nL/min, thus filling the sample loop to 75% capacity. Because 
water was always flowing through these sample loops immediately prior to sample flow, a plug 
of 1.5 μL of water preceded each sample effluent plug. This plug served to quickly and roughly 
equilibrate the column with an aqueous solvent. Once the loop was filled to 75% with online 
sample effluent, the small water plug and sample effluent were passed over the column, using 
the aqueous solvent line to generate the necessary backpressure. Once the effluent had cleared 
the sample loop and had been entirely passed over the column, an additional 2.3 minutes or 2.1 
μL of aqueous solvent (H2O with 0.1% formic acid) was run over the column to serve as the 
rinsing/purging step to remove residual salts. Following the salt purge, the column was eluted 
with organic solvent (90% methanol, 10% H2O, 0.1% formic acid). Each step of this process from 
the initial effluent flow through the SPE desalter is illustrated in Figure 4.4. Data were collected 
using MassLynx software (Waters Corp., MA) by Data Dependent Analysis (DDA) method cycle 
files, where each column elution was collected as an individual file. Collecting each column 
elution as individual data files aided sample analysis, as explained later.  
 
G. Data processing and multivariate statistical analysis 
 Resulting data sets from both online and in-culture experiments were processed using 
Waters MarkerLynx software along with Umetrics Extended Statistics software for multivariate 
statistical analysis (Waters Corp., MA). All spectra were corrected to sodiated HEPES buffer 
([M+Na]+ exact mass 261.0888), centroided, and peaks were normalized to 10,000 counts per 
sample. Only spectra from samples analyzed through UPLC were deisotoped and underwent 
chromatographic peak detection. Data from online experiments were processed by a combined 
scan range. An intensity threshold was set for all data at 1000. Principal component analysis 
(PCA) with Pareto scaling was performed to verify initial sample grouping. Further statistical 
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analysis with orthogonal partial least squares-discriminate analysis (OPLS-DA) was performed to 
identify significant contributors for group separation.  
 
3. Results 
 
A. Platform integration and evaluation 
 Successful integration of the platform has been achieved, as shown in Figure 4.5. The 
microfluidic bioreactor (MTNP) is controlled upstream by Harvard Apparatus syringe pumps, 
viewed under the Nikon Eclipse Ti-e for optional fluorescent and bright field imaging acquisition, 
and outfitted with a stage incubator for control of temperature, gas, and humidity. The effluent 
exiting from the MTNP flows through two inline filters for catching cell debris (1 µm stainless 
steel frit, followed by a 0.5 µm polymer mesh, IDEX Health & Science, Oak Harbor, WA). Once 
through the filters, the effluent fills one of the two sample loops vented to open air to avoid 
high backpressures in series with the compliant microfluidic device. After the effluent undergoes 
salt removal by the solid phase extraction desalting system, it is directed into the nESI source 
and sprayed into the Waters Synapt G2 nESI-IM-MS.  
 Initial work, which paired a previous arrangement of the online SPE design with MTNPs, 
resulted in ruptured devices. When LC pumps were used to rinse and elute the SPE columns, 
pressure would build up behind the column. When the valve was switched so that the MTNP 
was directly in series with the column, this high backpressure (>200 psi), would cause massive 
flow reversal and induce the PDMS device to physically delaminate from the glass to which it 
was bonded. This problem was mitigated by altering the valve arrangement to incorporate 
sample loops. By cutting off the direct pathway between the columns and the microfluidics, the   
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Figure 4.5. MTNP-SPE-nESI-IM-MS platform with Harvard Apparatus syringe pumps, Nikon Eclipse Ti-e 
inverted fluorescence microscope with stage incubator, solid phase extraction desalter with Eksigent 
and NanoAcquity pumps for solvent flow control, nanoelectrospray ionization source for continuous 
flow sample analysis in the Waters Synapt G2 ion mobility-mass spectrometer. Beyond the initial 
experimental setup, all components are fully automated and capable of running multi-hour experiments 
limited by the lifetime of cells in the MTNP.  
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buildup of pressure that occurred during rinsing/eluting was unable to take the least resistive 
path to the compliant microfluidic device and would instead be vented to the waste port, as 
shown in Figure 4.4. Although in extreme cases the inline filters downstream of the microfluidic 
device may become clogged with cells, thus interfering with effluent flows, this is a rare 
occurrence and can be prevented by using new filters for each experiment in addition to open-
outlet cell loading (allowing cells to exit the device during loading before attaching to the 
downstream components). 
The sample loop addition to the valve arrangement allowed for a two-step valve 
configuration, a simplification of the previous version. The new two-step arrangement 
generated a saw-toothed pattern as opposed to the rise-and-fall delta-function pattern 
observed with previous arrangements18. In this 180-minute experiment, an 18-minute-long 
cycle was used, producing an elution peak every 9 minutes. The sample loop volume was 
designed specifically to hold 9 minutes of sample effluent (4.5 µL at 500 nL/min flow rate). This 
cycle duration was determined to be optimal based on analyte concentrations. The file 
acquisition was set to account for the delay time from the device to the nESI source such that 
one column elution was captured per file while accounting for the roughly 12-second software 
delay between file acquisitions. Pump switching for control of the MTNP perfusion media was 
also timed with the SPE desalter valve switching. 
 Removal of salts in an online manner greatly increases signal-to-noise ratio. Yet with the 
low number of cells and high concentration of media components, detecting low concentrations 
of analytes is challenging. The signals are also affected by the dynamic range (~105) of the mass 
spectrometer.264 Presumably, post-desalting, and given cellular utilization of nutrients in the 
media, HEPES at 10 mM is the analyte of greatest concentration. The high concentration of this 
species limits the lower range of detection of exometabolomic contents to roughly five orders of 
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magnitude lower. This HEPES concentration can be reduced if necessary, but as its purpose is to 
buffer the media to maintain a physiological pH, there could perhaps eventually be a tradeoff. 
While detection of low concentration species remains a challenge, the ongoing advances in mass 
spectrometry technology will increase the detection capabilities of this system.  
 
B. PDMS surface passivation for increased signal-to-noise ratio 
The use of a biological model for testing the instrumentation platform does have a 
major downside in the form of potential loss of metabolite signal due to adsorption to PDMS 
bioreactor surfaces. Rectification of these types of issues requires changing the microfluidic 
device material or modification of PDMS surface properties. Switching device materials, and 
thus the techniques for producing such devices, often requires substantial changes in 
infrastructure as well as loss of desirable PDMS properties such as optical clarity and low feature 
size. Surface modification is more plausible, as procedures can be added onto existing 
fabrication or experimental methods. A variety of types of surface modification of PDMS 
microfluidic devices have been investigated, such as chemical vapor deposition, sol-gel coating, 
silanization, surfactant coating and dynamic coating.414,415 Due to the nature of this combined 
technology platform with mass spectrometry downstream of the microfluidic device, care must 
be exercised in the selection of a surface modification method. The presence of species in the 
bioreactor effluent necessary for the alteration of the PDMS surface can lead to complications in 
the detection of desired cell secretions due to issues of dynamic range. Instability of species 
used in surface modification can additionally lead to adsorption of secreted cellular materials to 
PDMS. A stable, inert coating is crucial for downstream mass spectrometry. Surfactants and 
dynamic coating methods are not appropriate for this application as the presence of 
electrostatically bound polymer or added analytes to the solution are not compliant with 
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detecting low levels of cellular signals. One method leading to a covalently bound surface 
modifier is silanization. Though silanes are often deposited on surfaces through chemical vapor 
deposition and can result in the production of chlorine gas, ethoxy- and methoxy-silanes can be 
purchased in a liquid form, resulting in ease of application to PDMS surfaces for the prevention 
of non-specific adsorption. 
While insulin is not necessarily a prime target of these experiments, it serves as an 
example of the potential complications from non-specific adsorption. Though high sensitivity is 
characteristic of mass spectrometry, this system seeks to identify secreted molecules from 
roughly 105 cells. Detecting these low-level signals becomes a greater challenge when a portion 
of the signal is lost due to interactions with seemingly inert materials. Although the PDMS 
passivation schemes returned positive results (data provided in Supplemental Material Figure 
4.6), some metabolite, peptide or protein species, such as insulin, are particularly “sticky” to 
most polymer and glass. In testing the capabilities of the system, we have noticed drastic 
reduction in and even absence of signal from insulin standards over time, even at low 
temperatures. Additionally, insulin hysteresis in the combined platform has been discovered 
after as long as 4 days of continuous perfusion of the SPE desalter tubing and columns. While 
the columns may be a source of insulin retention, this particular hysteresis occurred with freshly 
made columns, pointing to an alternate source of contamination as the culprit. The remaining 
sources of contamination could be from insulin retention in the PEEK and/or fused silica tubing 
lines, the valve rotors, or even on the source block or cone of the mass spectrometer. Insulin 
adsorption does not merely lead to a contamination problem; it also leads to reduction in the 
overall insulin signal.   
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Figure 4.6. PDMS channels were perfused FITC-insulin for 30 minutes (green), followed by 30 minutes of 
rinsing with Ringer’s solution (pink). The top three fluorescent images show the surface bound insulin at 
1 min, 31 min, and 60 min, with the bottom three images corresponding to the surface modified 
channels. Silanized PDMS channels (blue line) retain (at maximum) only 25% of the total insulin retained 
by untreated PDMS (red line).  
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C. Comparison of UPLC-ESI-IM-MS to MTNP-SPE-nESI-IM-MS 
A significant reduction in time is among the benefits of continuous sample flow from the 
microfluidic bioreactor to the solid phase extraction desalter and into the nESI-IM-MS. This 
integrated platform allows for the setup (~2-3 hours), execution (~4-8 hours), and data 
collection (no additional time) in the course of a day. Traditional in-culture experiments with 
UPLC-ESI-IM-MS analysis possibly require less initial setup (~1 hour), roughly the same execution 
time (~4-8 hours), significant additional sample processing time (~15-20 hours including 
overnight sample evaporation), and data collection (~50 hours for 120 samples with a 25-minute 
UPLC time per sample) for a total of ca. 4 days until data are ready for processing compared to 1 
day for the platform developed in this work. 
 Another advantage of the integrated platform compared to in-culture experiments is in 
the ease of obtaining mass spectra at multiple time points. Our process is automated with 
constant media perfusion control timed with the switching of the SPE desalter valves as well as 
the data file collection timing. With the in-culture experiments, a lengthier process is required to 
collect a single time point. The cell suspension must be centrifuged for 2 minutes, the 
supernatant removed, and the cell pellet resuspended in new media. The length of time 
required for this media change is on the same order of the time points taken with the integrated 
platform. Repeated centrifuging and pellet aspiration can introduce unnecessary stress to the 
cells, which may produce an exometabolomic profile resulting from both the media exposure 
and additional cell stress.  
 One downside compared to liquid chromatography data is the absence of retention 
time information. While the solid phase extraction desalter uses a column similar to those found 
in an LC system, any slight timing discrepancy from one file collection to the next prevents the 
use of any retention time data. Confounding this issue is the fact that processing data within the 
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Waters MassLynx software without retention time data available prevents the option for the 
removal of isotopes from the data. While this is a hindrance in some respects (roughly 3 times 
more peaks, redundant data, etc.), it can prevent the accidental removal of isobaric peaks of 
interest from the study. 
 
D. Cocaine metabolism in naïve and experienced T cells 
Online Cellular Analysis: Two populations of Jurkat T cells were compared in this study: 
naïve T cells that had never been exposed to cocaine and experienced T cells that had been 
incubating in cocaine at 60 µg/ml in RPMI 1640 for 4 hours prior to online experimentation. As 
shown in Figure 4.7, a high degree of variance was observed based not only on what type of 
media was present in the bioreactor (i.e., plain RPMI media or cocaine RPMI media), but also 
whether the cells experienced cocaine earlier in the day (i.e., whether the cells were 
experienced or naïve to cocaine exposure). The major unique contributors to group separation 
between naïve and experienced exometabolomic profiles included m/z 283, m/z 187, m/z 399, 
m/z 157, and m/z 337 (all at elevated abundance in the experienced group compared to the 
naïve group). The metabolites contributing to group separation between types of media to 
which cells were exposed in the MTNP consisted of m/z 312, m/z 182, m/z 304, m/z 290, and 
m/z 150. Though the data analysis pipeline prevented removal of isotopes, any m/z present in 
the list of top contributors negated the inclusion of their respective isotopes from these lists. 
 Benzoylecgonine (BE) (m/z 290 as [M+H]+, m/z 312 as [M+Na]+), a primary metabolite of 
cocaine, was identified as a contributing factor to the separation between the cocaine exposure 
steps and plain RPMI steps as well as to naïve cells and experienced cells. Analysis of this 
metabolite over the time course of the experiment revealed an expected increase during 
cocaine exposure steps, but also showed a significant increase from naïve to experienced cells (p   
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Figure 4.7. Walking principal component analysis of exometabolomic profiles of naïve (shades of yellow) 
and cocaine-experienced (shades of turquoise) Jurkat T cells obtained with on-line cellular analysis. Each 
numerically labeled data point represents a 9-minute column elution, with 6 data points collected per 
step (all marked with the step number and connected in order of collection with the dotted line). In 
steps 1 and 3, both cell populations received plain RPMI. In steps 2 and 4, both received cocaine in RPMI 
at 60 µg/ml. As profiles switch from RPMI to cocaine exposure, the data points move towards the right 
and vice versa, with the exception of naïve cell step 4, which stays closer to step 1. Further analysis of 
the data reveals this inconsistency may be explained by the death of the cells. Data were grouped not 
only based on the experimental step, but also by the experience level of the cells, as the cells receiving a 
4-hour pre-incubation in cocaine group separately from those that did not receive this dose.  
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value = 5.7E-4) (Figure 4.8). Fragmentation spectra revealed fragment ions m/z 82, m/z 91, m/z 
105, m/z 150, m/z 168, m/z 182 and m/z 272, as shown in Figure 4.8. Analysis of the remaining 
top three contributors to separation based on media revealed cocaine at m/z 304, 
anhydroecgonine methyl ester (AEME) at m/z 182 (produced from dehydration of ecgonine 
methyl ester (EME) rather than the pyrolysis of cocaine), and ecgonine aldehyde, the 
decomposition product of EME, at m/z 150. Cocaine metabolic pathways are described in Figure 
4.9.  
 To verify that this increased BE abundance was not purely a result of non-enzymatic 
hydrolysis of cocaine to BE in aqueous solutions over the time course of the experiment, an 
experiment replicating the naïve and experienced cell experimental time course was performed 
with the omission of the Jurkat T cells. In order to compare the experiment with cells to that 
without cells, we normalized the BE intensity to the cocaine intensity. On average, the percent 
of the total normalized BE from non-enzymatic hydrolysis was 34.1% in step 2 of the naïve cell 
experiment while the corresponding percentage for step 2 of the experienced cell experiment 
was 34.5%. 
 The time course of additional metabolites is provided in Figure 4.10, including cocaine 
metabolites anhydroecgonine (AHE) (m/z 168) and hydroxybenzoylecgonine (HOBE) (m/z 306), 
as well as several unknown metabolites (m/z 330, m/z 475, m/z 678). Some of these additional 
metabolites have higher abundance in the cocaine-experienced population while others have no 
overall change in abundance. Overall, BE, AHE, and m/z 645 show significant increases from 
naïve to experienced cell population (p- values = 5.7E-4, 1.12E-3, and 1.60E-3 respectively). While 
AHE is a typical product of AEME (the pyrolysis product of cocaine), some reports have shown 
the metabolic pathway from cocaine into AEME and AHE could result from loss of water of EME 
or ecgonine (EG).416 While there is much evidence that AEME and AHE can form as a result of  
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Figure 4.8. Top: Benzoylecgonine (BE) time course data for experienced (blue) and naïve (purple) cells. 
While data were gathered sequentially, plots are overlaid to highlight the increased abundance of BE in 
experienced cells. The absence of the expected increase in BE corresponding to step 4 (the last step of 
cocaine exposure) provides further evidence of cell death due to lack of cocaine metabolism. Bottom: 
The fragmentation spectra of BE are shown with parent ion of m/z 290.   
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Figure 4.9. Metabolism of cocaine showing molecular weight for each metabolite.  
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Figure 4.10. Additional metabolite time course data are shown compared to BE. Experimental 
conditions for each group of cells are shown above the graph with solid black lines indicating exposure 
to cocaine media. Anhydroecgonine (AHE) and hydroxybenzoylecgonine (HOBE), two additional 
metabolites of cocaine, provide examples of both variation between naïve and experienced cell groups 
in the case of AHE and consistency between these two groups in the case of HOBE. The increases in BE 
and AHE from naïve to experienced groups are statistically significant with respective p values of 5.7E-4 
and 1.12E-3. Three unidentified m/z 645, m/z 478, and m/z 330 that contribute to the separation 
between media exposure groups are also shown. The features at m/z 330 and m/z 478 show no 
statistical significance between naïve and experienced cell groups while the increase in m/z 645 is 
statistically significant (p = 1.6E-3).   
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the analysis technique, this is typical of gas chromatography separations that require 
vaporization of compounds, thus risking alteration of thermolabile compounds such as cocaine 
and its metabolites.417 Electrospray ionization is utilized when this type of compound is under 
investigation. 
 
E. In-culture cellular analysis 
To compare this instrumentation platform, as well as the resulting biological data of 
naïve and cocaine-experienced T cells, with the current standard in mass spectrometry analysis 
of biological samples, the online experiment was replicated in culture and samples were 
analyzed with UPLC-ESI-IM-MS. Figure 4.11 shows the PCA plot demonstrating sufficient 
variance when comparing steps 1 and 3 (plain RPMI 1640 exposure) with steps 2 and 4 (cocaine 
exposure). Unlike the online experiment, separation between cocaine-experienced cells and 
naïve cells is not achieved, with exception of the initial RPMI exposure of the naïve cell 
populations. While one major difference is the number of time points per step of media 
exposure, as discussed previously, replicating the 9-minute time point sampling of the online 
system would confound the length of time needed for media switching, as well as inflict 
unnecessary stress on the cells.  
 
4. Conclusions 
 
A. Platform capabilities and shortcomings 
 We have described the analysis and proof of concept of a technology platform 
for near real-time detection of the cellular exometabolome based on the combination of a 
microfluidic bioreactor, an online SPE desalting arrangement, and mass spectrometry. A great   
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Figure 4.11. Walking principal component analysis of exometabolomic profiles of naïve (shades of 
yellow) and cocaine-experienced (shades of turquoise) Jurkat T cells using in-culture analysis. Each 
numerically labeled data point represents the end point of a 54-minute exposure to the indicated 
media. As with the online experiment, during steps 1 and 3 both cell populations received plain RPMI, 
while during steps 2 and 4 both received cocaine in RPMI at 60µg/ml. Variance between step 1 and 3 
and steps 2 and 4 results in unsupervised grouping according to media exposure type. Separation 
between naïve and experienced cell groups, particularly when under cocaine exposure, does not occur 
to the same degree, as yellow and turquoise points corresponding to steps 2 and 4 are heavily 
intermixed.  
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strength of this platform is in its adaptability to different cell types and experimental conditions. 
Microfluidic cell trapping devices can be customized to the size of any adherent or non-adherent 
cell type. In this work, we demonstrate cell trapping and experimentation on naïve and cocaine-
experienced Jurkat T cells. While this work shows only one model system based around cocaine 
exposure, the environmental stimuli are limited only by the number of pumps one has available 
for providing variable perfusion conditions and the temperature change and gas exchange rates 
an incubator is capable of generating. The online SPE desalting arrangement allowed for 
sufficient desalting to permit a temporal resolution of 9 minutes. While this temporal resolution 
is not by any means a significant advance for cellular chemical detection methods, because it is 
dictated by the analyte abundance and detection capabilities of the TOF mass analyzer, it is 
(depending on the mass analyzer) the best resolution possible for this biological system using 
mass spectrometry. Because it is trivial to scale the loading time in this arrangement based on 
detection power, we believe a technology platform of this general system will be of 
considerable utility to the biological community, particularly as mass analysis detectors improve 
in the coming years. 
 
B. Cellular memory of cocaine experience 
 Cocaine metabolism in naïve and experienced Jurkat T cells was investigated with this 
near-real time platform developed for the study of the cellular exometabolome. It is well known 
that cocaine has an effect on immune cells, and that possibly there is some cell memory of prior 
cocaine exposure,418 though there has been no prior demonstration of this suggestion. With the 
advent of this innovative platform, unique metabolic profiles are obtained that are absent from 
the “in-culture” data or perhaps lost due to the increased sample processing and UPLC analysis 
time. Upregulation of cocaine metabolism into benzoylecgonine in experienced cells 
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demonstrates one contributor to the unique exometabolomic profile resulting from previous 
cocaine experience. Anhydroecgonine, as well as unknown metabolites m/z 645 and m/z 478, 
are also upregulated in cell populations with prior cocaine exposure, leading to the possibility of 
indicators of immune cell memory of cocaine other than cocaine metabolites alone. 
 While there is a previously reported non-enzymatic degradation rate of cocaine into 
benzoylecgonine at physiological temperatures and pH,419 we were able to confirm a rate 
specific to this platform. Through comparison of the BE to cocaine ratios from naïve and 
experienced cell experiments, as well as the platform absent of cells, it is evident that the 
portion of BE abundance from non-enzymatic degradation does not entirely explain the 
significant increase in BE during the cocaine exposure steps in the experienced cells, indicating 
the response is due to a unique exometabolomic profile of T cells with prior cocaine exposure. 
Further analysis of cellular memory of cocaine exposure is warranted based upon these findings. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
As stated previously, systems biology seeks to describe the function of a biological 
system using a holistic, multiscale approach. This approach encompasses the analyses of 
molecular classes such as the genome, transcriptome, proteome, and metabolome (among 
others) of a biological system. Systems biology asserts that while understanding genes and 
proteins is important, the most important aspects going forward are more closely related to the 
system’s network structure and network dynamics.1 Researchers of systems biology have 
adopted a hybrid discovery-driven/hypothesis-driven approach to meet these challenges. The 
first step of this proposed approach is to define all of the components in the system. Then, by 
systematically perturbing this system, while monitoring all of these components, one is able to 
use computational biological methods to generate a network structure model of what is 
observed. This model will define all components of the system in terms of their mathematical 
relationship with all other components. With this model in hand the researcher/computational 
method generates a new perturbation that best tests that network structure model. From here, 
subsequently more refined models are produced until all perturbation reactions can be justified 
by the model.2 
The system described in this text currently boasts the ability to measure dynamic 
biomolecular signals with a detector that is both highly sensitive and has a broad identity 
detection range. We have demonstrated the ability of the cell-trapping microfluidics to precisely 
control the microenvironment and the IM-MS’s ability to precisely monitor this control. 
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We are currently automating this experiment for a “robot scientist” approach420,421 with 
closed-loop control and symbolic regression of the underlying metabolic dynamical 
equations.422,423 An automated microformulator will assemble on demand media whose various 
components and additional stimuli or toxins are stored separately and can be supplied 
independently or in combination with one another. Ultimately both the control of the 
microformulator and the quantitative analysis of the data will be provided through machine-
learning algorithms developed by Lipson et al. at Cornell.422-424 Their self-modeling algorithm 
interprets the media components/stimuli as variable inputs and monitors the mass and other 
biological signals as outputs. Once the first data set is sent electronically from our platform to 
Cornell the algorithm will interpret the data and identify candidate models for the biological 
system’s metabolic network dynamics. The algorithm will then select a set of media conditions 
which it determines would best discriminate between the candidate models. This media 
condition command will then be relayed back to the microformulator and the new media 
mixture is supplied to the cell population for the next experiment, thus producing a self-
investigating robot scientist that derives a model of the metabolic or signaling network under 
investigation (Fig. 5.1). With the present microfluidic-IM-MS platform running in tandem with 
feeback control and self-learning algorithms as shown in Figure 5.1, this experiment will begin to 
collect data and make true systems biology measurements. 
Alterations to trap designs could easily make the system amenable to many different 
types of studies. One study that is of particular interest involves the use of differential, 
multiplexed IM-MS data interpretation. Figure 5.2 displays a microfluidic chip design which 
allows for the trapping of two different cell populations to investigate paracrine and autocrine 
signaling. Media is provided to the system through the left-most inlet. The first outlet allows for 
desalting and IM-MS characterization of any background contributions from the media   
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Figure 5.1. Robot scientist schematic. In this proposed experiment a microfluidic device, sustaining a 
live cell culture and under inspection by a microscope, is perfused with cell culture medium from a 
MicroFormulator. The MicroFormulator is able to mix and perfuse up to 32 different solutions to 
produce unique combinations of medium components and/or cellular stimuli (e.g., toxins, 
therapeutics). The output media from the device is run through the automated online dual-column 
desalter and subsequently analyzed by online IM-MS. The data collected from all components of the 
system (i.e., the MicroFormulator, the microscope over the microfluidic device, the online desalter, and 
the IM-MS) is sent to Cornell through an SQL-enabled server. Cornell then performs its estimation 
exploration algorithm on the data to generate system models. The algorithm then sends out the next 
set of media conditions to the MicroFormulator. These conditions are chosen to best discriminate 
between the generated system models.  
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components. Media, including any added chemical or biological stimuli, flows over the first cell 
population and induces a response. This effluent is split, with a portion going to the second 
outlet, where it is desalted and analyzed by IM-MS to determine the differential, cell-induced 
changes relative to the base media. The other fraction of the first-trap effluent perfuses the 
second population of cells, and the effluent from this second trap is directed to the third outlet 
and analyzed to elucidate the cell-to-cell mediated response. All three outlets will be analyzed in 
real-time by using a custom-built multiplexed 8-channel IM-MS instrument currently under 
construction. This would allow for continuous sampling of up to 8 flow streams, all of which are 
handled independently throughout the instrument. This arrangement allows for simultaneous 
measurement of seven experimental channels and one control. Special software packages can 
be used to explore differential signals to easily determine which species are being produced as a 
result of being directly downstream of a different cell population. 
There are numerous applications when one considers the various different cell types 
that can be sustained by this platform. Some of the applications this platform has been 
proposed to explore include everything from testing immune cells for long-term drug memory 
effects to diagnosing chemical and biochemical warfare agent exposure using pre-symptomatic 
exometabolome signatures. Additionally applications involving personalized medicine have been 
proposed. In these regards one could extract a cellular sample from a patient and (after isolating 
the appropriate cell type) expose these cells to the therapeutic in question and determine the 
patient’s specific reaction to the treatment. This could be especially useful for 
chemotherapeutic prescriptions where oftentimes cocktails of chemotherapeutics are 
prescribed in hopes that one will have a beneficial effect. Meanwhile all the therapeutics that 
had no beneficial effects are potentially causing many side effects and reducing the quality of 
life for that patient.  
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Figure 5.2. An example of a trap currently under development. This device will be used to perform 
differential studies whereby two cell populations can be probed simultaneously. Media will be supplied 
through the first inlet with a small portion running through the desalter and into the IM-MS to provide a 
control sample. Any paracrine or autocrine signaling material secreted by the first cell population would 
perfuse the second population, with a small fraction being collected by the second outlet. Finally the 
resultant secreted material from the second population would be analyzed through use of the third 
outlet port. These three signals could be analyzed in a differential manner to easily identify unique 
peaks in each effluent. Simultaneous IM-MS analysis could be achieved using a multiple nano-spray, 
multiple drift tube design as described in the text. Reprinted from reference 312.  
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 With the platform designed, built and proven to be working for simple studies, the 
immediate tasks ahead will involve reducing the idiosyncratic logistical difficulties that tend to 
stymie progress and often lead to unproductive experiments. In order to most expediently 
overcome these challenges, the reader is directed to Appendix C. 
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APPENDIX B 
IMAGING MS PROTOCOL 
 
Materials 
 
1. Sample prepared for MALDI analysis (thin tissue section washed, fixed to MALDI plate, and 
MALDI matrix applied). 
 
2. Mass and drift tube IM standards/calibrants. Mass standards correspond to peptides and 
proteins bracketing the mass range of interest. Ion mobility structural standards for DTIM are 
typically C60 and C70 fullerenes, because they exist in one structural form. These can be used for 
evaluating DTIM resolution and for day-to-day evaluation of instrument performance. 
Additionally, fullerenes can be used as mass standards as they are structurally separated from 
biomolecules in conformation space and provide a wide range of gas-phase reaction products 
resulting in peaks spanning a large mass range in increments of 24 Da. To validate gas pressure 
in DTIM, typically the peptide bradykinin (RPPGFSPFR) is used to compare collision cross section 
measurement with the accepted value of 242 ± 2 Å2.25 Bradykinin can be mixed with matrix of 
choice or a 1 mg/ml standard solution in H2O can be combined 1:1 v/v with 20 mg/mL α-cyano-
4-hydroxycinnamic acid in 50% methanol. Both calibrants can be applied to MALDI plate using 
the dried droplet method.425 
 
3. Traveling wave IM standards/calibrants. As discussed previously, estimated collision cross 
sections obtained by TWIM require internal standards with corresponding absolute collision 
cross section values obtained using DTIM. Published absolute collision cross sections can be 
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obtained from several published databases, including (i) peptide collision cross sections 
determined by ESI,128,187 (ii) intact protein collision cross sections determined by ESI,155 (iii) 
peptide collision cross sections determined by MALDI,66 and (iv) biologically relevant 
carbohydrate, lipid, and oligonucleotide collision cross sections determined by MALDI.224 
 
Methods 
Performing Collision Cross Section Measurements Using DTIM 
1. In order to take measurements, the samples for imaging (tissue, etc.) should be prepared the 
same as for conventional imaging MALDI-MS. Note: typically ionization is performed at the 
pressure of the DTIM (e.g., 1–10 Torr), which results in moderate pressure MALDI. Thus some 
collisional cooling typically takes place after ionization and can result in matrix-adducted and 
cluster species. These can be dissociated prior to DTIM by performing injected ion experiments. 
Furthermore, matrix optimization may be required. One effect of moderate pressure MALDI that 
we have observed is that higher ion currents can be achieved at slightly lower matrix-to-analyte 
ratios (i.e., 1,000–100:1) than those used in high-vacuum MALDI (i.e., 10,000–1,000:1). 
 
2. Following insertion of the sample target into the instrument, mass and ion mobility 
standard/calibrants are measured. In particular, to MALDI-IM-MS methods the laser pulse 
serves as the start signal (t0) for measuring the IM arrival time distribution (tatd). These time 
distinctions are necessary for the calculations in Step 4. 
 
3. Following separation in the IM drift cell filled with an inert gas (1–10 Torr), ions are directed 
through a skimming and differential pumping region where the pressure is reduced from 1–10 
to ∼10−8 Torr for mass analysis in the orthogonal TOFMS. The stop time for tatd corresponds to 
148 
 
the ion injection time for the TOFMS measurement. Note: as developed in more detail in the 
theory section, typically helium is used because of its low mass and low polarizability relative to 
other inert gases. However, other drift gases or drift gas additives can be used to promote long-
range interactions between the ion and drift gas. This is analogous to tuning selectivity in HPLC 
by changing the mobile or stationary phase that is used. 
 
4. To perform the calculations as described in Chapter 1 (e.g., equation [4]) the arrival time 
distribution must be corrected for time spent in regions outside of the drift cell (i.e., time spent 
traversing from the MALDI plate into the drift cell, in skimming and differential pumping regions, 
and ion optic regions prior to the source of the TOFMS). This will result in the drift time (td) of 
the ions within the IM drift cell used in the calculation of collision cross section: 
 
td = tatd − tdtc 
 
5. To determine the value of tdtc (i.e., the drift time correction factor), IM separations are 
performed by varying the voltage across the drift cell while maintaining all other experimental 
parameters constant. The arrival time distribution measured at each drift voltage is then plotted 
versus the inverse of drift voltage (1/V). Provided the range of voltages used maintains ion 
separations under low field conditions, this plot will result in a linear correlation. If non-linearity 
is observed, a calculation of the low-field limit should be performed, because curvature in this 
plot indicates that mobility is not constant over the voltage range used. For electrostatic fields 
higher than the low-field limit, the ion velocity distribution depends less strongly on the 
temperature of the separation and the mean ion energy increases as it traverses the drift 
region. Consequently, K is no longer constant and depends on the specific ratio of the 
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electrostatic field to the gas number density (E/N) (see reference 50 for a derivation of 
calculating the low-field limit for a particular analyte). A linear regression of this data results in a 
y-intercept corresponding to tdtc. The y-intercept of this plot corresponds to tdtc because it 
represents the limit of td→0 at infinite drift cell voltage. Also note that the accuracy with which 
this correction should be made is more important for shorter drift times and its significance is 
less important at longer drift times. For example, in fast separations as described for imaging 
IM-MS experiments the values of tdtc can approach the relative magnitude of td. Preferably at 
least five voltages should be used to define this line although for high-precision measurements 
as many voltages as is practical should be used. For the most accurate results, the drift time 
correction should be evaluated for each component in the IM profile. The motivation for 
evaluating individual drift time corrections arises from additional ion–neutral collisions in the 
differential pumping regions at the entrance and/or exit of the IM drift cell. In these regions the 
gas dynamics typically transition from viscous to molecular flow, e.g., at the exit aperture of the 
drift cell at 1–10 Torr to the high vacuum (∼10−8 Torr) of the mass spectrometer, respectively. 
 
6. After the td has been determined from the tatd, it can now be used to calculate the collision 
cross section, Ω, of the ion of interest through the equation [4]. Note that the equation for 
calculating collision cross section is derived from classical electrodynamics, and as such, great 
care should be exercised in the dimensionality of the units used. Specifically, the units for E 
should be expressed in CGS Gaussian units, i.e., statvolts cm−1, where 1 statvolt equals 299.79 V. 
Note that statvolts cm−1 is equivalent to statcoulombs cm−2 and that elementary charge, e, is 
4.80×10−10 statcoulombs. By comparing empirically determined cross sections with theoretical 
results, it has been shown that the hard-sphere approximation is best suited for analytes larger 
than ca. 1,000 Da, which is typically the size range in which many biological measurements are 
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made. However, as the size of the analyte approaches the size scale of the drift gases used for 
separation, long-range interaction potential between the ion and neutral must be considered for 
accurate results.62,226,228 
 
7. After the collision cross section has been calculated, this can be further related to the 
structure using molecular dynamic simulations. More information about these computational 
methods can be found in more detail in other resources.61-64  
 
8. For calculating relative collision cross sections using traveling wave ion mobility-MS, there are 
two main procedures used which can be found in the literature.51,52 
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APPENDIX C 
PLATFORM TROUBLESHOOTING GUIDE 
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Liquid Management 
Fittings and Connectors. Common thread types of fittings and connectors are shown in 
Fig. C.1. 10-32 thread type will most often be encountered when using 1/16” PEEK tubing for 
high-volume/high-flowrate applications. In order to use 10-32 1/16” PEEK connectors (as shown 
in top left) with 360 μm OD tubing, one must use IDEX Health and Science ‘Green sleeves’ (IDEX 
Health and Science F-242X). From IDEX: “Silica SealTight Sleeves are designed to connect 70 μm 
– 1mm OD capillary tubing to any standard 10-32 coned port normally intended for 1/16” OD 
tubing. The 1.6” long Silica SealTight sleeves withstand up to 50°C and can be finger tightened to 
hold up to 5,000 psi when using the NanoTight fittings”. Luer lock connections will most often be 
used to connect 360 μm OD tubing to syringes for liquid perfusion. The use of 5/16-24 fittings 
involves a male part (e.g., IDEX PN: P-888), which has threads on the outside, a female nut (IDEX 
PN: P-416), which has threads on the inside, and a ferrule piece (IDEX PN: F-152, for 360 μm OD 
tubing) which goes between those two parts. The ferrule receives force as the female nut is 
tightened and in doing so causes the ferrule to crimp the 360 μm OD PEEK or fused silica tubing. 
Fittings with 2-56 thread are common to VICI-Valco type fittings and will most commonly be 
used on VICI unions (VICI PN: C360UPK(G)4), and for valve fitting connectors (VICI PN: 
C360NFPKG, C360PPK, See Valves). Thread type 6-32 is found on coned nuts (e.g., IDEX PN: F-
124S) and is similar to ferrules (F-152) in the sense that it crimps 360 μm tubing directly. 
CAUTION: When using connectors on tubing and using finger tightening it is generally not 
recommended to tighten very strongly when direct connector-to-tubing combinations are used. 
For example, when using an IDEX P-888 (5/16-24) union, where a PEEK ferrule directly crimps 
the 360 μm OD tubing, one should tighten just tight enough to not let the tubing pull out under 
moderate force. Tightening past this point leads to occlusion of the line (especially for PEEK 
tubing). When using fittings that require a 1/16” sleeve to connect to 360 μm OD tubing, more   
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Figure C.1. A table detailing all the different types of threading used.  
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force can be used to tighten the fitting as the pressure applied must first penetrate the green 
sleeve before crimping the underlying 360 μm OD tubing. 
 
Syringe Pumps. Media perfusion of microfluidic devices was carried out using a Harvard 
Apparatus Model ‘11’ Plus Dual Syringe Pump with Serial Communication (MA1-70-2212). The 
syringe pumps drive the plunger of a syringe at a rate that is directly dependent on the user’s 
inputted syringe inner diameter. Common syringe diameters can be found in the manual. When 
operating the syringe pumps, the ‘pusher block brackets’ (small black bars that screw into place 
to hold the disc shaped end of the syringe plunger) are often removed to provide a more level 
surface for the edge of the syringe plunger to rest against. Infusion can be performed manually 
using the pump’s interface and LED screen, or automatically using the RS-232 data connection 
cables and either the pump control buttons or a macro written in NIS Elements. When operating 
manually the choice between infusion and withdraw can be selected based on the direction of 
the “FLOW” button. If operated using software and then disconnected and used manually, 
occasionally the “FLOW” button can become reversed. When operating the syringe pump it 
may become customary to press on the pusher block to expedite flow, however, after pressing 
on the block, the pump driving mechanism will ‘kick’ back, causing cessation of flow 
immediately thereafter. Use of syringe retainer is recommended, however, use of the syringe 
block bracket is not necessary. It is important to be sure the “Infuse limit switch adjuster” is 
placed at the maximum position (as shown on page 6 of the instruction manual) and tightened 
often (as use of the pump seems to loosen this adjuster). 
 
Syringes. Commonly, 250 μL (Hamilton 81120 250 µL, Model 1725 TLL) or 500 μL 
(Hamilton 81220 500 µL, Model 1750 TLL) syringes are used to infuse media through 
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microfluidic devices. Syringe-to-360μm tubing connections are made using a PEEK female luer 
adapter assembly (IDEX Health and Science, P-662, 5/16-24 thread port connection, 0.006 in 
thru hole). This results in less leaking than that experienced when using 10-32 PEEK female luer 
lock adapter (IDEX Health and Science, P-659, 10-32 thread port connection, coned Female). 
 
Tubing. Typically polyether ether ketone (PEEK) tubing is used wherever possible. An OD 
of 360 μm with varying ID’s (IDEX Health and Science, 1574, 1570, 1573, 1571) will be used for 
most applications (with 1/16” tubing being required very infrequently). Polymer tubing cutters 
(IDEX Health and Science, A-327, Standard Polymer Tubing Cutter for 1/16” and 1/8” tubing) are 
used to cut PEEK tubing to best ensure the severed end is not occluded. A main drawback to 
PEEK is the fact that noticeably large amounts of sample and biomolecular material have 
potential to adhere (reversibly and irreversibly) to its surfaces. This has been seen to cause, at 
times, massive tailing and memory effects. For this reason fused silica is used on sections of long 
uninterrupted tubing due to the glass’s less adherent surface properties. Teflon tubing is 
available from IDEX as well (PNs: 1930, 1931, 1932, and 1933) in 360 μm OD and 50-150 μm IDs. 
Teflon is recommended as being compatible with all type of solvents, which could lead one to 
believe that chemical reactivity with this material is low relative to other types of tubing. 
 
Microfluidic Device 
Device Design. Microfluidic devices are designed in 2D through the use of AutoCAD or 
similar computer-aided design software. Designs are compiled by VIIBRE staff engineer (David 
Schaffer) and sent to Advanced Reproductions for creation of a chrome mask. It can take 
anywhere from two weeks to several months for a mask to be sent out and to arrive depending 
on how full the mask design is when drawings are submitted.   
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Figure C.2. Photolithography and replica molding diagram.  
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Photolithography. A master is created from the chrome mask through photolithography 
techniques. The protocol for a ~12um high T12 trap design such as those on Mask 38iii in the 
mask repository is as follows (Fig. C.2):  
 
1. Silicon wafers are rinsed with acetone then isopropanol, dried under a stream of nitrogen, 
dehydration baked for 5 minutes at 180°C and allowed to cool to < 60°C 
2. SU-8 2010 is spun on clean wafers for 10 seconds at 500rpm (acceleration of 2) followed by 35 
seconds at 2500rpm (acceleration of 5) 
3. The wafer is then covered with SU-8, soft baked under a ramped temperature from 50 to 95°C 
(2 min at 95°C), and allowed to cool to < 60°C 
4. The edge bead is removed by spinning under a stream of edge bead remover 
5. The mask is positioned over top of the SU-8 coated master with uncovered portions covered by 
ruby tape and exposed for 20-45 seconds at a 45 J/cm2 dose 
6. The master is covered, post-exposure baked with a temperature ramp of 180°C/hr, baked for 5 
minutes at 95°C, and allowed to cool to < 60°C 
7. The master is developed on the spinner for 3 minutes or until rinsing with isopropanol is 
completely clear 
8. The master is hard baked with a temperature ramp of 120°C/hr, baked for 30 minutes at 180°C, 
and allowed to cool completely 
 
Soft Lithography and Device Silanization. PDMS devices on glass coverslips are 
constructed through replica molding and silanized with a PEG-silane to prevent non-specific 
metabolite, peptide and protein adsorption. The protocol is as follows (Fig. C.3):  
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1. The cooled master is placed in a round petri dish, poured with mixed 10:1 Sylgard 84 elastomer: 
curing agent (until roughly 3-4mm deep), and degassed under vacuum until bubbles are gone 
2. PDMS is allowed to cure for 4 hours at 60°C  
3. Patterned areas are cut with a scalpel and removed from the master 
4. Inlet and outlet ports are created by inserting a sharpened biopsy punch through the cut PDMS, 
patterned side up, with a sacrificial PDMS layer underneath to protect the punch, NOTE: Cores 
should be removed after each punch and can be aided by keeping a piece of wire inserted into 
the shaft of the punch stopping a few millimeters before the tip 
5. Both sides of the PDMS are cleaned with tape and coverslips are cleaned with acetone and IPA 
6. The device is placed patterned side up along with one of the coverslips on a 2”x3” glass slide and 
placed in the chamber of the Harrick Plasma cleaner ca. 3 inches from the back of the chamber 
7. Device and coverslip are plasma activated under vacuum for 30-45 seconds, removed from the 
chamber and the device is placed patterned side down on the coverslip, NOTE: Tweezers can be 
used to lightly press on the top of the PDMS to assist with bonding if needed 
8. Immediately after bonding, the PEG-Silane solution (2% in 95% EtOH, 5% H2O, 10mM Acetic 
Acid) is flown through the device from the outlet until it just comes out the inlets 
9. Devices are allowed to incubate at room temperature for at least 10 minutes and are then 
rinsed with EtOH and H2O 
10. Devices are incubated at 110°C for 10 minutes and allowed to cool 
 
Priming. Prior to experiment, the microfluidic device is primed by first putting a drop of 
methanol on the outlet port, and allowing it to move by capillary action through the device. If it 
does not easily move, gently flick one end of the cover slip against the bench top. Devices that 
do not easily allow ethanol to flow in this way should not be used. The outlet can then be   
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Figure C.3. PDMS silanization procedure.  
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intubated with PEEK tubing attached to a syringe containing the basic media for the experiment 
(i.e. RPMI or running buffer) and the plunger can be depressed until beads of media form on the 
inlets. The outlet and inlets should be covered with a drop of the same media before removing 
the PEEK tubing from the outlet.  
 
Cells 
Culture. Cells should be cultured according to manufacturer’s instructions. Techniques 
will not be addressed herein as many cell culture resources exit. 
 
Loading. An aliquot of cells is obtained just prior to experiment. For non-adherent cells, 
~500uL of cell suspension is dispensed into a clear or light-colored microcentrifuge tube (dark 
colors are difficult to see through under the microscope). These cells can be used almost any day 
during the culturing procedure and volume dispensed adjusted to account for changing cell 
density. For adherent cells, sub-culturing procedures are followed to detach cells from surfaces 
of the culture flask. When cell suspensions are transferred to a centrifuge tube for trypsin 
removal, an aliquot is placed in an additional tube that is destined for the experiment. Cells are 
centrifuged according to culture instructions (typically low speed, ~100xg, is best). 
Media/trypsin is removed from the cell pellet and aliquot for the experiment is resuspended in 
desired media at the desired cell density (recommended at full density of split flask or 
greater).The cell suspension is transferred to a clear or light-colored microcentrifuge tube. For 
either adherent or non-adherent cell suspensions, aliquots are centrifuged at 1200 rpm for 2 
minutes in McLean lab centrifuge (Eppendorf Minispin Plus) just prior to cell loading. 
 The tube of pelleted cells is placed in the orange foam tube holder and onto the stage 
insert, fitting over the four pegs on the insert. The microscope and software are both ready for 
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use (see below for instructions) and all syringes have been prepared and set to run forward on 
syringe pumps. The DIC optical configuration in NIS Elements is selected and the Ti-pad is 
checked for the halogen shutter to be open with the lamp in the on position and at 3V. The light 
will be physical visible if settings are correct. The stage is then positioned with the light 
immediately overtop of the open tube containing cells. Looking into the eye piece, the focus is 
adjusted to bring some portion of cells into focus. This can be tricky at first, but with experience 
it becomes easy to quickly bring cells into focus. The light path can be switched from the eye 
piece to the camera and play button hit to view the cells on the monitor. The end of the PEEK 
tubing into which the cells are to be loaded is then placed in the microcentrifuge tube (fluid 
should always be exiting the tubing when inserting into the cells to avoid any air bubbles) and 
pushed down towards the bottom to contact the cell pellet. It is useful to put a small kink in the 
tubing ca. 1.5 in from the end, but keep the bend <90 degrees. The plunger of the syringe 
attached to this tubing can be clamped to the pusher and the pump flow direction can then be 
reversed to withdraw cells into the PEEK tubing. There is a delay when the flow is revered 
before suction occurs. For a flow rate of 500nL/min, it is around 1.5 minutes. The PEEK tubing 
should be constantly held in order to manipulate the location of the end relative to the cells. It is 
helpful during the loading process to adjust the exposure as needed and to move in and out of 
focus of the tubing end in order to view moving cells. Once cell movement into the tube is 
visually confirmed, loading continues for 3 minutes at 500nL/min with a 2 ft PEEK tubing length 
with an inner diameter of 50µm. If the tubing length, ID or the flow rate is altered, the amount 
of time for loading should be recalculated. Once the desired loading time has been achieved, the 
pump is reversed and plunger unclamped from the pusher. Again, there will be a delay before 
the flow is in the forward direction. During this time, the device should be intubated with tubing 
from the remaining forward flowing syringes. If the cells need to avoid the contents of the 
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syringe, the pump can be stopped right before the tubing is intubated, but a drop of liquid 
should be on the end while inserting the tubing to prevent air bubbles. The tubing containing 
the cells can then be intubated as well to begin the loading. The outlet tubing is also connected 
at this time. Note that if a given pump is stopped while cells are loaded into the device, some 
back flow of cells into those lines may occur. One way to prevent this is by putting crimped plugs 
of PEEK tubing into the remainder of the inlet ports during loading, then intubating with syringe 
tubing post-cell loading. Cells are allowed to load the device completely while the device is 
carefully moved into the stage incubator. Outlet tubing should not be connected until the rate 
of cells exiting the device has slowed significantly (Fig. C.4). 
 
Microscopy 
Nikon Eclipse Ti. The startup procedure must be followed or connection to the 
microscope/camera will not work correctly. Startup procedure is as follows: 
 
1. If the computer has been shut down or logged off, it is started, logged into and allowed to load 
completely. 
2. Power to all microscope components (except for the mercury arc lamp and the camera) is 
achieved by turning on the power strip on the back right of the cart.  
3. If fluorescence images are to be taken, the mercury arc lamp power must be turned on 
separately from its power switch.  
4. Once the initialization procedure has completed, the camera can be turned on from its power 
switch.  
5. NIS Elements is then started.  
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Figure C.4. Cell loading diagram  
(i)
(ii)
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A common issue results from the software not loading the camera driver. In the event of this 
error message, close the software, wait and try to reopen again. This problem is just as likely a 
result of a faulty shut down procedure as it is from the startup procedure. Shut down procedure 
is as follows: 
 
1. All desired image files are saved. 
2. NIS Elements is closed.  
3. The camera power is turned off from its specific power switch. 
4. If the mercury arc lamp is on, its power switch can be set to off. 
5. The power strip is then turned off.  
NIS Elements. For detailed instructions on the use and capabilities of NIS Elements, 
consult the user guide located in the NIS Elements folder.  
 
Incubator. Temperature, gas and humidity control can be achieved using the stage 
incubator. The gas line with luer lock fitting is attached to the incubator for CO2 control, the tank 
turned on and the stop valve and needle valve on the back of the cart are adjusted 
appropriately. (The end of the tubing can be placed in a beaker filled with water to check the gas 
flow rate.) Once the device has been intubated and loading has begun, the device is carefully 
moved onto the stage incubator. It is important to have the stage incubator pressed into place 
on the stage before transferring the device. The clips are screwed into place to hold the cover 
slip, the side channels are filled with water to maintain humidity, and the lid of the incubator is 
placed carefully on top, allowing inlet and outlet tubing to rest between the top and bottom 
pieces. The incubator channel is then set to 37°C. Once the experiment is completed, the 
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channel is set to off and the gas turned off. The control box power is turned off with the 
microscope power strip. 
 
Desalter Apparatus 
Inline Filters. Inline filters have been used to prevent cellular debris escaping from the 
microfluidic device from entering the valves and column setup, where clogging is much more 
likely and problematic. Two types of inline filters are primarily used: black 0.5 μm PEEK frit inline 
filters (IDEX PN: M-120X) and natural colored 1 μm SST filter screen (IDEX PN: M-130X). 
Typically, these filters were replaced every experiment as it can be difficult to assess their level 
of occlusion. 
 
Eksigent/desalting pumps. An Eksigent Nanoflow Metering System is used to supply the 
organic-based elution solvent. The Eksigent system is capable of flowing from 10-500 nL/minute 
from each of four independent channels, all of which are gas driven by 100psi of either air or 
nitrogen. Typically the organic solvent is perfused through the desalting apparatus at 500 
nL/min. This flowrate was chosen to match the flow of the microfluidic bioreactors but also due 
to typical pressure constraints with regards to downstream columns and frits. To track this 
pressure, one must create a “Run Manager” flow profile. While this is running the pressure 
information is automatically collected and displayed on the chart on the main window of the 
Eksigent software. Maintenance and calibration must be performed routinely to ensure the 
pumps work efficiently and without the complications of air bubbles. 
 
Waters NanoAcquity UPLC pump. The NanoAcquity pump is used to perfuse the 
desalting apparatus with aqueous solvent for the purpose of rinsing the columns of salt 
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contaminants. The NanoAcquity pump is controlled through the Binary Solvent Manager portion 
of the MassLynx program and set to a flow rate of 0.9µL/min in arrangement 2.  
 
Valves. Three 10-port Nanovolume UPLC Valves with 360 μm fittings, C72MH-4690ED 
(VICI Valco Instruments Co. Inc., Houston, TX), were used. These valves connect to the computer 
through a RS-232 daisy chain cable to the “2-position actuator control module”. The “manual 
controller”, the valve itself and the power supply cable also all connect to this control module 
(see Figure C.5). It is important to note that there are different models of controller modules 
and using the incorrect part will cause torque-related valve malfunction. 
 
Columns. Columns are comprised of three components: the fused silica tubing, the 
chemically interactive silica packing phase, and the frit, which prevents the phase from escaping 
with the solvent flow. Columns are made from 360 μm OD fused silica tubing. The ID of the 
tubing is chosen based on the size of the packing phase particles that are going to be used to 
pack the column. The packing phase used in these exometabolomic experiments was 3 μm C18 
silica phase (Jupiter 3 μm C18 300 Å bulk packing phase, PN: 04A-4263, 404951-1, Phenomenex) 
and typically fused silica with 100 μm ID and 360 μm OD. Column frits are made by using the 
following protocol:  
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Figure C.5. Wiring and connection diagram for VICI/Valco/Cheminert actuated valves.  
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1. Mix 170 μL of KASIL (PQ ®KASIL® 1 Potassium Silicate Solution) and 30 μL of formamide (F9037 
SIGMA) in an Eppendorf tube. Vortex mixture. 
2. Spin mixture down for <2min at a moderate RPM in a benchtop centrifuge. Yields a semi-solid 
lower layer of unusable polymerized material, and an upper layer of mixed unpolymerized 
material. 
3. Dip pre-cut fused silica tubing into liquid upper layer for ~5-10 seconds. Liquid will rise into 
tubing due to capillary action. 
4. Remove tubing from liquid and, keeping as still as possible, bake the fritted ends under a 
heating block for >3 hours/overnight at 100°C (Setting of 4.5 (high) on the VWR analog 
heatblock). 
5. Cut frit to a few millimeters or shorter (depending on back pressure desired). Typical length for 
these experiments was a 1-2mm frit 
 
Columns are bomb loaded using a New Objective Nanobomb apparatus (New Objective PIP-500 
Pressure Injection System). The Nanobomb accepts an incoming air/nitrogen pressure of 1000 
psi to generate the necessary pressure to drive the beads into the tubing. It is not necessary to 
use ultra-pure nitrogen as the gas is only used as a pressure source. Follow standard protocol for 
the Nanobomb and always wear eye protection. 
 
Sample Loop. The sample loops in this experiment were made from fused silica tubing 
with the dimensions: 360 μm OD and 250 μm ID. This large ID allowed the sample loops to be 
much shorter. 
 
Desalter Arrangements. There are two primary valve arrangements that have been used 
to desalt a continuous bioreactor sample stream. The first arrangement is a six-step 
arrangement, as depicted in Figure C.6, which was employed for multiple years and was used for 
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collecting most the preliminary data for the system. This cycle provides a constant loading 
condition, ensuring that all analyte material in the online sample effluent is collected. In 
addition, contaminants were rinsed from the SPE columns during a purge step which is directed 
to waste. Valve cycle steps can be scaled in time uniformly to yield a cycle which is better for 
detecting high frequency oscillations (short step durations) or one which is better for detecting 
very low abundance analytes (long step durations). Figure C.7(c) outlines the valve switching 
scheme for online sample preparation. In step 1, the valve orientation was as pictured in Figure 
C.6, such that SPE column A was loaded with online sample effluent and SPE column B was 
desalting a sample plug and sending salts to waste. Valve 3 was switched such that SPE column 
A was receiving sample effluent and SPE column B was eluted and directed towards the MS for 
ion detection. Because this is the first time through the cycle, column B has not actually been 
loaded with any analytical material at this time and so this elution is blank. After this, valve 3 
was switched so that SPE column B was equilibrated with aqueous solvent in preparation for its 
subsequent loading step. SPE column A continued to load sample throughout the equilibration 
of SPE column B. Next, valve 1 was switched such that the online sample effluent was directed 
to the newly equilibrated SPE column B. SPE column A was purged with water at this step 
allowing for desalination of the sample collected on the column. Valve 2 switched and SPE 
column A was eluted with organic solvent, while SPE column B was left in the loading position. 
Lastly, valve 2 was switched to equilibrate SPE column A and the SPE apparatus started the 
entire cycle again. This cycle is depicted graphically in Figures C.7 and C.8. 
If operated with dynamically varying solvent compositions (i.e., not isocratic), solvent 
levels can be maintained such that the solvent composition reaching the detector does not 
experience predominantly aqueous or predominantly organic solvent. These changes in solvent 
composition have been observed to cause non-ideal ionization conditions at times. This solvent 
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maintenance as demonstrated in Figure C.8, can be achieved using the “Run Manager” in the 
Eksigent software. However, while trying to implement these strategies, numerous problems 
were experienced with regards to timing. Specifically, the file acquisitions system (Waters 
MassLynx) has an inherent delay between file acquisitions. Similarly, the Eksigent system has 
inherent delays between “Run Manager” profiles. These two separate delays made coordination 
of the two timing events very difficult to achieve. The two processes could be lined up to begin 
with but would eventually drift completely out of phase within a few cycles. 
This arrangement suffered from problems associated with back pressure. As aqueous 
solvent was perfused over the columns, a high back pressure, usually on the order of 2000-3000 
psi, was generated immediately preceding the columns. Because there was a direct “line of 
sight” between the SPE columns and the microfluidics, when the valves switched back to load 
from the microfluidics, this enormous back pressure plug would travel backwards and cause the 
PDMS device to delaminate from the glass cover slip. 
The second arrangement was designed in response to the frequent problems 
experienced with back pressure when using the first arrangement. This second arrangement was 
designed to ensure that the microfluidics never had a direct “line of sight” with the SPE columns. 
In Figure C.9, it can be seen that the arrangement is almost identical to the previous design 
except for the incorporation of sample loops. This addition simplified the valve switching 
scheme required by shortening it to only two steps. To explain the arrangement: sample loops, 
which were made of 360 μm OD/250 μm ID tubing, were 12.2cm long, providing a sample loop 
volume of 6 μL. The continuous sample stream was diverted into each sample loop for exactly 9 
min at 500 nL/min, thus filling the sample loop 75% of the way. Because water was always 
flowing through these sample loops immediately prior to sample flow, a plug of 1.5 μL of water 
preceded each sample effluent plug. This plug served to quickly and roughly equilibrate the   
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Figure C.6. Valve arrangement 1. This arrangement incorporated a 6-step valve cycle to achieve online 
SPE desalting. This arrangement was entirely capable of performing online desalting of a continuous 
sample stream, but suffered from back pressure problems when used for online desalting of PDMS 
bioreactor effluent.  
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Figure C.7. Stepwise depiction of the 6-step desalting method using valve arrangement 1. The top 
portion shows the valve positions during each step. The chart in the bottom portion shows a graphical 
representation of these valve positions during each step, where the number in the circle between each 
step (at the top of the chart) is indicative of which valve is switching to achieve the next step.  
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Figure C.8. Example of how valve arrangement 1 may be used in conjunction with automated varying 
flow, such as can be achieved with the Eksigent pump system.  
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column with an aqueous solvent. Once the loop was filled to 75% with online sample effluent, 
the small water plug and sample effluent were passed over the column, using the aqueous 
solvent line to generate the necessary backpressure. Once the effluent had cleared the sample 
loop and had been entirely passed over the column, an additional 2.3 min or 2.1 μL of aqueous 
solvent (H2O with 0.1% formic acid) was run over the column to serve as the rinsing/purging 
step to remove residual salts. Following the salt purge, the column was eluted with organic 
solvent (90% Methanol, 10% H2O, 0.1% formic acid). Whenever effluent was filling through a 
sample loop, the other end of the sample loop was open to a waste port. This allowed residual 
back pressure that may have been generated by the pumping of water over the columns to be 
alleviated out of the waste port instead of traveling upstream and delaminating the PDMS 
device. This cycle is depicted graphically in Figure C.10. 
Additional arrangements were conceived but never built. The first design is based on 
valve arrangement 1 except for the inclusion of an analytical column (meant to perform true 
chromatography, as opposed to SPE) immediately preceding the mass spectrometer (Fig. C.11). 
This valve has a cycle similar to valve arrangement 1 (Fig. C.12). Importantly, the solvent 
composition passing over the analytical column would range between 52.5% and 95% organic as 
indicated in Figure C.13. This arrangement could prove useful for polar compounds which may 
require more harsh highly organic elution conditions. 
Another arrangement that was designed but never built was one that was centered on 
efficient duty cycle. The basic cycle (from valve arrangement 1) contains 6 cycle steps. Only 
during two of these steps is there actually analyte material being eluted. This is due to the 
duration of the preparation process (i.e., equilibrating, eluting, rinsing). By incorporating 6 
columns one maximizes instrument analysis time (Fig C.14)  
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Figure C.9. Valve arrangement 2. This valve arrangement was a simplification of valve arrangement 1 
and negated the effects of back pressure on the microfluidics by providing a waste port to vent 
excessive pressure. This arrangement incorporated a 2-step valve switching cycle to achieve online SPE 
desalting.  
176 
 
 
 
Figure C.10. Stepwise depiction of the 2-step desalting method using valve arrangement 2. The top 
portion shows the valve positions during each step. The chart in the bottom portion shows a graphical 
representation of these valve positions during each step, where the number in the circle between each 
step (at the top of the chart) is indicative of which valve is switching to achieve the next step.  
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Figure C.11. Valve arrangement 3. Designed but never built due to the unreliable nature of the timing 
agreement between the Eksigent software and MassLynx program.  
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Figure C.12. Valve cycle steps for valve arrangement 3.  
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Figure C.13. Depiction of the solvent composition scheme for valve arrangement 3.  
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Figure C.14. A valve arrangement incorporating 6 columns. This arrangement was designed but never 
built.  
181 
 
 
Mass Spectrometry Data Acquisition 
nESI Source. The nano-electrospray ionization (nESI) source is a probe “door” for the 
Waters Synapt G2 (Fig. C.15). The nESI source can produce a sufficient spray so long as the 
incoming flow is in the range of 200nL/min to 2 μL/min. The output line of the online SPE 
desalter is connected directly to the nESI source. The incoming tube is connected with a PEEK 
fitting to a stainless steel union. The nanospray capillary connects to the other end of the union. 
This union and also the nanospray capillary are very susceptible to clogging when analyzing 
complex sample matrices such as bioreactor effluent. 
 
Sample List. Continuous collection of discrete “files” of data for processing in 
MarkerLynx is accomplished by creating a sample list within MassLynx, analogous to UPLC type 
sample collection. Each sample is a set length of continuously running analytes eluted off of the 
columns. For the medium length sample loops (12.2 cm), an 8.8 minute data file is collected, 
allowing for delay time between each sample. Analogous data file length for the long sample 
loops (24.5 cm) is 17.8 minutes. Samples are named chronologically to prevent confusion. Once 
samples are ready to be acquired, the sample list can be saved and started. 
 
Method File/Data Dependent Analysis. When performing online, real-time analyses, 
data collection can be quite onerous. In traditional discreet sample analysis, such as might be 
performed with LC or just by direct infusion, it may be customary to acquire a preliminary data 
file and search through this file to find the pertinent feature/peaks and then during a second 
acquisition, set up the instrument to fragment or better accentuate these features/peaks. When 
performing online, real-time analyses, it can be difficult to setup the instrument to collect the 
information most pertinent to your study because there is no indication of when this material  
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Figure C.15. The nESI source as it appears when the spray assembly is retracted (top) and during normal 
operating conditions (bottom).  
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will show up and it may only show up once and perhaps only for a very short period of time. For 
this reason it was quickly decided to acquire data using Data Dependent Analysis (DDA). 
MassLynx provides the option for this type of experiment in the MS method portion of the 
software. Within the DDA profile there are many options that can be used to tailor this type of 
acquisition to the experiment being performed. The DDA profile settings displayed in Table C.1 
were used for most online cellular effluent acquisitions. 
 
Mass Spectrometry Data Analysis 
Once data files are collected, they can be transferred to a data analysis computer, 
aligned through MassLynx and processed with MarkerLynx and GEDI, if desired. 
 
MassLynx Data Alignment. Data collected in the method described above does not 
correct, on-the-fly, or collect data to allow for a lock spray collection. To align the data, a peak of 
reasonable intensity and presence in all samples is chosen, commonly HEPES + Na+ (m/z = 
261.0888 Da). Data is aligned by first opening any file in the data set in Chromatogram to set the 
file path, then in the MassLynx window selecting ‘Tools’, ‘Automated Mass Measure’. In the 
AFAMM box, files desired to be aligned are double-clicked to change the red ‘ ’ to a green ‘ ’. 
‘Automatic Peak Detection’ parameters are set such that the lockspray mass is 261.0888, if 
aligning to HEPES, the mass window is +/-0.150 and background subtraction is not selected. 
Samples are then processed. Once complete an additional, centroided data file is created with 
the name as set in the ‘Automatic Peak Detection’ parameters. The sample list is then altered to 
include these new file names along with any standards that may be ideal to incorporate into the 
data processing. A method file for processing must be created within MassLynx by selecting 
‘Tools’, ‘Edit Method’. For this type of non-chromatographic data, ‘Combined Scan Range’ is   
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Table C.1. Parameters for MassLynx MS Tune DDA method file for the Synapt G2 used 
throughout chapter IV. 
 
2012_03_06_ENDERS_880_ONLINE_MS_DDA_LOCK_FILE_trapCE_50.EXP 
[ACQUISITION] [COLLISION ENERGY] 
Survey Start Time    0.00 
Survey End Time    8.80 
Using MS Auto Trap Collision Energy (eV)                    
4.000000 
Using MS Auto Transfer Collision Energy (eV)
 0.000000 
[MS SURVEY] [CONE VOLTAGE] 
 Survey Start Mass    50.0000 
Survey End Mass   
 2000.0000 
Discard uninteresting scans   NO 
Switch to MS/MS when   Intensity 
rising  
                                                                                                   above  
                                                                                                   threshold 
Intensity Threshold    15.0 
Survey Scan Time    1.000 
Survey Interscan Time   0.024 
Survey Data Format   
 Continuum 
ADC Sample Frequency (GHz)   3.0 
Survey Use Tune Page CV   YES 
MSMS CV Ramp Start Voltage   0.0 
MSMS CV Ramp End Voltage   80.0 
[INCLUDE] 
Precursor Selection    Included 
Masses Take Priority 
Use Include Masses List   YES 
Include Mass Range    600-
1200 
Use Include File Masses   NO 
Include Window +/- (mDa)   100.0 
Include Retention Time Window                     10.0 
[MS/MS] [EXCLUDE] 
MSMS Start Mass    50.0 
MSMS End Mass    2000.0 
Number of components   1 
Switchback threshold (intensity / second)                    10.0 
Use MSMS to MS Switch After Time  NO 
Use MSMS to MS Switch After 1 Scan  NO 
Use MSMS to MS Switch After N Scans  YES 
MSMS Switch After Scans   1.0 
MSMS Scan Time (sec)   1.000 
MSMS Interscan Time (sec)   0.024 
MSMS Data Format   
 Continuum 
Use MS/MS ipr File    NO 
Detected Precursor Inclusion   Using 
Real Time Exclusion 
Detected Precursor Inclusion   Include 
After Time 
Include After Time (s)    120.0 
Use Exclude Masses List   NO 
Use Exclude File Masses   NO 
Exclude Window +/- (mDa)   100.0 
FragmentationMode    CID 
[MOBILITY] 
Use Precursor Drift Times   NO 
Maintain Mobility Separation   YES 
Calibration    Dynamic 
1 
[PEAK DETECTION] 
Use Intensity based Peak Detection  YES 
Peak Detection Window   3.0 
Deisotope Peak Selection   YES 
Charge State Tolerance Window   3.0 
Charge State Extraction Window                     2.0 
Deisotope Tolerance Window   3.0 
Deisotope Extraction Window   2.0 
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selected, with a threshold of 1000 and mass tolerance of 0.05. Deisotoping of the data is not 
possible in the ‘Combined Scan Range’ feature. The method file is then saved. 
 
MarkerLynx. Once data is aligned and centroided, it can be processed with MarkerLynx 
for detection of peaks across the samples within the sample list. Data is processed by selecting 
‘MarkerLynx’ from within the MassLynx window. In the box that appears, the appropriate 
project file which contains the data set to be processed, the altered sample list, and the method 
file are selected. The output file is named, all boxes checked, and data processed (a time-
consuming process). Once the MarkerLynx file is created, samples are labeled both in terms of 
the experimental condition(s) and order of experiment for a “walking Principal Component 
Analysis (PCA)”. For statistical analysis of the data, the ‘XS’ button is selected. This creates an 
Extended Statistics report (if not already produced during the data processing). Within Extended 
Statistics, the template is changed to PCA with pareto scaling and applied. Any plot can be 
double-clicked to enter the plots and something window. Data labels are changed to reflect 
given labels and desired plots and data lists are saved for further analysis. Groups are selected 
to produce OPLS-DA plots if needed for the particular data set.  
 
Gene Expression Dynamics Identification (GEDI). If desired, data sets can be exported 
from Extended Statistics and processed with GEDI for the production of heat map style plots for 
enhanced data visualization. GEDI, along with documentation and instructions, is free for 
download. For large data sets (>16,000 columns), data cannot be copied or opened within Excel 
prior to transposition. To transpose data, it is first saved in Extended Statistics as a .dif file, and 
then opened as a new project. Within this new project area, the data can be transposed, 
selected, copied and then pasted in Excel. Once in Excel, the header is adjusted to comply with 
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GEDI input format and the file is saved as a tab delimited text file. If standards are to be 
subtracted, the data must be run as ‘Static’ even though it is dynamic data. From within GEDI, 
this file can be selected, and settings altered to those desired, typically 50 x 51 tiles, random 
seed with Pearson correlation. GEDI is then set to analyze. Once finished, averages of standards 
are calculated and subtracted from samples.  
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PERSONAL STATEMENT 
For the past five years, while at Vanderbilt University, I have worked on technological 
integration and implementation involving the use of mass spectrometry and microfluidics for 
measuring living biological systems. I am the primary graduate student on U.S. Defense Threat 
Reduction Agency grant (HDTRA-09-1-0013) which received funding in 2009 and was renewed in 
2012. I am the first author on a number of peer reviewed publications, as well as one patent 
currently under review. In my five years at Vanderbilt I have worked closely with the Searle 
Systems Biology and Bioengineering Undergraduate Research Experience (Searle SyBBURE, 
www.sybbure.org) program and have been highly involved in guiding undergraduate research 
projects, ultimately leading to publication in one such case [“Publications” #5].  
 
QUALIFICATIONS 
 Bioanalytical mass spectrometrist with strong analytical chemistry background 
 Skilled at using the following instrumentation (listed from most experienced to least): 
Waters Synapt G2 (nESI, LC, ESI, ETD, MALDI, GC), Applied Biosystems Voyager STR 
MALDI-TOF, Thermo-Finnigan LCQ, and custom ion mobility-mass spectrometer 
instrumentation made by Ionwerks 
 Performed proteomic and metabolomic analyses on various biological fluids including 
whole blood, serum, plasma, tissue homogenate, wound fluid, culture effluent, and 
heart perfusate 
 Fabricated new means of online desalting using online solid phase extraction (patent 
under review) 
 Familiar with cell culturing techniques having worked directly with primary islets and 
primary lymphocytes, as well as Jurkat cell and insulinoma Rin-m5f cell lines 
 Qualified to perform clean room UV photolithography and soft lithography of PDMS-
based microfluidic devices 
 Designed and ran experiments to quantitate metabolite levels in tissue homogenate 
samples using isotope labeled standards  for UPLC-MS 
 Implemented ICP-OES for the quantitation of salts and protein in samples 
 Adept at utilizing Waters MassLynx and MarkerLynx line of programs 
 Proficient in html, php, and flash and familiar with javascript for developing and 
maintaining websites and online databases 
 Skilled at AutoCAD (2009, 2010, 2011), and SIMION 8 
 Experienced in setting up and maintaining server computers for data storage and/or 
website/data hosting 
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EDUCATION 
 Vanderbilt University, Nashville, TN 
 Ph.D., Chemistry, August, 2012 
 Mentor: John A. McLean 
 Concentration: Coupling real time ion mobility-mass spectrometry to online bioreactor 
microfluidics, solid phase extraction 
 
Drexel University, Philadelphia, PA 
B.S./M.S. Dual Degree, Chemistry, Graduated June, 2007 
 Advisor: Kevin G. Owens 
 Senior project: Microwave assisted strong acid digestion of proteins 
  
EXPERIENCE 
 Graduate research, Vanderbilt University, Nashville, TN   
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o Built an integrated platform to combine cell-trapping microfluidics with ion 
mobility-mass spectrometry in an online fashion 
o Designed new means of online solid phase extraction (SPE) for sampling 
secreted materials from a cellular bioreactor 
o Fabricated PDMS microfluidic devices using photolithography and soft 
lithography and cultured various cell lines to be placed in these devices 
 Chemist, PQ Corporation, Exploratory research department, Conshohocken, PA  
Mar 2004-Sept 2005 
o Performed medium scale batch autoclave synthesis of inorganic titanium silicate 
zeolites using multiple autoclaves and pressure microwave reactors 
o Analyzed/interpreted products using FTIR spectroscopy analysis, DTA, particle 
size distribution analysis, X-ray diffraction, X-ray fluorescence spectroscopy, gas 
sorption, and Raman/UV spectroscopy 
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 David Hercules Fellowship Award, Vanderbilt University (2007) 
 Anthony J. Drexel Academic Scholarship, Drexel University (2002-2007) 
 Admitted into the Honors Program, Drexel University (2002) 
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1. Christina C. Marasco, Jeffrey R. Enders, Kevin T. Seale, John A. McLean, John P. Wikswo. 
Real-Time Cellular Exometabolome Analysis with a Microfluidic-Mass Spectrometry 
Platform. In preparation for submission to PLoS One. 
 
2. Jeffrey R. Enders, Christina C. Marasco, John P. Wikswo, John A. McLean. A Dual-Column 
Solid Phase Extraction Strategy for Online Collection and Preparation of Continuously 
Flowing Effluent Streams for Mass Spectrometry. Submitted to Analytical Chemistry. 
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by Ion Mobility-Mass Spectrometry”. Invited chapter for inclusion in Encyclopedia of 
Analytical Chemistry, Robert Myers and David Muddiman, Eds., John Wiley & Sons, Ltd. 
In press. 
 
4. Jeffrey R. Enders, Cody R. Goodwin, Christina C. Marasco, Kevin T. Seale, John P. 
Wikswo, and John A. McLean, Advanced structural mass spectrometry for systems 
biology: Pulling the needles from haystacks, Current Trends in Mass Spectrometry, July 
2011, pgs. 18-23. 
 
5. Jeffrey R. Enders, Michal Kliman, Sevugarajan Sundarapandian, John A. McLean, 
“Peptide and Protein Analysis using Ion Mobility-Mass Spectrometry”. Invited chapter 
for inclusion in Protein and Peptide Mass Spectrometry in Drug Discovery, Michael 
Gross, Ben Pramanik, Guodong Chen eds. John Wiley & Sons, 2011, chapter 6. 
 
6. Jeffrey R. Enders, Christina C. Marasco, Ayeeshik Kole, Bao Nguyen, Sevugarajan 
Sundarapandian, Kevin T. Seale, John P. Wikswo, and John A. McLean, “Towards 
monitoring real-time cellular response using an integrated microfluidics-MALDI/nESI-ion 
mobility-mass spectrometry platform”, IET Systems Biology 2010, 4 (6):416-427. 
 
7. John A. McLean, Larissa S. Fenn, and Jeffrey R. Enders. “Structurally Selective Imaging 
Mass Spectrometry by Imaging Ion Mobility-Mass Spectrometry”. Invited chapter for 
inclusion in Mass Spectrometric Imaging: History, Fundamentals and Protocols, Methods 
in Molecular Biology Series, Jonathan Sweedler and Stanislav Rubakhin, eds. Humana 
Press, 2010, pgs.363-383. 
 
8. Jeffrey R. Enders, John A. McLean, “Chiral and Structural Analysis of Biomolecules Using 
Mass Spectrometry and Ion Mobility-Mass Spectrometry”, Chirality 2009, 21:S253-S264. 
 
INVITED TALKS 
 “Strategies and Challenges in Dynamic Systems Biology Analysis Using Structural Mass 
Spectrometry”,  in Ion Mobility MS Workshop on Applying Ion Mobility-Mass 
Spectrometry to Challenges in Proteomics and Systems Biology American Society for 
Mass Spectrometry Annual Conference, Vancouver, BC Canada (May 2012) 
 
 “Microfluidic-ion mobility-mass spectrometry for assessing cellular response in real 
time”, Quantitative Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM 
(August 2009) 
 
 “Development of a Platform for Online Analysis of the Metabolic Footprint”, The 
Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) Annual 
Conference, San Diego, CA (January 2012) 
 
PRESENTATIONS 
1. Jeffrey R. Enders; Christina Marasco; Kevin Seale; John Wikswo; John A. Mclean, Online 
analysis of a constant-perfusion cell culture microfluidic device for exometabolomic 
measurements, 60th American Society for Mass Spectrometry Annual Conference, 
Vancouver, BC (May 2012). 
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2. Jeffrey R. Enders, Christina Marasco, Cody Goodwin, Jody May, Kevin Seale, John 
Wikswo and John A. McLean, A Microfluidic-Ion Mobility-Mass Spectrometry Platform 
for Presymptomatic Diagnoses of CBW Agent Exposure, 2011 Chemical and Biological 
Defense Science and Technology Conference, Las Vegas, NV (November 2011) 
 
3. Jeffrey R. Enders, Christina Marasco, Cody Goodwin, Jody May, Kevin Seale, John 
Wikswo and John A. McLean, Development of a Platform for Online Acquisition of 
Empirical Systems Biology Data, 5th Annual Conference on Cellular Information 
Processing (q-bio), Santa Fe, NM (August 10-14, 2011). 
 
4. Jeffrey R. Enders, Christina Marasco, Cody Goodwin, Jody May, Kevin Seale, John 
Wikswo and John A. McLean, Microfluidic-Coupled Ion Mobility-Mass Spectrometry 
Platform for Real-Time, Temporally-Resolved Analysis of Excreted Cellular Materials, 
59th American Society for Mass Spectrometry Annual Conference, Denver, Co (June 
2011). 
 
5. Jeffrey R. Enders, Cody Goodwin, Christina Marasco, Jody May, Kevin Seale, John 
Wikswo, John McLean. Temporal Analysis of Biological Fluid for the Analysis of Cellular 
Signaling and Response Using Ion Mobility-mass Spectrometry Analyses. Chemical and 
Biological Defense Science & Technology conference, Orlando, FL (November 2010). 
 
6. John McLean, Jeffrey Enders, Jody May, Kevin Seale, John Wikswo. Advanced Structural 
Mass Spectrometry for Systems Biology – Towards Presymptomatic Diagnosis of Threat 
Agent Exposure . Chemical and Biological Defense Science & Technology conference, 
Orlando, FL (November 2010). 
 
7. Jody May, Jeffrey R. Enders, Sevugarajan Sundarapandian, Kevin Seale, John Wikswo, 
and John A. McLean. Development of a Multiplexed (8-Channel) Ion Mobility-Mass 
Spectrometer Chemical Analyzer for Rapid Interrogation of Biochemical Response . 
Chemical and Biological Defense Science & Technology conference, Orlando, FL 
(November 2010). 
 
8. Jeffrey R. Enders, Christina Marasco, Cody Goodwin, Kevin Seale, John Wikswo, John 
McLean. Characterizing the Saccharomyces cerevisiae respiratory oscillation 
exometabolome by ion mobility-mass spectrometry. Quantitative Understanding in 
Biology (q-bio) Annual Conference, Santa Fe, NM (August 2010). 
 
9. Jody May, Sevugarajan Sundarapandian, Jeffrey R. Enders, Kevin T. Seale, John P. 
Wikswo, and John A. McLean. Development of a Multi-Channel Ion Mobility-Mass 
Spectrometer for High-Throughput Interrogation of Cellular Response. Quantitative 
Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM (August 2010). 
 
10. Christina Marasco, Jeffrey Enders, Kevin Seale, John McLean, John Wikswo. Investigating 
Leukocyte Dynamic Response to Stimuli in an Integrated Microfluidic-Ion Mobility-Mass 
Spectrometer Quantitative Understanding in Biology (q-bio) Annual Conference, Santa 
Fe, NM (August 2010). 
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11. Jody C. May; Jeffrey R. Enders; Sevugarajan Sundarapandian; Kevin T. Seale; John P. 
Wikswo; John A. Mclean, High-Throughput Ion Mobility-Mass Spectrometry Strategies 
for Monitoring Cellular Response in Real Time, 58th Annual American Society for Mass 
Spectrometry Annual Conference, Salt Lake City, UT (May 2010). 
 
12. Jeffrey R. Enders, Sevugarajan Sundarapandian, Kevin Seale, John P. Wikswo, John A. 
McLean, Measuring real-time cellular responses to chemical and biological warfare 
agents using structural mass spectrometry techniques, Chemical and Biological Defense 
Science and Technology (CBD S&T) Conference, Dallas, TX (November 2009) 
 
13. Jeffrey R. Enders, Sevugarajan Sundarapandian, Kevin Seale, John P. Wikswo, John A. 
McLean, Real time analysis of cell signaling and response using microfluidic cell 
trapping-ion mobility-mass spectrometry, Federation of Analytical Chemistry and 
Spectroscopy Societies conference, Louisville, KY (October 2009) 
 
14. Jeffrey R. Enders, Sevugarajan Sundarapandian, Ayeeshik Kole, Bao Nguyen, Kevin Seale, 
John P. Wikswo, John A. McLean, Microfluidic-ion mobility-mass spectrometry for 
assessing cellular response in real time, Quantitative Understanding in Biology (q-bio) 
Annual Conference, Santa Fe, NM (August 2009) 
 
15. Jeffrey R. Enders, Sevugarajan Sundarapandian, Kevin Seale, John P. Wikswo, John A. 
McLean, Combining microfluidic cell trapping with real time monitoring of biomolecular 
exudates by ion mobility-mass spectrometry, American Society for Mass Spectrometry 
Annual Conference, Philadelphia, PA (June 2009) 
 
16. Jeffrey R. Enders, Sevugarajan Sundarapandian, Kevin Seale, John P. Wikswo, John A. 
McLean, Dynamic Biomolecular Measurements of Cellular Response by Ion Mobility-
Mass Spectrometry: a New Strategy for Systems Biology, Southeast Regional Meeting of 
the American Chemical Society, Nashville, TN (November 2008) 
 
17. Jeffrey R. Enders; Larissa S. Fenn, Michael F. Aldersley; James P. Ferris; Prakash C. Joshi; 
John A. Mclean; Dmitri Zagorevski, Ion Mobility Mass Spectrometry of the products of 
oligomerization of activated nucleotides with Montmorillonite, 4rd Annual Meeting of 
the Vanderbilt Institute for Chemical Biology, Nashville, TN (August 2008) 
 
18. Jeffrey R. Enders; Larissa S. Fenn, Michael F. Aldersley; James P. Ferris; Prakash C. Joshi; 
John A. Mclean; Dmitri Zagorevski, Ion Mobility Mass Spectrometry of the products of 
oligomerization of activated nucleotides with Montmorillonite, American Society for 
Mass Spectrometry Annual Conference, Denver, CO (June 2008) 
 
PROFESSIONAL MEMBERSHIPS 
 The Society for Applied Spectroscopy  
 The Coblentz Society 
 The American Society for Mass Spectrometry 
 The American Chemical Society 
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TEACHING EXPERIENCE 
 Teaching Assistant, August 2007 – June 2008, August 2008 – December 2008, August-
September 2009 
Vanderbilt University, Department of Chemistry 
